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Abstract 
Healthcare associated infections (HCAIs) are a large and growing problem. 
Bacterial infections of patients and on the medical devices used to treat 
them represent a significant source of morbidity and mortality. There is also 
a significant economical impact to the healthcare system attributed to 
HCAIs. While bacterial infections per se are not a novel problem, the 
discovery of an adherent polymicrobial phenotype called a biofilm is. A 
biofilm is defined by its structure and the community of bacteria therein. 
This study investigated bacteria biofilms in a number of pertinent clinical 
scenarios. To achieve this, samples were taken from five different but 
related clinical areas where biofilms are known to infect or are suspected to, 
namely endotracheal tubes, tracheostomy tubes, burn wounds, chronic 
wounds and chronic wound dressings. Samples were analysed using 
microbiological and molecular analysis techniques, the latter included 
polymerase chain reactions, species-specific PCR and denaturing gradient 
gel electrophoresis to assess microbial diversity. Fluorescent in-situ 
hybridization was used subsequently to analyse species orientation and 
biofilm structure within the biofilm. This study showed a diverse bacterial 
population in all the samples, with the presence of oral biota in the ETT 
specimens, changing to commensal bacteria over time. Large three-
dimensional biofilm structures were present in the specimens confirming 
the presence of biofilms, and within one of the chronic wound dressings 
where a complex biofilm was visible within the matrix of the dressing itself. 
These findings have considerable significance clinically, not only in 
demonstrating the need for biofilm targeted diagnostic techniques, but also 
in highlighting the need for specific biofilm treatment modalities in critical 
care, burn services and chronic wound management. 
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Chapter 1: Introduction 
 
Biomedical sciences are constantly evolving often with the aim of 
improving patient outcomes and promoting efficiency at reduced fiscal 
outlay.  One area into which research and health promotion initiatives are 
focussed is that of healthcare-acquired or associated infections (HCAIs). 
There is a wealth of media coverage both abroad and in the United 
Kingdom regarding commonly acquired or difficult to manage organisms 
such as Meticillin Resistant Staphylococcus aureus (MRSA) or Escherichia 
coli (Boyce et al., 2009). The topic of HCAI is an especially emotive one, 
and one that is often quickly highlighted in the media. In the modern era 
many elective operations are seen as routine, yet the introduction of HCAI 
into this environment turns a routine procedure into a potentially life-
threatening one; a recent meta-analysis by Hu et al (2011) shows that 
infection of total knee joint replacement prostheses is still the most common 
complication in this type of surgery. The advent of the antibiotic era was 
meant to herald an end to bacterial infection as a significant source of 
mortality, yet the main advances in promoting life-expectancy have come 
from epidemiological interventions, from hand-washing in labour wards to 
improvements in sanitation and vaccination. Even as mankind once felt it 
was on the verge of eradicating malaria, so resistant forms of the 
Plasmodium falciparum parasite begin to predominate. Similarly wherever 
antibiotics are employed, bacterial resistance emerges. The debate on where 
the fault lies with the creation of antibiotic resistance continues. Some 
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theories place the blame with the food industry, for regular prophylactic 
administration of antibiotics to poultry to prevent the large scale financial 
disaster resulting in an untamed respiratory infection spreading within the 
broiler industry (Hughes et al., 2008). 
Other theories feel that over-dispensation of antibiotics in Primary Care 
medicine is at fault, that the relatively quick and easy solution to manage a 
self-limiting viral illness with a prescription of entirely unnecessary 
antimicrobials is providing an evolutionary selection pressure which favours 
antimicrobial resistance (Gonzales et al., 1997). A recent study performed 
at Intensive Care Units in Havana, Cuba by Medell et al. (2012) showed 
moderate to very high resistance by Acinetobacter spp. Pseudomonas spp. 
and Klebsiellas spp. to almost all modern antibiotics including meropenem, 
aztreonam, and pipercillin/tazobactam (Medell et al., 2012) and they 
concluded that the liberal use of these agents as preventative therapy was 
actively inducing resistance in these species. However, while it easy to 
suggest preventing General Practitioners or farmers from using antibiotics 
in an injudicious manner, in an Intensive Care setting where patient survival 
may depend on rapid application of an antimicrobial based on empirical or 
best-guess reasoning it is not so clear or easy to propose a dogmatic 
restriction on antibiotic prescription.  
Rapid emergence of bacterial resistance to antibiotics is not a modern 
phenomenon however; while Alexander Fleming (1881-1955) is said to 
have discovered Penicillin in 1928, by the Normandy landings in June 1944 
there had been only 2.3 million doses of Penicillin manufactured, yet the 
first reports of antibiotic resistance were being published within two years 
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of that date (Dowling et al., 1946). While it is often portrayed as an arms 
race between mankind and bacteria, it is felt by many that eventually we 
will be unable to come up with new antibiotics, or we will remain unwilling 
to save them until the situation is dire enough. This leads us on to the 
question of alternative strategies that may be employed.  
Where Semmelweiss introduced hand-washing by medical students in the 
labour ward, and Mussolini advocated the drainage of swamp land to reduce 
the incidence of malaria (Hite and Hinton 1998) so current studies of 
microbial species are also being undertaken looking at the nature and 
pathology of bacterial species. Current clinical initiatives such as the 
National Hand Hygiene NHS Campaign (Health Protection Scotland, 2007) 
aiming to decrease transmission of fomites, or the MRSA pre-admission 
screening policy operated by many NHS trusts to decrease the spread of 
MRSA (Department of Health, 2006) illustrate that new solutions to 
microbial infections are being sought. Clinical and laboratory based studies 
form another important aspect of the current research agenda in this area; a 
key aspect of this agenda is to develop a deeper understanding of the life-
cycle of bacteria.  
Recently it has become clear that 19
th
 century theories on the nature of 
bacteria only consider one phenotype, that of the planktonic or free floating 
cells.  With the advances made in the latter half of the 20th century such as 
scanning electron microscopy and molecular analysis techniques including 
polymerase chain reaction (PCR) technology, newer theories regarding 
bacterial phenotypes emerged. Transmission electron microscopy was 
introduced by Ernst Ruska in 1931, and by 1939 Piekarski and Ruska had 
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published pictures of bacterial flagellae (Linke, 2011). The subsequent use 
of scanning electron microscopy in the 1950s allowed closer examination of 
bacterial morphology, and theories regarding bacterial evolution and their 
familial relationships could be expounded (Bartlett 1967). 
It has become clear that many microorganisms have evolved to protect 
themselves, usually as a response to adverse conditions, by being able to 
encase themselves in a complex matrix called a biofilm. Biofilms were first 
recognised in some marine species of microorganisms, which could adhere 
to and grow on surfaces in communities (Zobell 1943; O‟Toole et al., 
2000).  The relevance of this became apparent when it was recognised that 
organisms were growing in micro-colonies within the biofilms, of their own 
making (Costerton et al., 1978), as stable and adherent phenotypes 
(Lawrence et al., 1991); this approach is very different to the concept of 
free-floating planktonic forms noted by van Leeuwenhoek, Pasteur and 
Lister as the cause of spoilt wine and surgical infection.  One current 
definition of a biofilm is that of „a surface-associated microbial community, 
that is composed of various phenotypes and commonly various genotypes, 
which encases itself in a three dimensional matrix of extracellular polymeric 
substances (polysaccharides, nucleic acids, proteins) and demonstrates 
increased resistance to cellular and chemical attack‟ (Thomas 2008).  
Current research is centred on the study of biofilms and bacteria in this 
stable phenotype form (Percival and Cutting 2009), principally because in 
this state, bacteria are resistant to both host defences and antimicrobials 
(antibiotics and antiseptics). This may be, in part, why bacterial biofilms are 
so topical and relevant in the arena of chronic wounds and wound-healing; 
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being uniquely placed at the interface between host defences, trying to heal 
the wound intrinsically and antimicrobial wound therapies, trying to heal 
the wound extrinsically. 
The term biofilm remains poorly understood and, although they do exist in 
open chronic wounds healing by secondary intention, the commonly seen 
„slimy‟ appearance on the surface may be mistaken for a biofilm. It is 
usually only when infection is overt and progressive that organisms can be 
cultured from simple swab specimens; it is difficult to mimic the conditions 
that some microorganisms exist in within biofilms in the laboratory setting 
(Munson et al., 2002). It is felt that biofilms may have quiescent periods 
and acute exacerbations, and infection in a surgical wound or related to an 
implanted prosthesis, such as a hip replacement or vascular graft, may be 
delayed or concealed by a biofilm. The acute exacerbations may be 
successfully treated by clinicians using antibiotics, but the biofilm nidus is 
not resolved (Costerton, 2005). This often causes the initial diagnosis to be 
missed or incorrectly assessed leading to delay in patient therapy and a 
subsequent increase in morbidity (Nayeemudin et al. 2008, Nadeem and 
Hadden 1999). The treatment of infected or exposed (and therefore 
presumably colonised) prostheses of all types remains debatable.  
When breast implants have been used for augmentation procedures and 
have become infected, multiple different strategies have been attempted to 
salvage the prosthesis including antibiotic therapy, debridement, curettage, 
pulse lavage, capsulectomy, device exchange, primary closure, and/or flap 
coverage with varying degrees of success (Spear et al., 2004). In the case of 
infected knee arthroplasty prostheses, which have the potential to be 
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significantly more debilitating for the patients, early infections may be 
treated in such a way as to allow retention of the primary prosthesis, using 
antibiotics and vigorous surgical debridement. However prosthetic 
infections that occur late (i.e. after 30 days of initial implantation), and may 
therefore be indicative of a biofilm infection, necessitate the removal of the 
prosthesis and a two-stage reconstruction at significant risk and morbidity to 
the patient (Hanssen, 2002).  
The incidence of prosthetic joint infection has been estimated at 1 to 3%, 
with a small but significant number of these cases remaining negative on 
standard microbiological culture due in part to the presence of the abiotic 
matrix which forms part of the biofilm (Peel et al., 2011). The matrix of a 
biofilm is not only protective but allows communication between different 
bacterial species, by a process known as quorum sensing, and even transfer 
of plasmid-DNA. Aerobic Gram-negative bacilli in particular are able to 
attach to surfaces by pili or flagella and are resistant to adverse conditions 
(Canals et al., 2006; Toutain et al., 2007; Jagnow and Clegg 2003; O‟Toole 
et al., 1998). In addition, biofilms have a three-dimensional structure and an 
increased surface area, which allows absorption of nutrients through built in 
water channels. 
Aside from medical interest, biofilms have been found extensively in water-
treatment facilities and, for example, ice cream factories face a constant 
battle to keep the luminal surfaces of their pipes free of biofilms (Gunduz 
and Tuncel, 2006). Biofilms have been recognised for a long time in dental 
plaque, often containing fungal elements as well as common oral pathogens 
such as Streptococcus mutans and Porphyromonas gingivalis (Le Magrex et 
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al., 1993; Bowden and Hamilton, 1998).  Biofilms have also been 
associated with medical devices as diverse as contact lenses, breast 
implants, urinary catheters and hip prostheses (Costerton et al., 2005; 
Weisbarth et al., 2007; Kuhn and Ghannoum, 2004). 
Biofilms therefore have the potential to have a significant impact on patient 
care, and both clinical and microbiological research is now directed at 
elucidating the makeup and pathogenicity of bacterial biofilms and 
subsequently how to diagnose and treat them.  
This study will look at the scope of the problem of HCAIs within the critical 
care environment as well as in the arena of chronic wound healing and 
provide an up to date review of biofilm literature, their composition, life-
cycle and pathogenic traits.  The research itself will focus on diagnosing the 
presence of a bacterial biofilm, elucidating the different bacterial 
populations within a biofilm and their orientation to each other within 
medical devices used in critical care, on burn and chronic wounds, and 
within dressings used in the management of chronic wounds.  This will be 
done using different techniques including standard microbial cultural 
analysis, DNA analysis, both species-specific PCR and denaturing gradient 
gel electrophoresis, and finally using confocal laser scanning microscopy to 
delineate the structure of a bacterial biofilm. 
The overall aim of this study was to examine bacterial biofilms in a clinical 
context, especially as pertaining to healthcare-acquired infections and those 
on medical devices.  A specific objective of the study was to evaluate 
different methodologies for the identification and and quantification of 
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bacterial biofilms, and also to compare the performance of these different 
methodologies across a range of different clinical samples. 
The first clinical setting selected was that of endotracheal tubes (ETTs).  
These devices are in contact with a known biofilm forming area (the oral 
cavity) and have also been shown to have a role in healthcare-acquired 
infections such as ventilator associated pneumonia (VAP).  It was then 
decided that evaluation of tracheostomy tubes could provide deeper insights 
into the evolution and ecology of biofilms within the cannulated airway. 
Tracheostomy tubes are sited within the airway and give rise to VAP but are 
not in direct contact with the oral cavity.  Any oral bacteria found in these 
samples would have to either come from previous inoculation of the airway 
by the endotracheal tubes, or migrate from the lungs or oral cavity. Since 
the tracheostomies would be coming from burn injured patients, the third set 
of samples chosen to be examined were those of burn wounds themselves.  
Although not from the same patients, burn injured tissue is known to be a 
harbinger of infection, and the detrimental role of bacteria in burn wound 
healing is well known.  This deleterious effect of bacterial colonisation on 
burn wound healing is mirrored in the delayed healing of chronic wounds, 
especially those heavily contaminated by bacteria, presumably in the 
biofilm form.  
These different sample types have a common theme of healthcare-
associated infection running through them, and by using cultural, molecular 
and structural analysis techniques the role of bacterial biofilms in these 
HCAIs may be assessed.  Finally, to elucidate whether information about 
biofilms may be obtained using non-invasive or destructive techniques, it 
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was decided to assess and examine the dressings of chronic wound patients 
to investigate whether dressing analysis might be used as a surrogate in the 
diagnosis of biofilm infections. 
Current methods of attempting to diagnose biofilm infections involve the 
use of painful debridement and biopsy techniques to physically disrupt the 
biofilm (methods that are unpleasant and unpopular with patients), or 
expensive ultrasonication of the biofilm to disrupt the abiotic matrix, 
causing damage to the architecture, while at the same time being too 
expensive or sophisticated for routine everyday use. The concept of a 
surrogate dressing to mirror the biofilm on a wound may provide a simple 
and painless method of biofilm diagnosis. 
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Chapter 2: Literature Review 
Introduction 
Healthcare-Associated Infections 
Infection has been a problem for mankind since its inception.  Evidence of 
Brucellosis destruction of spinal vertebrae has been identified in the 
vertebrae of Australopithecus africanus (a prehistoric ancestor of man) and 
is considered to be between 1.5 to 2.8 million years old (D‟Anastasio et al., 
2009).  This infection was thought to have been contracted from the 
consumption of infected meat products, as indicated by nearby animal 
bones which had been scored by human-like canines and incisors.  By the 
19
th
 century, a clearer understanding of infection, and post-operative sepsis 
was beginning to form.  Semmelweiss (1858) noted the high levels of post-
puerperal sepsis in patients treated by medical students contaminated by 
„cadaverous particles‟ and instituted hand washing techniques, lowering 
mortality from 18.3% to 1.2% in just two months, although it should be 
noted pregnant women themselves had long been aware that it was more 
hazardous to deliver on a medical student led ward, than a midwife-led 
ward.  Subsequently, Joseph Lister (1867) became aware of the need to try 
and control infection in injuries, and famously instituted the use of carbolic 
acid as pre-operative skin prep and described the use of antiseptic dressings 
in attempts to control infection, usually in the post-operative period. 
Healthcare-associated infections (HCAIs) are infections acquired by contact 
with healthcare services, devices or staff.  Every year at least 300,000 
patients develop an HCAI and it is estimated that around 1 in 10 patients 
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acquire an infection during their stay in a UK hospital (HCAI Research 
Network, 2009).  This has a significant impact on the care of patients, their 
outcomes and their subsequent morbidity.  HCAIs are a leading cause of 
death in United States health care settings, with an overall estimated annual 
incidence of 1.7 million (Welsh et al., 2011).  A recent Scottish study 
showed an increase in HCAIs with a linear relationship to age; in the most 
elderly groups (75-84 and 84+ years) the commonest type of infection was 
urinary and gastro-intestinal, but in under 75s year-olds, surgical site 
infection represented the largest healthcare burden (Cairns et al., 2011). 
HCAIs have received widespread attention in recent times in both the media 
and in healthcare settings, with those caused by „superbugs‟ such as 
Meticillin Resistant Staphylococcus aureus (MRSA) and Clostridium 
difficile, a particular focus of attention.  The national mandatory reporting 
system for surveilling MRSA rates has been in place since 2006.  Between 
2006 to 2009 there were 4404 cases of MRSA bacteraemia reported in 
England, approximately one third of these cases suggested a probable 
source of the infection, of these 20% were related to the use of intravascular 
devices and a further 28% to skin and soft-tissue infections (Wilson et al., 
2011).  However, other bacterial species are actually the primary causes of 
the majority of HCAIs ranging from infections acquired in the highly 
interventionist areas of healthcare, such as Intensive Care Units (ICUs) and 
Burn ICUs through to chronic wounds such as venous leg ulcers (VLUs), 
which are often managed in the community.   
Infection in patients being treated in ICUs can have a significant effect on 
the patient, including increased mortality (Malacarne et al., 2010).  Not only 
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is there the potential for the patient to develop an infection as a direct 
consequence of their existing condition, but the possibility also exists for 
the medical devices used to treat them to introduce infection (Eisenberg, 
2009).  This, in turn, causes increased mortality, morbidity and increased 
incidence of device failure.  In addition to the detrimental effect on the 
health of the patient, the failure of medical devices is a source of significant 
additional expenditure to the healthcare provider.  One study from New 
Zealand estimated the cost of a healthcare associated bloodstream infection 
as being between $11,000 and $20,000 per patient per episode (Burns et al., 
2010). 
The insertion of peripheral venous cannulae is associated with local risks 
such as haematoma formation or extravasation injury, but these risks are 
magnified when the device is being replaced (Lepor and Maydeen, 2009).  
The same applies for a central line or airway management device, such as 
an endotracheal tube (ETT) or tracheostomy tube.  Even replacement of 
something as seemingly benign as a urinary catheter has been implicated in 
prostatic damage, and of course, the introduction of infection and sepsis 
(Syed et al., 2009).  It is thought the use of urinary catheters is a likely point 
of entry into the blood stream for nosocomial fungal infection by Candida 
albicans (Tiraboschi et al., 2000), with the mortality from candidaemia 
being greater than 40% (MacPhail et al., 2002).  Fungal infection in an 
Italian ITU showed a healthcare-associated infection rate from mycoses as 
high as 10.08 per 1000 admissions with C. albicans infection rates shown to 
be as high as 60% of those infections; 77% of these occurred in surgical 
patients (Tortorano et al., 2011). 
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A recent Polish study, showed that device-associated healthcare-associated 
infections (DA-HCAIs) in ITU patients caused a significantly longer stay in 
ITU; compared with an average stay of 6.9 days, those with central-line 
associated bloodstream infection stayed for 10.0 days, those with VAP 15.5 
days and those with catheter-associated urinary tract infection stayed on 
average for 15.0 days (Kubler et al., 2011).  There is a wide variation of 
reported incidence rates of DA-HCAI but one study showed rates in a 
paediatric and neonatal ICU of up to 15.5% (Duenas et al., 2011).  Indeed, 
it has been shown that the presence of a centrally placed indwelling venous 
catheter is an independent risk factor for the conversion of nosocomial 
MRSA colonisation into a MRSA HCAI (Harinstein et al., 2011).  Central 
line associated infections have a reported mortality of between 12 and 25% 
(Centers for Disease Control and Prevention, 2011). 
The same device-related problems exist for burn injured patients, but these 
are coupled with the (usually) extensive burn wound, which also frequently 
becomes infected.  Burns Units along with Intensive Care Units have the 
highest rates of HCAI, cited as up to 34% in some cases (Lahsaeizadeh et 
al., 2008).  Burn sepsis is still the leading cause of mortality in burn-injured 
patients (Wang et al., 2009) and control of bacterial colonisation of these 
wounds is of paramount importance; however, it has been shown that the 
presence of healthcare-associated blood stream infections has a significant 
effect on the duration of hospitalisation of burn injured patients (Brusselaers 
et al., 2010). 
Chronic wounds, such as venous leg ulcers(VLUs) or Pressure Ulcers 
(PUs),are defined as wounds that have failed to proceed through an orderly 
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and timely reparative process to produce anatomic and functional integrity 
over a period of three months (Mustoe et al., 2006); these wounds often 
provide an area where bacteria are able to grow and even thrive.  As a 
consequence, these wounds are predisposed to recurrent incidents of 
infections, and delayed wound healing.   
Chronic wounds are a major cause of morbidity, affecting more than 1% of 
the population and with treatment costs of at least £2-3 billion per year in 
the UK and $25billion in the USA (Sen et al. 2009; Thomas and Harding, 
2002).  The impact of infected wounds on a patient should not be 
underestimated.  Pain and subsequent lack of sleep, and overpowering 
odour along with delayed wound healing are a few of the complications of 
infection that patients cope with on a daily basis (Price and Harding, 1996; 
Ebbeskog and Ekman, 2001).  The combat of infection in such patients is 
often a prime objective of wound management strategies (Price 2005; 
Edwards 2009).  A significant delay in wound healing may occur with a 
contaminated or infected wound (Robson, 1997), and the number of bacteria 
present is directly related to the success of wound healing strategies (Krizek 
and Davis, 1967; Robson and Heggers, 1969).  There is no clear theory as to 
why this happens but it is felt that the relative hypoxia within a chronic 
wound may be compounded by the presence of bacteria, which causes an 
impaired migratory response from the keratinocytes present leading to a 
delay in wound healing (Xia et al., 2001). Another theory is that the healing 
wound is damaged through the host‟s attempt to combat the bacteria, since 
the lysozymal enzymes released into the wound environment equally 
damage host tissue as well as microbial contaminants (Glaros and Larsen, 
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2009).  It is felt that the bacteria/host interaction within the wound induces a 
chronic inflammation, and this causes a subsequent delay in wound healing 
(Rhoads et al., 2008).  Despite this, the majority of wounds will heal if the 
underlying cause is treated, i.e. the VLU will heal if treated with 
compression therapy or the diabetic ulcer will heal if off-loaded (Kirketerp-
Moller et al., 2011). It should, also be mentioned that wound healing can 
still occur even in the presence of bacterial contamination (Krizek and 
Robson, 1975). 
It is, however, becoming increasingly clear that the current concepts of 
infection are flawed.  While Louis Pasteur (1822-1895) identified bacteria 
growing within a broth, and Leeuwenhoek‟s (1632-1723) free-floating 
„animalcules‟ led microbiological theories down a ‟free-floating‟ or 
planktonic train of thought, it now appears that a more persistent and 
adherent part of the bacterial life cycle exists.  Specific bacterial 
phenotypes, which instead of behaving like free-floating plankton, exist in a 
semi-permanent adherent colony; these have become known as biofilms.   
It is now accepted that many bacteria exist within a biofilm for the majority 
of their existence.  Certain adherent species, such as Streptococcus 
viridians, the bacterium often responsible for bacterial endocarditis, are 
recognised by clinicians (Cunha et al., 2010).  This may be in part due to 
the relative ease of diagnosing bacterial „vegetations‟ on diseased mitral 
valves, using echocardiography, and due to the significant complications 
that bacterial embolisation from the valve leaflets can cause.  However, S. 
viridians is a notable exception, and many other bacterial biofilm-related 
infections are poorly understood or recognised in the clinical context.  A 
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recent study by the Center for Disease Control (CDC) in the USA estimated 
that approximately 80% of HCAIs are due to a biofilm related infection and 
it is here that modern research is now focused (Gristina and Costerton, 
1984; Percival and Cutting, 2009. 
 
Biofilms 
In 1943 it was reported that the preference of some marine bacterial species 
was to adhere to, and grow on, surfaces (Zobell, 1943).  The implication of 
such adherent bacteria often encased within a matrix material did not 
become apparent until 1991, when living organisms were identified growing 
in micro-colonies within these biofilms (Lawrence, 1991).  O‟Toole et al. 
(2000) subsequently defined biofilms as communities of surface attached 
organisms.  Therefore, a currently accepted definition of a biofilm is one of 
„a polymicrobial community of adherent organisms within an extracellular 
polysaccharide matrix, of their own making‟ (Costerton et al., 1999). This 
definition was subsequently further expanded to: 
A surface-associated microbial community that is composed of 
various phenotypes and commonly various genotypes, which 
encases itself in a 3-dimensional matrix of extracellular polymeric 
substances (EPS; e.g.  polysaccharides, nucleic acids and proteins) 
and demonstrates increased resistance to cellular and chemical 
attack (Thomas, 2008).  
This definition reflects the complexity of the composition and functions of a 
biofilm and incorporates its potential to resist various treatment modalities.   
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In order to understand why biofilms are so problematic in the healthcare 
setting, as well as within the water treatment and food preparation 
industries, we need to recognise why biofilms are resistant to removal by 
host defences and administered therapeutics, and also to identify potential 
therapeutic targets.  To do this we first need to understand the dynamics of a 
biofilm population from its inception, to its eventual break-up and 
dispersion. 
 
Biofilm formation 
 
Microbial adherence 
The adherence of microorganisms to a surface, be it in the lumen of a 
medical device or on a eukaryotic surface, is the critical first step required 
in the formation of a biofilm.  Adherence may be divided into primary or 
secondary adhesion or may be classified according to the host surface: for 
example, the biomaterial of a medical device or host tissue in a wound bed. 
The first stage of adherence involves the microorganisms coming into 
contact with a surface to which they can adhere.  This may occur randomly 
(as is the case for bacteria being buffeted along in an airflow stream within 
an ETT), it may occur as a result of contamination (e.g., a hip prosthesis 
making contact with the patient‟s skin during insertion), or as a result of 
bacterial motility.  Certain bacteria such as Aeromonas, Pseudomonas and 
Klebsiella spp. are all noted for their pili and flagella (Jagnow and Clegg, 
2003; Canals et al., 2006; Toutain et al., 2007) and enhanced motile 
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capacity.  It is not surprising therefore that Pseudomonas aeruginosa is 
reported as being able to attach and form biofilms under almost any 
conditions that allow its growth (O'Toole, 1998). 
Primary adhesion depends upon the net effect of repulsive and attractive 
forces being attractive.  The hydrophobicity of bacteria, especially oral 
bacteria, is known to be a key element in their binding to coated surfaces 
(George and Kishen, 2007).  Oral bacteria bind to salivary glycoproteins, 
collectively known as the salivary pellicle (Gibbons and Etherden, 1983).  It 
is thought that it is these types of conditioning films, which allow the 
bacteria to overcome the physico-chemical forces acting at the interface 
between microbial and host surfaces.  These forces include electrostatic and 
hydrophobic interactions, steric hindrance, van der Waals forces and 
hydrodynamic forces (An, 2000).  Electrostatic charges tend to militate 
against attachment due to the overall net negative charge of both the 
bacteria and biological surfaces, meaning hydrophobic attraction is a more 
crucial element (Carpentier, 1993).  This phenomenon is outlined by the 
Derjaguin, Landau, Verwey and Overbeek (DVLO) theory, which describes 
particle adherence within a colloid (Geoghegan et al., 2008).  It is best 
thought of as two particles moving towards each other.  There is a double 
layer repulsive force acting on the two particles that attempts to keep them 
separate, yet if they can come together with sufficient energy to overcome 
the repulsive force, and then they will bind strongly and irreversibly 
together (Figure 1). 
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Figure 1: Derjaguin, Landau, Verwey and Overbeek theory, showing that a 
certain amount of net energy is required to overcome the repulsive force, 
but which then allows binding within a colloid. Reproduced from 
www.malvern.com 
The attachment of bacteria to a surface is also dependent on surface factors.  
These include the conditioning of the surface, whereby an initial protein or 
glycoprotein layer is laid down.  The most commonly used example of this 
is the covering of dental enamel by saliva, thus forming the salivary pellicle, 
where agglutinin or other proteins within saliva, allow the initial attachment 
phase to occur.  Bacterial factors are also heavily implicated in the initial 
adherence step, where the expression of bacterial adhesion molecules, 
called adhesins, can play a vital role.  For example, Streptococcus mutans 
has a specific surface protein adhesin (P1), which has a specific binding 
domain on it for the purpose of interacting and binding to immobilized and 
fluid phase salivary agglutinin (Crowley et al., 1993).  The initial „net 
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repulsion‟ between cells and surfaces can be overcome by covalent 
molecular binding mechanisms and it is these „adhesins‟ which are 
responsible for both secondary adhesion and primary adhesion to eukaryotic 
surfaces (Bos, 1999).  However, the progress from the single planktonic 
phenotype which has adhered to a surface to a mature polymicrobial biofilm 
is not clear; Hodl et al. (2011) have proposed that there is an initial 
clustering of planktonic bacteria which occurs in a non-random pattern, and 
they feel this clustering and progression to early biofilm formation is 
mediated by various biotic interactions and the role of adhesins. 
Adhesins have been identified for different bacterial species (Table 1) and 
examples include the fimbrial component H (FimH) for E. coli and the cell 
surface protein antigen I/II (Ag I/II) for S. mutans (Hajishengallis, 1992; 
Schembri and Klemm, 2001).  A key adhesin associated with S. aureus is a 
polymer of β-1,6-linked N-acetylglucosamine, called polysaccharide 
intercellular adhesion (PIA; Gotz, 2002).  It is also clear that the exact 
mechanism is not clear, and that certain pathological strains may exhibit one 
or more adhesin type molecules; a recent study in America, showed 
enteropathic strains of E. coli expressed only certain adhesions, namely the 
E. coli common pilus (ECP), but not other known adhesins such as the 
haemorrhagic coli pilus (HCP) and E. coli laminin-binding fimbriae (ELF) 
as was expected (Hernandes et al., 2011). The authors felt that these 
findings indicate that these strains bear several pili operons that could 
potentially be expressed in different niches favouring colonization and 
survival in and outside the host. Spurbeck and colleagues showed that one 
subtype of E. coli responsible for pyelonephritis carried operons for 12 
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different fimbriae and that the genes responsible for these were significantly 
more frequently expressed in those strains responsible for infection 
compared to human commensal strains (Spurbeck et al., 2011).  Conversely, 
however, a recent Israeli study suggest that the initial adherence step for 
Mycoplasma pneumoniae is solely mediated via the interaction of the tip of 
its organelle with sialic residues of serum glycoproteins (Kornspan et al., 
2011) possibly mediated by only one or two operons, although this was 
solely an in vitro study and may add credence to the theory that many of 
these factors are environmental or exogenous.  Indeed the American Center 
Species Name Adhesin Name Shorthand 
Nomenclature 
Reference 
Escherichia coli 
 
Fimbrial 
component 
Fim H Hajishengallis 
1992 
Streptococcus 
mutans 
Antigen I/II Ag I/II Schembril and 
Klemm 2001 
Staphylococcus 
aureus 
B,1-6-linked N-
acetyl 
glucosamine 
PIA Gotz 2002 
Streptococcus 
pyogenes 
Protein F PrtF Okada 1998 
Neisseria 
gonorrhoeae 
N-methylphenyl 
alanine pili 
T4 pili Swanson  1973 
Pseudomonas 
aeruginosa 
Pseudomonas 
aeruginosa 
lectin 
PA-IL Boteva 2005 
 
Table 1: A table showing a selection of adhesin molecules associated with 
bacterial interaction with host surfaces which may be associated with initial 
adherence steps. 
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for Meat Safety and Quality showed that E. coli attachment to beef-contact 
surfaces was influenced by the type of soiling and temperature. 
Interestingly, attachment occurred not only at a temperature representative 
of beef fabrication areas during non-production hours (15°C), but also 
during cold storage (4°C) temperature, suggesting current procedures may 
not be adequate (Dourou et al., 2011). 
Orgad et al. (2011) showed that as well as genetic variation between strains 
being responsible for alginate production and biofilm thickness in P. 
aeruginosa strains, local concentrations of calcium and elevated ionic 
strength of the biofilm affected adherence and steric hindrance. Adhesins, 
therefore, have an additional role beyond that of the initial adherence phase.  
Many adhesins or fimbrial pili are coded for on genes that appear to have 
multiple functions which influence general virulence; for example, the 
MP65 gene expressed in C. albicans as well as having a role in adherence, 
exhibits increased cell wall stability and biofilm formation compared to an 
MP65 mutant strain (Sandini et al., 2011). This co-coding of virulence 
factors on certain genes is seen in S. epidermidis with the CcpA gene 
(Sadykov et al., 2011) and the Yad and Ygi genes in E. coli coding for 
motility, adherence, biofilm formation and in vivo fitness respectively 
(Spurbeck et al., 2011). Biofilms also use adhesins in a role referred to as 
steric cohesion, and this involves the addition of polymers to the colloid to 
overcome net repulsive forces, to keep the biofilm stable and prevent 
flocculation or „flaking off‟ of parts of the biofilm.  However, flocculation 
in biofilms is an essential part of their life-cycle, allowing the bacteria to 
disperse and colonise elsewhere. 
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Biofilm dispersal 
 
Dispersal or detachment is an important part of the biofilm „life-cycle‟ and 
represents a return to the free-floating or planktonic state for some of the 
biofilm bacteria (Kierek-Pearson, 2005).  Different definitions are applied 
to different forms of detachment, sloughing is where large portions of the 
biofilm itself detaches (Stoodley, 2001), compared with the release of free 
swimming cells, which is called erosion (Kierek-Pearson, 2005).  Erosion 
may be responsible for the dispersal of bacteria within a flow-system, such 
as in endotracheal or tracheostomy tube sited in an airway.  It has been 
shown the free swimming bacteria revert to a planktonic mode of growth, 
and therefore the „life cycle‟ can turn full circle (Sauer et al., 2002).  
However, these types of dispersal mechanisms were generally thought of as 
passive processes, occurring as a result of shear forces and other 
environmental factors acting on the biofilm surface (Purevdorj et al., 2005).  
Only more recently has it become clear that dispersal is the result of an 
active process.   
Biofilm dispersal is multi-faceted and a necessary modulation of the biofilm 
architecture and population for many different reasons.  Living within a 
surface-associated multicellular biofilm has disadvantages, as well as 
advantages.  Growth is restricted and the rate of bacterial DNA transcription 
resembles that of stationary phase cells (Waite et al., 2005).  Another of the 
disadvantages of bacteria cohabiting within a biofilm matrix assembly is an 
inability to move easily, either to more advantageous locations or to escape 
a hostile environment.  This is seen in the Barraud and Hassett study in 
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2006, where nitric oxide was shown to initiate biofilm dispersal and inhibit 
biofilm aggregation, even at levels insufficient to be bactericidal (Barraud et 
al., 2006) indicating a possible therapeutic role for nitric oxide in the 
management of biofilm infections.  Nitric oxide was also found to sensitise 
the bacteria, so that they were vulnerable to concentrations of 
antimicrobials, which would not previously have been bactericidal.  This 
potent effect of nitric oxide may be due, in part, to the fact that it is an 
endogenous product of anaerobic metabolism (Ren et al., 2008), and 
therefore may represent an indicator of an impending hostile environment. 
It is, also, one of the methods that host defences fight infection. Nitric oxide 
has been shown to be used by phagocytes to kill bacteria, which have been 
ingested intracellularly (Forslund and Sundqvist, 1997), but also, that 
phagocytic activity increases in the presence of increased concentrations of 
nitric oxide (Zagryazhskaya et al., 2010). Interestingly, some species have 
developed mechanisms to try to counteract intracellular antimicrobial 
activity to survive even after being phagocytosed (Fernández-Arenas et al., 
2009). 
The regulation of adhesin synthesis could govern the cohesion and 
attachment of bacteria in biofilms (Thormann et al., 2006), but this would 
depend on environmental erosion factors to actively decrease the size of the 
biofilm in the face of adverse circumstances.  Alternatively the oral 
pathogen Aggregatibacter actinomycetemcomitans secretes a hydrolytic 
enzyme that cleaves poly-β-1,6-N-acetyl-D-glucosamine, which is a 
polysaccharide adhesin common to many species (Itoh et al., 2005).  It may 
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therefore be that stasis of biofilm mass is dependent on two balanced 
competing forces, one for cohesion and one for disaggregation.   
Detachment has been shown to be crucial in the shaping of the 
morphological features and structure of mature biofilms (Picioreanu et al., 
2001), which adds weight to the concept that detachment is integral to the 
function and behaviour of biofilms in general.  This may be further fine-
tuned for biofilm streamlining, as exhibited by P. aeruginosa biofilms 
existing within a flow system.  Here the biofilm produces surfactants to 
remove some of the surface attached cells to further model the three-
dimensional architecture, in effect, to make the biofilm itself more 
aerodynamic (Davey et al., 2003), which would be advantageous if the 
biofilm was, for example, existing within a patient‟s airway.   
Some biofilms can exhibit quite dramatic and devastating incidences of 
disaggregation; most notably the P.  aeruginosa „seeding‟ dispersal.  This 
tends to occur in ageing P.  aeruginosa biofilm biofilms, where internal 
microcolonies undergo disintegration leaving behind voids within the 
ageing biofilm (Purevdorj-Gage et al., 2005).  Seeding dispersal is caused 
by mediators released by the bacteria in anaerobic environments.  This form 
of dispersal is often associated with a period of cell death as the biofilm 
attempts to lose some of its dependent bacteria, however, among the 
bacteria released, viable cells are also present that can generate new 
colonies elsewhere (Sauer et al., 2004).  A similar migratory behaviour is 
exhibited by S.  mutans populations where the agglutinin specific adhesin 
P1 can be lysed by surface protein-releasing enzyme (SPRE) allowing the 
bacteria to detach from the pellicle to move to a less inhospitable site (Vats 
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and Lee 2000, Lee et al., 1996). The marine bacteria Bacillus licheniformis 
has been shown to produce a powerful supernatant containing an 
extracellular DNase which rapidly breaks down the biofilms of both Gram-
positive and Gram-negative bacteria; the authors hypothesise that this 
product not only disperses establish biofilms but also acts to prevent the 
formation of new competing biofilms (Nijland et al., 2010). Similarly the 
BdcA gene which had previously been shown to mediate dispersal of E. coli 
biofilms has been found to increase dispersal in other bacterial biofilms, 
including P. fluorescens and Rhizobium meliloti (Ma et al., 2011). 
The ability to trigger biofilm dispersal either through targeting cell-to-cell 
signalling apparatus or by using exogenous glycoproteins that hold the 
biofilm together, such as using SPRE, may prove to be important 
therapeutic tools to use against microorganisms that exist within a three-
dimensional biofilm.  When nutritional limitation or other unfavourable 
environmental factors limit further biofilm development in a given site 
(O'Toole et al., 2000), it is felt that Quorum Sensing (QS) plays a role in 
detachment and dispersal. 
 
Quorum sensing 
 
Quorum sensing (QS) is the mechanism by which microorganisms within a 
biofilm recognise environmental changes and react to them, by the 
expression of certain genes only when a sufficiently high cell concentration 
has been reached (Fuqua et al., 1996). This phenomenon is common to both 
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Gram-positive and Gram-negative bacteria using cell signalling to 
coordinate biofilm activity (Davies and Geesey, 1995).  As the biofilm 
develops, sufficient numbers of bacteria produce the signalling molecules to 
generate a required response, by expressing specific sets of genes (De 
Lancey Pulcini, 2001).   
QS systems generally consist of a four component circuit; e.g., a LuxI-type 
signal synthase, a N-acylhomoserine lactone (AHL) signal molecule, a 
LuxR-type signal receptor, and the target gene (Atkinson et al., 1999).  The 
signal synthase enzyme synthesizes the AHL signal molecule at a constant 
low basal rate.  As the bacterial population increases, so does the 
concentration of AHL in the environment as it diffuses from the growing 
cells.  At a threshold local AHL concentration the signal receptor is 
triggered, to modulate the expression of the QS regulated genes (Hentzer et 
al., 2003a) (Figure 2). Some QS pathways are subject to positive feedback, 
or auto-induction loops to allow a rapid and ever increasing production of 
signal molecules, in response to environmental stimuli, or a „critical mass‟ 
of bacteria numbers.  It has been postulated that this may be used to 
overwhelm host immunity (Donabedian, 2003).  The biofilm essentially is 
stable until it has sufficiently high numbers of bacteria that lead to 
modulation of virulence genes, greatly increasing the biofilm‟s chances of 
inducing an infection, allowing increased bacterial reproduction and 
enhanced spread (Hentzer et al., 2003b).  Similarly, the light producing 
bacteria Vibrio harveyi and Vibrio fischeri do not emit light unless they 
detect a high enough concentration of their own AHL (Gray and Garey, 
2001). 
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Figure 2. A  pictorial schematic of Quorum sensing, showing that as 
bacterial concentration increases, so does concentration of AHL eventually 
reaching sufficiently high concentrations to trigger the target gene. 
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This suggests each bacterium‟s behaviour is affected by the presence of its 
own kind, and in sufficient numbers, in this case to make generating light 
worthwhile (Donabedian, 2003).   
As well as mediating light production, or virulence factors, QS has been 
implicated as having a role in biofilm formation, structure and motility.  
Rapid motility or swarming of bacteria has been identified as being QS 
dependent in Serratia liquefaciens (Morohoshi et al., 2007).  Here the QS 
system is based around an N-butanoyl-L-homoserine lactone (BHL), which 
is also seen in Aeromonas hydrophilia biofilms in the gut of the common 
leech (Swift et al., 1997).   
As well as bioluminescence, virulence and motility, QS has also been 
shown to play a role in controlling metabolic rate in Rhizobium 
leguminosarum.  In the case of the latter, expression of growth factor 
inhibitors occurs under conditions of carbon and nitrogen starvation, which 
serve to protect the biofilm in times of nutritional limitation (Thorne and 
Williams, 1999). 
QS also has a role in biofilm defence mechanisms.  For example, the plant 
pathogen Erwinia carotovora produces the antibiotic carbapenem under the 
influence of N-(3-oxohexanoyl)-L-homoserine lactone (OHHL) (Bainton et 
al., 1992) and Pseudomonas aureofaciens produces phenazine antifungals 
via an N-hexanoyl-L-homoserine lactone (HHL) dependent QS circuit 
(Wood et al., 1997). These give the biofilm enhanced defence capabilities 
against competing bacterial or fungal species.  Atkinson et al. (1999) 
showed that a more complicated hierarchical QS system was involved in the 
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motility and clumping of Yersinia pseudotuberculosis, where an interactive 
regulatory cascade was able to respond to at least three different AHLs to 
affect secretion, motility, flagellin expression and morphology.  A study by 
Davies et al.  (1998) shows that the QS molecules produced by some Gram-
negative bacteria, called acyl-homoserine lactones (HSLs), are responsible 
for modulating biofilm architecture.  When the genes responsible for this 
molecule are „knocked-out‟ of mutant strains of P.  aeruginosa, they 
produce biofilms that lack the characteristic towers and water channels 
(Davies, 1998).  Furthermore, the addition of HSL to a Pseudomonas 
fluorescens biofilm culture resulted in a significant increase in the biofilm 
mass and density of the extracellular polysaccharide matrix (Allison et al., 
1998). A table summarising QS molecules which are mediated through gene 
regulation is included below (Table 2). 
Targeting of these QS systems for clinical reasons is called Quorum 
Quenching (QQ). This involves the specific targeting of a QS system, such 
as that linked to dispersal, to treat a biofilm infection, or to be used in 
conjunction with antimicrobials to make them more efficacious. By April 
2012, 45 patents had been filed for QQ agents and this number is increasing 
(Romero et al., 2012). 
Specific QQ agents would be able to prevent dispersal or aggregation within 
a biofilm, and this would clearly have a clinical benefit, in preventing the 
spread of bacterial infections throughout a patient, for example.
31 
 
 
Table 2: A selection of known Quorum Sensing (QS) molecules present in 
different bacterial populations and the genes and virulence factors they 
trigger; adapted and abridged from: Eberl, L. et al. 1999
Bacterium Primary 
Signal 
Molecules 
Regulatory 
proteins 
AHL regulated properties 
Aeromonas 
hydrophilia 
BHL,  HHL AhyI/AhyR Unknown 
Agrobacterium 
tumefaciens 
OOHL TraI/TraR Ti plasmid conjugal transfer 
Burkholderia 
cepacia 
OHL CepI/CepR Protease, lipase, and ornibactin 
synthesis 
Chromobacterium 
violaceum 
HHL Unknown Production of violacein pigment, 
exoproducts 
Erwinia cartovora OHHL ExpI/ExpR-CarR Carbapenem antibiotic synthesis 
Pantoea stewartii OHHL EsaI/EsaR Extracellular polysaccharide capsule, 
virulence factors 
Photobacterium 
fischerii 
OHHL, OHL LuxI/LuxR Bioluminescence 
Pseudomonas 
aeruginosa 
OdHL, BHL LasI/LasR, 
RhiI/RhiR 
Extracellular virulence factors, 
biofilm formation, rhamnolipid 
synthesis, twitching motility 
Pseudomonas 
aureofaciens 
HHL PhzI/PhzR Phenazine antibiotics 
Ralsontia 
solanacearum 
HHL,  OHL SolI/SolR Unknown 
Rhizobium etli AHL RaiI/RaiR Root nodulation 
Rhodobacter 
sphaeroides 
7,8-cis-tDHL CerI/CerR Clumping factor 
Serratia 
liquefaciens 
BHL,  HHL SwrI/SwrR Swarming motility, serrawettin W2 
synthesis 
Vibrio 
anguillarum 
ODHL VanI/VanR Unknown 
Vibrio harveyi HBHL LuxM/LuxN-
LuxU-LuxO 
Bioluminescence, 
polyhydroxybutyrate synthesis 
Yersinia 
enterocolitica 
OHHL, HHL YenI/YenR unknown 
Yersinia 
pseudotuberculosis 
? YspI/YspR Motility, morphology 
Xenorabdus 
nematophilus 
HBHL Unknown virulence 
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Extracellular Polysaccharide Matrix 
 
Extracellular Polysaccharide Matrix (EPS) constitutes 85% of the biofilm, 
with only 15% of the volume due to microorganisms (De Beer, 1994).  
Polysaccharide Intercellular Adhesin molecule (PIA) produced by S. aureus 
an important molecule in S.  aureus biofilm formation, not only because it 
forms the basis of the matrix within which the staphylococci are embedded, 
but also for its role in promoting adherence (Costerton et al., 2005).  
Synthesis of PIA is fundamental in terms of biofilm accumulation, because 
it ensures cell to cell adhesion of proliferating cells (Cramton, 1999).   
Exopolysaccharides are divided into two main groups, 
homopolysaccharides and heteropolysaccharides (Sutherland, 2001); the 
difference being the makeup of each type, of exopolysaccharide.  
Homopolysaccharides consist of one monosaccharide molecule that is 
constantly repeated, whereas heteropolysaccharides are made up of large 
and different polysaccharide molecules (Pereira et al., 2009).   
Exopolysaccharide structure can vary significantly between biofilms 
produced by different bacterial species.  Such differences occur not only in 
non-sugar aspects such as lactate, glycerol, acetate and phosphate (De Vuyst 
et al., 2001), but also the carbohydrate compounds can contain varying 
amounts of acetylated amino sugars (Girard and Schaffer-Lequart, 2007). 
While the composition of bacterial exopolysaccharides varies between 
species, it also differs with surrounding environmental factors, such as 
nutrient availability and bacterial growth phase (De Vuyst and De Geest, 
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1999; Panhota et al., 2007; Fischer et al., 2003).  An understanding of the 
structure of various exopolysaccharides, is considered necessary to predict 
their physicochemical properties (De Philippis and Vincenzini, 1998).  For 
example, certain biopolymers have been shown to have rheological 
properties, affecting viscosity, and may therefore be integral to the colloidal 
structure of biofilms (Sutherland, 1996).  It is felt that the resistance of 
many bacterial biofilm species is due in part, to the poor antibiotic 
penetration through the EPS (Sutherland, 2001), and a mature biofilm 
exhibits significantly increased resistance to antimicrobial agents when 
compared with its planktonic counterparts (Jefferson, 2004).   
Mechanically, the biofilm matrix allows bacteria to thrive in hostile 
environments, such as those encountered in device related infections such as 
in heart pacemakers and haemodialysis catheters (Costerton, 1999).  Indeed, 
electron micrographs of these devices show layers of bacteria embedded 
within the matrix (Marrie, 1982; Marrie and Costerton, 1983).  In addition 
to the mechanical resistance shown by these biofilms, the matrix protects 
the bacteria from dehydration, phagocytosis, antibody recognition and viral 
lysis (Pereira et al., 2009).   
The actual composition of the EPS matrix also allows bacteria to survive in 
hostile conditions, with species of cyanobacteria living within sand dunes 
and secreting UV-screen pigments (Bohm et al., 1995).  In addition, a 
number of cyanobacteria have been shown to be able to survive virtually 
without water, secreting both internal and external polysaccharides, which 
help to stabilize not only the external cell wall, but also internal 
macromolecular structures (Grilli Caiola et al., 1993). 
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Microscopic imaging of biofilms using confocal scanning laser microscopy 
(CLSM) can reveal the structural complexity of a biofilm, with mushroom-
like towers and water channels throughout (Stoodley, 1994; Figure 3).  As 
the biofilm matures it develops into a heterogeneous structure interspersed 
with channels which allows nutrients and gaseous access to the deepest 
parts of the biofilm, as well as waste removal (De Lancey Pulcini, 2001).  
The heterogeneity of the biofilm allows different bacteria to exist within it, 
or even the same species to exist in different physiological states, for 
example in a Pseudomonas biofilm, some bacteria may be living in aerobic 
conditions while at lower oxygen concentrations, some will be living in 
anaerobic conditions (Xu, 1998). Until recently it had been assumed that 
diffusion of nutrients throughout a biofilm was constant, and various 
mathematical models had been proposed to describe it, however a recent 
paper by Van Wey et al. (2012) showed that diffusion within a biofilm is 
often depth dependent and not isotropic as previously thought, with 
enhanced diffusion within horizontal layers of the biofilm to offset the 
decreased diffusion through the horizontal layers of the biofilm (Van Wey 
et al., 2012). These environmental differences within the biofilm allow for 
many separate „microenvironments‟ to co-exist within the same matrix, and 
as a result different bacterial phenotypes can co-exist to the extent that 
antimicrobial uptake will vary in different areas of the biofilm based on 
bacterial metabolic rate (Stewart, 1994a; Stewart 1994b; Anderl, 2000).
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Figure 3: A stylised picture of biofilm development (Costeron and Stewart 2001), showing initial adherence and biofilm 
colonisation, subsequent biofilm growth, and maturation. There is also a diagrammatic representation of how the surface flora 
of a biofilm may be added to or altered by the addition of further bacterial numbers. 
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Biofilm resistance to antimicrobials and host defences 
 
With the variation in bacterial metabolic rate evident within the biofilm, 
there is logically a variation in the effect of growth dependent antibiotics 
within the biofilm (Anderl, 2000) which, coupled with the impedance of the 
biofilm to antibiotic penetration, make the biofilm innately resistant to 
many antibiotics.  For example, quinolones have poor biofilm penetration 
while glycopeptide or lipopeptide antibiotics (such as vancomycin or 
daptomycin) exhibit good penetration of staphylococcal biofilm matrices 
(Dunne, 1993; Stewart, 2009).  This may explain the high prevalence of 
ciprofloxacin resistance exhibited by pseudomonads in chronic wounds 
(Howell-Jones, 2005).  However, some studies have shown that most 
antibiotics diffuse freely across the biofilm (Shigeta, 1997), and that the 
biofilm matrix should not impede the diffusion of the small antibiotic 
molecules (Stewart, 1998) or that once the biofilm is saturated free diffusion 
could follow (Walters, 2003).  Yet even where bactericidal concentrations 
are reached, bacterial biofilms remain resistant to killing (Darouiche, 1994), 
suggesting other mechanisms are responsible for the increased resistance 
seen in biofilm phenotypes (Hoyle, 1991).  The use of daptomycin is a 
common treatment for MRSA, however, in biofilm models, such as 
implant-associated infection, a concentration of 500 µg/ml failed to kill 
adherent bacteria, when previously a concentration of 0.625µg/ml killed 
planktonic bacteria (John et al., 2011).  Notably, however, when calcium 
ions were increased to a physiological concentration, bactericidal activity 
was enhanced and prevention levels rose to almost 60% of normal.  
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Periplasmic sequestration of antibiotics by bacteria within a biofilm has 
been shown to reduce antibiotic efficacy by preventing the antibiotic 
reached its target site (Mah and O‟Toole 2001).  Analysis of the genetics of 
antibiotic resistant forms of P. aeruginosa, which can still form biofilm 
architecture, reveals the presence of the ndvB locus.  This encodes for a 
periplasmic glucan which interacts physically with the antibiotic and these 
glucose polymers prevent the antimicrobials reaching their target, and 
sequester the antibiotics periplasmically (Mah, 2003).  Antifungal resistant 
strains of Candida albicans have been shown to exist in biofilm form, but 
also interestingly in the absence of the specific antifungal (fluconazole), the 
antifungal sensitive strain of C. albicans was a much more virulent biofilm 
former and responsible for greater mortality in a mouse model, suggesting 
adaption to survival in different environments (Schulz et al., 2011), but also 
that the genetic resistance prevalent in biofilms is not solely a survival 
benefit. 
A further hypothesis extended from the decreased metabolism theories is 
that of the existence of persister cells within the biofilm (Moker et al., 
2010).  This is based on the observations that even when 99% of a bacterial 
population is killed by minimum doses of bacteriocides, the remaining 1% 
of cells survive even in the face of greatly increased concentrations (Keren 
et al., 2004), this may be due to a highly resistant phenotype, analogous to 
microbial spores (Stewart 1998; Lewis 2001).  It is felt that the ability of 
bacteria to recolonise seemingly clean wounds, and the presence of 
multidrug tolerant biofilms can be explained by the theory of persister cells, 
and their ability to enter a dormant or non-dividing state (Lewis 2007). 
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Persister cells are also postulated to produce specific endogenous proteins 
which can turn off vulnerable areas of their metabolism.  For example, 
glycopeptide antibiotics target translation within a metabolically active 
bacterium, and it has been shown that E. coli encodes for toxins such as 
ReIE, which will inhibit its own protein translation (Lewis 2005).  It may be 
said, therefore, the persister cells are cells which altruistically forego 
propagation in order to ensure biofilm survival. 
Additionally, the close proximity of bacteria within a biofilm 
microenvironment provides an excellent milieu for horizontal transfer of 
resistance genes.  This, coupled with the accumulated density of mobile 
genetic elements from the variety of phenotypes present, means the biofilm 
state is an excellent environment in which to spread antibiotic resistance 
(Costerton et al., 2005).   
Horizontal transfer of mobile genetic elements, or conjugation between 
different species of Pseudomonas has been shown to be significantly 
increased in biofilms compared with planktonic cells (Ehlers, 1999).  
Conjugation is an important mechanism by which resistance is spread 
through bacterial populations (Gehring et al., 2009).  A number of 
environmental factors, including antibiotic exposure, and water and nutrient 
availability, can affect the frequency of conjugation (Johnsen and Kroer, 
2007).  These factors are all influenced by biofilm formation, and their 
relative resistance to penetration by antimicrobial agents, and the formation 
of water channels within the EPS.  There is experimental evidence to show 
that the use of antibiotics against a bacterial population will actually 
promote the horizontal transfer of mobile genetic elements responsible for 
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resistance between individuals within a bacterial population (Showsh and 
Andrews, 1992; Sorensen et al., 2005).  The polymicrobial biofilms 
favoured by oral and intestinal bacteria favour horizontal gene transfer, 
using transposons or plasmids, to enhance virulence of normally 
apathogenic strains both within and between species (Hausner, 1999; 
Roberts, 1999), and allows bacteria such as enterococci, which are already 
inherently resistant to several antibiotics (Fabretti, 2005), to gain resistance 
to newer antibiotics such as vancomycin and teicoplanin (Leclercq, 1988; 
de Allori et al., 2006). 
Biofilm cells are also resistant against host defences such as neutrophils 
which eliminate bacteria by ingestion and the production of antimicrobial 
peptides (AMPs; Otto, 2006).  However, there is increasing evidence that 
bacteria within biofilms are able to evade neutrophils (Leid, 2002) and 
protect themselves from phagocytosis (Jesaitis, 2003).  Additionally, the 
EPS present in staphylococcal biofilms protects the bacteria from the action 
of AMPs possibly due to the cationic nature of the EPS repelling the 
positively charged AMPs (Otto 2006).  The PIA may play a similar 
protective role in impeding the activity of positively charged 
aminoglycoside antibiotics (Kierek-Pearson, 2005). The N-acyl homoserine 
lactone QS produced by P.  aeruginosa signals for the production of 
virulence factors such as rhamnolipids, which have been shown in vitro to 
eliminate neutrophils (van Gennip et al., 2009). Indeed, examination of two 
different Streptococcus pneumoniae strains showed an increased ability of 
the biofilm forming strain to create EPS and also to translocate to the lungs 
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and brains of mice, suggesting extracellular matrix formation enhances the 
ability of pneumococci to cause disease (Trappetti et al., 2011).  
Biofilms involved in ‘healthcare associated infections’ 
Biofilms on medical devices 
Biofilms have been shown to exist on the surfaces on a diverse array of 
medical devices including contact lenses, breast implants and urinary 
catheters (Table 3) (Nickel, et al., 1989; Garcia-Saenz et al., 2002; Reiger et 
al. 2009; Costerton et al., 2005).  The presence of biofilms on medical 
devices can have significant implications for patient care.  Not only do such 
biofilms cause increased rates of device failure necessitating the removal 
and possible replacement of the device with an increased risk to the 
patients, but their presence also increases the financial burden on the health 
care system (Bayston et al., 2007).  Furthermore, the presence of biofilms 
within medical devices also predisposes the patient to infections at other 
distal body sites such as septicaemias, urinary sepsis and pneumonia 
(Hussain, et al., 1993; Hustinx and Verbrugh, 1994; Bauer, et al., 2002; Di 
Filippo and De Gaudio, 2003). 
 
Biofilms on endotracheal tubes (ETTs) 
 
Endotracheal tubes are often used in the management of patients receiving 
intensive care.  The ETT is inserted into the patient‟s trachea usually 
through the oral cavity and is then secured in place with an inflatable 
balloon (Figure 4).  The tube essentially closes off the alimentary tract from  
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Figure 4: Endotracheal tube (clinical specimen number 7) with arrow 
denoting inflatable balloon cuff at most distal end, there is a port at the 
most proximal end of the tube for inflating and deflating this ballon, 
and an adapter to allow the tube to be connected to the air circuit. Of 
additional note is the heavy soiling in the centre of the tube, at the point 
of maximum flexion, which most likely is an amalgamation of mucus, 
saliva and biofilm.  
 
 
Device Organism Reference 
Urethral catheter 
 
Uropathogenic E. coli Nickel et al. 1989 
Contact lenses 
 
S. epidermidis Garcia-Saenz et al.2002 
Breast implants S. aureus, 
Propionbacterium acnes 
Reiger et al.2009 
Hip implant 
 
S. maltophilia Trampuz  2007 
Table 3: Table showing commonly colonised medical devices, the bacteria 
found therein and the reference of the paper which first described it. 
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the patient‟s airway and this serves two functions; 1) it protects the patient‟s 
airway from aspiration of their gastric contents, and 2) it allows mechanical 
ventilation of the patient through a relatively robust and secure airway.  
ETTs, therefore, tend to be used in patients who are unable to maintain and 
protect their own airway, for example if they are unconscious, or if they 
require increased respiratory support, for example in pneumonia or other 
inflammatory lung conditions.  
Complications associated with ETT insertion may be due to the initial 
procedure, cannulation of the oesophagus, or impaction of the tube on the 
tracheal wall.  Certain complications relate to the length of intubation, such 
as VAP or tracheal stenosis or tracheomalacia (Divatia, 2005; Table 4).   
The incidence of VAP varies between 30.67 and 15.87 per 1000 ventilator 
days in a tertiary care facility (Joseph et al., 2009).  VAP is a significant 
cause of mortality in intubated patients (Chastre and Fagon, 2002) and 
biofilms within the ETT are heavily implicated in VAP (Sottile et al., 1986; 
Adair et al., 1999; Ramirez et al., 2007).   
Many bacterial species along with fungi of the genus Candida have been 
identified within the lumen of ETTs with species such as Staphylococcus 
epidermidis, Klebsiella spp., P. aeruginosa and S. aureus (Adair et al., 
1999; Feldman et al., 1999; Bauer et al., 2002; Boddicker et al., 2006; Ader 
et al., 2008) frequently encountered.  Enteric bacteria have also been 
isolated (Adair et al., 1999), as have other Gram-negative bacterial species  
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Complications of Endotracheal Tube Insertion 
At the time of Intubation While ETT is in-situ 
Failed Intubation Tension pneumothorax 
Spinal cord injury Pulmonary aspiration 
Occlusion of central artery/blindness Airway obstruction 
Corneal abrasion Disconnection 
Orofacial trauma Dislodgement 
Noxious autonomic reflexes Fire 
Hypertension, tachycardia, bradycardia 
and arrhythmia 
Unsatisfactory seal 
Raised intracranial and intraocular 
pressure 
Leaky Circuits 
Laryngospasm Swallowed ETT 
Bronchospasm Tracheomalacia 
Laryngeal Trauma Stenosis 
Cord avulsions, fractures and 
dislocation of arytenoids 
Ventilator Associated Pneumonia 
Airway perforation  
Airway, oesophageal trauma  
Oesophageal intubation  
Bronchial intubation  
 
Table 4. Table showing the many complications associated with 
Endotracheal Intubation, both from the initial insertion of the tube, and the 
longer term complications that come from being intubated. Adapted from 
Divatia and Bhomwick 2005.  
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(Chen, et al., 2007), showing that the ETT can play host to a wide range of 
microbial species.  Dispersal from the luminal biofilm of viable cells, 
allows mobilisation of bacterial and fungal elements into the lower 
respiratory tract, enabling the development of potentially fatal respiratory 
infections (Pneumatikos et al., 2009).   
Many strategies have been employed to suppress the influence of the 
bacterial biofilms in VAP.  The effectiveness of such interventions, 
including the use of nebulised antibiotics (Adair et al., 2002), silver coated 
tubes (Kollef et al., 2008), silver sulfadiazine and antiseptic coated tubes 
(Adair et al., 1993; Jones et al., 2002; Orhan-Sungur and Akca 2006; Berra 
et al., 2008), along with tube sterilisation and sterile insertion techniques 
(Adair et al., 2002; Triandafillu et al., 2003; Balazs et al., 2004; Cheung et 
al., 2007), remain difficult to assess.  This is due, in part, to the difficulty of 
diagnosing VAP, as opposed to respiratory infections already present prior 
to intubation, but not yet clinically apparent.  Additionally the mortality of 
intensive care patients is often multi-factorial, and as such VAP may be an 
attributable factor in the patient‟s death, yet not be the main causative factor 
(Kollef et al. 2008).  This makes it difficult to ascribe any decrease in 
mortality to one particular intervention 
Ultimately, any intervention at the site of the ETT or tracheostomy tube, 
may reduce bacterial numbers at this site, yet have no measurable impact on 
overall patient mortality.  The study performed by Rello et al. (2006) looked 
at 156 patients, in Spain and North America.  The patients were intubated 
with either a silver-coated ETT (n=78) or a control device (n=77).  This 
study looked at the rates of ETT and tracheal colonisation, and amount of 
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bacterial burden in ETT and tracheal aspirates.  The researchers reported the 
differences between the two groups when comparing rates of colonisation 
were significant but allowed the fact that study limitations, including non-
blinding, and non-matching of the population samples in terms of their 
Clinical Pulmonary Infection Score (CPIS) and variation of infection 
control practices in different centres may have impacted the results.  Part of 
the problem is in examining sufficient numbers of patients, although the 
North American Silver-Coated Endotracheal Tube (NASCENT) trial 
examined 1932 patients who required endotracheal intubation in 54 North 
American centres.  Kollef et al. (2008) found there was a reduced frequency 
of VAP from 7.5% for the control group to 4.8% to the treatment group.  
However, there was no difference in mortality rates, duration of intubation, 
or duration of ITU or hospital stay.  Kollef et al. (2008) acknowledge that 
their study had limitations, notably, non-blinding of the participants, and the 
fact the study population did not reflect the greater population as whole, due 
to the inability to consent emergency intubations for the study.  Also, three 
additional episodes of VAP in the control group would have rendered the 
results insignificant (Chastre, 2008).   
The use of hexetidine (a lipophilic nonantibiotic antimicrobial agent) as a 
method for decreasing initial bacterial adherence to ETTs has been 
described with good effect in in vitro conditions (Jones et al.,2002), but has 
limited effect after 21 days.  Similarly Balazs et al.(2004) showed that 
sodium hydroxide and silver nitrate impregnated ETTs in vitro decreased 
bacterial adhesion, particularly that of P.  aeruginosa, but this was only 
measured up to 72 h post-inoculation.  Selective gastric decontamination 
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has been examined with a view to potentially decreasing the incidence of 
VAP.  A study in 1993 (Adair et.al., 1993) examined 11 ETTs from patients 
undergoing selective decontamination of the digestive tract using the 
antibiotics amphotericin B, tobramycin and polymyxin.  These tubes were 
sectioned at their distal tip to look for any adherent bacteria present, as well 
as tracheal aspirates.  The study showed a predominance of Gram-positive 
bacteria when assessed using standard cultural identification techniques.  
Interestingly, there were wide variations in the concentrations of antibiotics 
present, and in particular the Mean Inhibitory Concentrations (MICs) were 
deficient, and in the case of tobramycin the MIC was uniformly less than 
the median MIC.  Despite limited success in in vitro and animal models, 
these techniques have yet to be translated to clinical practice.  This may be 
due in part to the difficulty in recognising biofilm infections, and inherent 
difficulty in culturing the full range of microorganisms present using 
standard hospital culture techniques (Davey, 2000; Spratt, 2004), coupled 
with the relatively low bacterial numbers that detach and disperse from the 
sessile colonies (Costerton, 1999). 
 
Biofilms in tracheostomy tubes 
 
Under certain circumstances it may be necessary to replace the ETT with a 
longer term tracheostomy tube (Figure 5). 
47 
 
 
Figure 5: Photograph of a tracheostomy tube. The uppermost tube is the tracheostomy tube itself, which like the endotracheal tube has a 
balloon to inflate to secure it in the airway, beneath this is an inner liner for the tracheostomy tube, which in the model depicted may be 
removed so a clean inner may be inserted. The lowermost device on the picture is the introducer, which is inserted into the tracheostomy 
tube prior to being placed in the airway, so the rounded tip allows for less traumatic placement. 
Tracheostomy tube showing inflatable balloon 
Replacable inner lumen 
Introducer 
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Tracheostomy tubes are usually surgically sited directly through the skin in 
the neck, below the level of the larynx, directly into the trachea, under direct 
vision.  Tracheostomy tubes tend to be used where a patient is liable to need 
ventilation over a longer period of time, i.e. where the patient has 
significant underlying medical conditions, such as a large burn injury, or 
where existing lung morbidities suggest a quick extubation would be 
unsuccessful, and that a slow wean off the ventilator might be preferable 
(Jaeger et al., 2002).   
The main benefits of tracheostomy tubes over ETTs include a reduction in 
pulmonary workload (by eliminating dead space), reduced need for 
sedation, and assistance in weaning a patient off ventilation (Table 5).   
In contrast to the large body of work regarding biofilms in ETTs, relatively 
little research has been done on tracheostomies, yet these too are associated 
with VAP (Keith, 1996).  One study suggests a potential method for 
decreasing the incidence of ETT related VAP is for patients to undergo 
early tracheostomy, yet the authors admit this is still controversial (Ramirez 
et al., 2007).  Logically, however, tracheostomies would be susceptible to 
colonisation in a fashion analogous to ETTs, and indeed have been shown 
to harbour similar bacterial species (Jarrett et al., 2002) interestingly, 
however, it has been shown that the flora within the tracheostomies of 
children can be subject to significant changes in bacteria or antibiotic 
sensitivity in two consecutive cultures (Cline et al., 2012).  It is possible 
that tracheostomy tubes, with their potential to be in-situ for longer, may 
have a greater risk of colonisation or device failure. 
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A recent study found that patients with significant burn injuries (Total Burn 
Surface Area (TBSA) >60%) were more likely to undergo tracheostomy, 
and were associated with a higher prevalence of chest infection (Aggarwal 
et al., 2009), although this may have been due to a greater incidence of 
inhalational injury, and prolonged mechanical ventilation in this group. 
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Comparison of tracheostomy and endotracheal intubation 
Tracheostomy Endotracheal intubation 
Reduced need for sedation Easier and quicker to perform 
compared with tracheostomy 
Reduced damage to glottis Tolerated well for short periods 
Reduced work of breathing Weaning more difficult after long 
period of placement 
Reduced patient discomfort Need to be sedated 
More invasive and complicated 
insertion 
Prevents aspiration of secretions 
Scar formation Can be used to give certain 
medications e.g. adrenaline 
Tracheostomy site can bleed or 
become infected 
Gases need to be warmed and 
humidified 
Very skill intensive Improper placement can occur 
May be associated with long-term 
complications e.g. swallowing 
difficulties 
 
 
Table 5: Comparison of the possible advantages and disadvantages between 
using tracheostomy tube or endotracheal tube intubation. 
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Figure 6: Facially burn injured patient, with an endotracheal tube in place, 
which can be seen entering the airway via the oral cavity. 
 
Figure 7: Tracheostomy tube in place on a burn injured patient, with 
evidence of a constricting burn around the neck which has been released 
superiorly, the tracheosomty can be seen entering the airway through the 
anterior neck skin.
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Biofilms in burn wounds 
 
Burn wound sepsis is a frequent complication in the management of burns, 
and it is felt that wound infection is a common cause of wound progression 
or deepening (Singh et al., 2007) and septicaemias.  Early debridement or 
surgical removal of areas of full-thickness skin loss has significantly 
improved morbidity and mortality of burn-injured patients (Gray et al., 
1982).  However, along with low platelet counts and ventilator dependence, 
sepsis remains a key source of mortality in these patients (Wang, Tang et 
al., 2009).  Despite the prevalence of infective complications, there is little 
evidence regarding biofilm formation within burn wounds.  A recent study 
by Kennedy et al. (2010) shows that biofilms can form on burn wounds, and 
may therefore play a role in the delayed healing of some burn wounds.  
Pseudomonas aeruginosa is a common opportunistic pathogen in burn 
wounds, and has been shown to be an excellent biofilm former (Figure 8).  
Genome analysis of P. aeruginosa taken from a burn wound shows that 
genes responsible for infection, iron acquisition, toxin production and QS 
were expressed (Bielecki et al., 2008).  
Infection is the most frequent and most severe complication of burn injuries 
(Wassermann, 2001).  The innate resistance shown by bacterial biofilms is 
often potentiated by the presence of highly resistant microbes which 
commonly infect burn-injured patients (Pruitt, McManus et al., 1998) e.g. 
Acinetobacter baumannii is a frequent pathogen in burns and other ICUs.
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Figure 8: Severe facial burn, with an endotracheal tube in-situ, the large 
amount of facial swelling resulted in this being replaced with a 
tracheostomy tube.  P. aeruginosa was grown from this burn. 
 A study looking at resistant rates in A. baumannii found in ICUs showed 
between 16 and 55% of isolates were resistant to ampicillin, 72-90% 
resistant to gentamycin, and up to 4% resistant to meropenem (Babiket al., 
2008).  Burns which are not treated with topical antimicrobials have been 
shown to contain up to 10
7
 microorganisms per cm
2
, with normal skin 
microflora becoming opportunistic pathogens (Jones et al., 1990).  A 
Tunisian study looking at the incidence of multiple-drug resistant bacteria in 
intensive care settings found that 24.1% of isolates were resistant to two or 
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more antibiotics.  The vast majority of these (82.6%) came from the burns 
unit.  Enterobacteria resistant to third generation cephalosporins were the 
most common (47%), along with MRSA (29.2%), A. baumannii and P. 
aeruginosa were present in 14.8% and 9% of isolates respectively, with 
over half (51.7%) of the A. baumanii resistant to imipenem and ceftazidime, 
along with 20.5% of the P. aeruginosa (Thabet et al., 2008). 
The burn injury itself is known to cause a burn-related immunosuppresion 
(Wurtz, Karajovic et al., 1995).  The burn causes a lowering in the levels of 
endogenous AMPs, which would ordinarily inhibit microbial colonisation, 
and therefore a predisposition to the formation of a biofilm within the 
wound occurs (Bhat and Milner, 2007).  The presence of biofilm-forming 
bacteria within burn wounds has implications for their management.  Burns 
of a partial-thickness depth, which would in the normal clinical course be 
expected to heal without surgery or complications, may then go on to 
become infected and deepen requiring surgical intervention.  This scenario 
is becoming increasingly likely as silver dressings, which are commonly 
used in burn management, are having less effect.  This is due to bacteria, 
and especially those within a biofilm becoming increasingly resistant to 
silver (Loh et al., 2009; Woods et al., 2009).
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Management of Burn wounds 
 
The decision of whether to treat a burn wound surgically or conservatively 
is largely based around a clinical estimation of the depth of the burn wound. 
The rationale being that a burn which has penetrated all of the layers of the 
dermis would take much longer to heal, and therefore, predispose to scar 
formation and the contracture problems inherent therein (Jaskille et al., 
2009). Many techniques have been employed to improve the estimation of 
burn depth with varying success (Jaskille et al., 2010; Still et al., 2001). Yet 
the goal of them all is the same: is there a reason that this burn wound 
would take longer than 21 days to heal? It is known that bacterial biofilms 
delay wound healing (Robson, 1997) and while there is a paucity of 
information regarding the presence of biofilms within burn wounds, it 
follows that a biofilm infection of a burn wound could induce a delay in 
healing in this scenario too. A method, therefore, to diagnose the phenotype 
of bacteria colonising a burn wound surface may allow the clinician to make 
a more accurate assessment of whether or not there is likely to be a delay in 
wound healing, and thus influence treatment modalities down a surgical or 
non-surgical route. 
Biofilms in chronic wounds 
 
Chronic wounds are a major cause of morbidity, affecting more than 1% of 
the UK population and are associated with treatment costs of at least £1 
billion per year (Thomas and Harding, 2002).  Chronic wounds are defined 
as any interruption in the continuity of the body‟s tissue that requires a 
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prolonged time to heal, that do not heal, or that recur (Wysocki, 1996).  
Examples of chronic wounds are VLUs, arterial ulcers, diabetic neuropathic 
ulcers and pressure ulcers (Figures 9-12).  Among the hallmarks of chronic 
wounds are the loss of tissue, underlying conditions such as diabetes, 
cancer, or arterial disease and the presence of bacterial colonisation 
(Wysocki 2002).  The concept of a sterile wound is now obsolete, and 
microbial contamination of open wounds is now accepted (Schultz et al., 
2003).  
 
Figure 9: Venous leg ulcer, on the medial side of the lower leg. Note the 
haemosiderin staining of the skin around the ulcer, which is a common 
outcome of venous stasis in the lower limb. 
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Figure 10: Arterial leg ulcer, note the absence of haemosiderin deposition, 
the necrotic centre of the ulcer, and generalised muscle wasting.
 
Figure 11: Diabetic neuropathic ulcer. This patient has an ulcer over the 
weightbearing point of the head of the fifth metatarsal which is a common 
site for these ulcers, additionally the dry cracked foot skin is typical of the 
sudomotor skin changes often seen in Diabetes. 
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Figure 12: Pressure ulcer. The sacrum is a bony prominence which often 
has problems with pressure damage. Here a healthy bed of granulation 
tissue can be seen in the base of the wound, which suggests it has been 
offloaded and treatment has already begun.
59 
 
It is now considered that most wounds exist within a spectrum of infection, 
from surface colonisation through to frank spreading infection (Edwards 
and Harding, 2004).  Microbial contamination of wounds, whilst being 
relatively ubiquitous, is still a problem, and can lead to significant 
morbidity and mortality, such as septicaemia.  A mortality rate of 8%, 
which is attributed to septicaemia, is associated with pressure ulcers after 
spinal cord surgery (Reuler and Cooney 1981).   
The presence of microbes within chronic wounds has been shown to 
significantly delay wound healing (Robson, 1997), although wound healing 
can still occur (Krizek and Robson, 1975).  The number of microcolonies 
present has been related to the success of wound healing, within areas such 
as burns, pressure ulcers and skin graft take (Krizek and Davis, 1967; 
Robson and Heggers, 1969).  However, the actual phenotype or species of 
bacteria present within wounds might be a more important correlator, with 
the biofilm phenotype being strongly implicated in delayed wound healing.  
Interestingly it has been shown that the presence of four or more bacterial 
species co-existing in a wound, perhaps in a biofilm phenotype, strongly 
correlates with delayed wound healing (Trengove et al., 1996; Hill et al., 
2003).   
Biofilms have been shown to exist within chronic wounds (Davis, et al., 
2008) and the presence of biofilms is thought to have a deleterious effect on 
many of the treatment modalities usually used to control bacterial numbers, 
specifically silver-based dressings and antibiotics, both topical and systemic 
(Saye, 2007; Davis et al., 2008; Morgan et al., 2009).  It has therefore been 
speculated, that different treatment options targeting the physiology of 
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biofilms should be adopted, such as QS antagonists (Smith and Bu, 2003), 
enzymatic debridement agents (Singh et al., 2002) or antibiotics used to 
inhibit biofilm formation (Mitsuya, et al., 2000). 
It is clear therefore that a link exists between biofilms and HCAIs, and that 
this link is often poorly highlighted in the clinical setting.  Part of this is due 
to the difficulty in recognising biofilm infections and their colonisation of 
medical devices.  Many hospital trusts in the UK have policies for the 
management of medical devices, whether it is the removal and replacement 
of cannulae at 48 hours or the role of a specific team in managing semi-
permanent venous access lines, such as those used in long-term total 
parenteral nutrition patients.  For UK-based practising clinicians, the 
microbiological load of a wound or device is still by and large, assessed 
using standard microbiological culture techniques. 
Management of Chronic Wounds 
 
There exists a massive multimillion pound industry to diagnose and manage 
chronic wounds. The crucial first step in managing a chronic wound is in 
diagnosis of aetiology. There are countless case reports of neoplastic lesions 
masquerading as chronic wounds (Schottler et al., 2009; Nishimura et al., 
2010) as well as the eponymous Marjolin‟s ulcer, where a cancer can arise 
de novo within a chronic burn wound. While the clinical signs of a venous 
leg ulcer, or the symptoms associated with arterial disease are often clear, in 
a significant cohort of patients further investigation is warranted. Once, 
however, the diagnosis is made, an orderly progression to healing is 
expected. Unfortunately, this is not always the case, and it is now clear that 
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the presence of bacteria within a wound can significantly delay healing 
(Robson, 1997). Using an in vivo polymicrobial biofilm to infect mice 
wounds with a biofilm infection, it was noted by Dalton et al.  (2011) that 
the polymicrobial wounds displayed an increased delay in wound healing 
and resistance to antimicrobials compared to mice infected with a single 
species biofilm, suggesting that a polymicrobial biofilm may contribute 
synergistically to a delay in wound healing (Dalton et al., 2011). Currently 
detection of bacteria within wounds relies solely on the use of standard 
microbiological analysis using various culture techniques. This method does 
not tell the clinician about the phenotype present and whether or not a 
biofilm is present. Additionally, molecular techniques are being employed 
to assess the number of genera present in a wound (Han et al., 2011). If a 
method could be found that allows rapid diagnosis of a polymicrobial 
biofilm infection in a chronic wound, this would have a significant impact 
on the potential treatment modalities the clinician could employ 
Treatment of Biofilms 
With a greater acceptance of the concept of biofilm infections, clinicians are 
attempting to combat them through a variety of means. Simply washing the 
wounds or cleaning medical devices such as tracheostomy tubes was not 
sufficient to remove biofilms (Silva et al., 2012). Initially radical surgical 
debridement has been proposed as a method to physically remove the 
biofilm, although this has the downsides of often being skill and resource 
intensive, as well as often being only a temporary measure (Wolcott et al., 
2010). If a fungal element is suspected, often as a result of wound location 
(e.g. Tinea pedis  the organism responsible for athlete‟s foot, if a wound is 
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on a foot), then antifungals may be employed to target the hyphal element 
of the biofilm. There have been reported uses of low-frequency ultrasound 
to break-up the biofilm and thus make it more susceptible to antimicrobials 
or to gentle debridement (Seth et al., 2012; Apatzidou, 2012). Finding new 
agents to directly target the biofilms is currently following two paths. On 
one hand we have the scientifically sought Quorum Quenching (QQ) 
molecules to directly target known QS pathways (Romero et al., 2012), and 
on the other, a group from Arkansas is examining whether traditional 
medicine applications that have been used to treat wounds historically have 
any effect on the formation of biofilms (Hobby et al., 2011).Yet, successful 
treatment of any condition is first reliant on accurate diagnosis, and it is in 
this arena that this study concentrates. 
Current methods of identifying and characterising bacterial 
biofilms 
 
There exist multiple approaches for studying bacterial biofilms, including 
examining aspects relating to their formation, morphology and relationship 
with disease.  In this present study, standard clinical microbiological culture 
methods were used with molecular and structural analytical methods.  
Standard culture techniques provide quantifiable data regarding the viable 
numbers of bacteria present, on specific media to assist characterisation.  
The role of standard culture media to analyse the bacteria present is 
invaluable, however it should be noted that many bacteria are simply not 
culturable using current methodologies due to a lack of understanding of 
their natural habitat and the inherent difficulty in recreating these 
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environments in the laboratory (Sprat 2004; Munson et al., 2002).  This is 
further complicated by difficulties in sampling the bacteria within a biofilm, 
and any co-dependencies on each other.  Isolating these bacteria may 
deprive them of the complex intercellular cytokine signalling pathways they 
require to grow (Kell and Young, 2000).  It is also felt there are a number of 
bacteria which exist in a viable, but essentially non-culturable state, 
maintaining a very low metabolic state, but not actually replicating (Lleo et 
al., 2005).  Molecular methods were also utilised in this present study to 
identify bacteria based on DNA content.  Molecular analysis of bacterial 
DNA allows a more comprehensive investigation of the bacteria present. 
The presence of the 16s rRNA gene within all bacterial species makes it a 
highly useful tool for examining bacteria using „universal‟ primers 
(Clarridge, 2004), thus providing accurate identification of both viable 
bacteria and non-viable bacteria which may be within the biofilm. 
In the present study, identification techniques were supplemented with the 
use of molecular probes, capable of binding to specific bacteria in the 
biofilm, and thus allow them to be imaged using Confocal Laser Scanning 
Microscopy (CLSM).  Species-specific peptide nucleic acid (PNA) probes 
can be used to identify multiple bacterial species within a biofilm (Malic et 
al., 2009).  This not only provides information about which bacteria are 
present, due to the specificity of the probes, but also on their spatial 
orientation within the biofilm. It could be argued that since the Extracellular 
Polymeric Substances itself have not been imaged, that the “true” biofilm is 
not being investigated. However, it is the bacteria which make the EPS, 
which form the biofilm, and which have the greatest clinical impact. 
64 
 
Aims 
The key aims of this study were therefore as follows: 
1. Collection of appropriate clinical specimens for analysis including, 
ETTs, tracheostomy tubes, excised burnt tissue, chronic wound 
biopsies and wound dressings. 
2. Cultural analysis of biofilms from the clinical specimens using 
standard microbiological methods to determine the presence of 
microbial species. 
3. Molecular analysis of clinical specimens to further elucidate the 
microbial diversity and composition of biofilms. 
4. Utilise specific molecular probes to establish the biofilm structure 
and distribution of targeted species within biofilms. 
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Chapter 3: MATERIALS & METHODS 
DESIGN 
The design of this study was to examine bacterial biofilms in a clinical 
context, especially as pertaining to HCAIs and those on medical devices.  
The initial aim of the study was to evaluate different methodologies for the 
identification and quantification of bacterial biofilms, and also to see how 
these different methodologies fared with different clinical samples. The first 
clinical setting chosen was that of endotracheal tubes, these devices are in 
contact with a known biofilm forming area (the oral cavity) and have also 
been shown to have a role in healthcare acquired infections such as 
ventilator-associated pneumonia (VAP). In addition, analysis of 
tracheostomy tube biofilm was incorporated into the study for comparison 
with the endotracheal tubes. Tracheostomy tubes are sited within the airway 
and may be associated with the occurrence of VAP but are not in direct 
contact with the oral cavity (Keith, 1996). Any oral bacteria found in these 
samples would have to either come from previous inoculation of the airway 
by the endotracheal tubes, or migrate from the lungs or oral cavity. Since 
the tracheostomies would be coming from burn-injured patients the third set 
of samples chosen to be examined were those of burn wounds themselves.  
Although not from the same patients, burn injured tissue is known to be a 
harbinger of infection, and the detrimental role of bacteria in burn wound 
healing is well known (Murless, 1940; Fadeyibi et al., 2012).  This 
deleterious effect of bacterial colonisation on burn wound healing is 
mirrored in the delayed healing of chronic wounds, especially those heavily 
contaminated by bacteria, presumably in the biofilm form. These different 
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sample types have a common theme of healthcare associated infection 
(HCAI) running through them, and by using cultural, molecular and 
structural analysis techniques the role of bacterial biofilms in these HCAIs 
may be assessed.  Finally to elucidate whether information about biofilms 
may be obtained using non-invasive or destructive techniques, it was 
decided to assess and examine the dressings of the chronic wound patients 
to investigate whether dressing analysis might be used as a surrogate in the 
diagnosis of biofilm infections. 
SPECIMEN ACQUISITION 
3.1 Ethical considerations 
Ethical approval was sought for this study for a number of reasons.  The 
endotracheal and tracheostomy tubes, although ordinarily discarded after 
use, were being taken from patients who were critically-ill and therefore 
needed careful explanation of what was being undertaken.  Additionally, 
wound dressings and wound biopsies, all potentially contain samples of 
human DNA, and therefore are covered under the Human Tissue Act 
(2004).  The ethics committee required details of sample storage and 
subsequent disposal, and to ensure the researchers were blinded to patient 
identifiers.  Subsequently, ethical and trust approval was obtained for the 
collection of all clinical specimens used in this study. (REC reference 
number: 08/MRE09/48 SSA reference number: 08/WMW02/61).  For the 
endotracheal component of this study, ethical approval was sought, and 
following discussion with the ethics panel, it was deemed approval would 
not be required for the use of these discarded devices. 
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The consent for ETT specimen collection was obtained within the Intensive 
Care setting by a Senior Consultant anaesthetist.  In all cases, for the 
tracheostomy tubes, wound dressings, chronic wound samples and burned 
tissue, written consent was obtained by the principal investigator prior to 
specimen collection.  Written patient information was supplied to the 
patients 24 h prior to expected decannulation for the endotracheal and 
tracheostomy tube patients.  The patients with chronic wounds and 
dressings were initially contacted in an out-patient setting, and supplied 
with written information.  Arrangements were made at this time for the 
patients to return to The Department of Wound Healing, Cardiff, UK the 
next day to sign a consent form, and for sample collection. 
Patients in the chronic wound and dressings cohort had the dressing 
removed from their wound and stored in a sealed bag, along with piece of 
moistened gauze to prevent dehydration of the specimen. In order to collect 
the biopsy, an area on the wound which appeared to be representative was 
identified. 5ml of 1% Lignocaine anaesthetic was injected subcutaneously 
around the identified area using a sterile technique. When sufficient time 
had elapsed to allow complete anaesthesia of the region a punch biopsy was 
performed (Figure 13) using a standard biopsy punch (Brymill Cryogenic 
Systems, UK).  The specimen was then transferred immediately to the 
laboratory for specimen preparation. Patients admitted for surgery on their 
burn wounds were contacted by the principal investigator the day before 
their surgery, and supplied with written information.  The next day, patients 
were approached to sign a consent form prior to entering the theatre suite.  
At all times, and with all the patient cohorts, great care was taken to 
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separate the principal investigator from the medical team caring for the 
patient, to ensure patients understood that refusal to participate in the study 
would not jeopardise their standard of care.  
Once the patient had been anesthetised and prepared on the operating table, 
the burn surgeon used an instrument called a Modified Braithwaite knife 
(Downs Surgical, Sheffield, UK) to shave off the top layer of burned skin 
(Figure 14), burned tissue is removed incrementally in a procedure called 
tangential excision, until a healthy base, onto which a skin graft could be 
placed, is reached. After the first pass of the knife, which usually removes 
surface tissue including biofilm, down to mid-dermis level, the excised 
tissue was passed out to the principal investigator who stored it in a sealed 
bag, along with a piece of moistened gauze, and then transferred to the 
laboratory for immediate specimen preparation.
 
Figure 13: A drawing showing the technique used to perform a Punch 
biopsy, the cut-section of the left demonstrates how a specimen including 
the full-thickness of the epithelium may be obtained. 
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Figure 14: In this picture a Watson knife is being used to shave off the burnt 
upper layers of epidermis and dermis from the patient‟s right upper arm. 
This shaving is repeated until a healthy, non-burnt, bed is reached.
3.2 SPECIMEN PREPARATION 
3.2.1  In vitro control biofilm preparation on endotracheal 
and tracheostomy tubes 
A series of controls were employed in this study, predominantly to show 
that biofilms would form on the material of the tubes, and were 
subsequently recoverable. 
Sections (1 cm) of sterile unused endotracheal tubes (ETTs) and 
tracheostomy tubes (TTs) were placed in glass universals with either Brain 
Heart Infusion (BHI) or Fastidious Anaerobic (FA) broth, and inoculated 
with known microbial species.  The reference strains used were; 
Staphylococcus aureus NCTC 1671, Candida albicans ATCC 90028, 
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Pseudomonas aeruginosa ATCC 15692, Streptococcus mutans DSM 
20523
T
, and Porphyromonas gingivalis NCTC 11834
T
. All media were 
inoculated to give a final bacterial concentration of 10
4 
cells/ml based on 
turbidity comparisons with McFarland indices.  
Different incubation conditions were initially assessed for in vitro biofilm 
development.  Incubation at 37
o
C for 48 h in an aerobic atmosphere for 
aerobic organisms was undertaken, whilst for the anaerobic species P. 
gingivalis, the standard incubation was 48 h at 37
o
C in 10% v/v CO2, 20% 
v/v H2, 70% v/v N2 36-37
o
C.  In addition, tubes were also incubated in an 
anaerobic environment for 48 h before being transferred to an aerobic 
environment, whilst other replicate preparations were retained in an 
anaerobic environment for 96 h.  Throughout the incubation period the glass 
universals were constantly rolled on a mixer to promote standardised 
biofilm formation.  The tubes were then subjected to the same analytical 
preparation as described for the clinical specimens, outlined below (Section 
3.2.2). 
 
3.2.2 Collection and preparation of clinical endotracheal and 
tracheostomy tubes 
 
A total of 25 ETTs were obtained from intensive care unit (ICU) patients 
(n=20), mean age 58.7 years (range 20 – 79 years) at the University 
Hospital of Wales, Cardiff, UK (Table 6).  In addition, 10 tracheostomy 
tubes were obtained from the Burns Intensive Care Unit at the Welsh 
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Regional Centre for Burns and Plastic Surgery, Morriston Hospital, 
Swansea, UK (Table 7). 
All tubes were immediately transported to the microbiology laboratory for 
urgent processing (Dental School, Cardiff) in sterile sealed plastic bags, 
containing dampened tissue to prevent sample drying.  No tubes required 
storage and the longest period between decannulation of the patient and 
commencement of specimen preparation was 2 h.
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Table 6: Demographics of endotracheal tube patients  
ETT 
Number 
Patient  Age Gender Admission diagnosis Hours 
intubated 
1 1 48 Male Cerebral infarct post 
cranioplasty 
33 
2 2 78 M Fourniers gangrene 108 
3 3 20 M Subarachnoid Haemorrhage 
(SAH) 
60 
4 4 77 M Cardiac arrest 95 
5 5 59 F SAH/Crohns  43 
6 6 41 M Cerebellar infarct 25 
7 2 78 M Fourniers gangrene 94 
8 7 62 M Peritonitis 289 
9 8 76 M Abdominal Aortic Aneurysm 173 
10 6 41 M Bilateral cerebellar infarcts 41 
11 9 74 F Peritonitis 198 
12 10 71 F Peritonitis: perforated colon 56 
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ETT 
Number 
Patient  Age Gender Admission diagnosis Hours 
intubated 
13 11 79 M Gall bladder empyema 137 
14 12 76 M Perforated Duodenal Ulcer 
(DU) 
12 
15 12 76 M Perforated DU 20 
16 12 76 M Perforated DU 96 
17 13 49 M Pancreatitis 224 
18 14 77 M Cardiac arrest-comm 49 
19 15 52 F SAH + pneumonia 29 
20 16 38 M Gastric varices/laparotomy 67 
21 17 76 M Trauma perf colon 20 
22 18 77 F Acute Subdural 76 
23 19 44 F SAH 32 
24 17 76 M Trauma perf colon  143 
25 20 66 F ARDS C.diff 125 
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Table 7: Demographics of Tracheostomy tube patients 
Tracheostomy 
tube number 
Patient 
number 
Age Gender % of total body 
surface area 
burned 
Hours 
intubated 
1 1 34 M 55 1128 
2 2 54 M 52 840 
3 3 26 F 31 1209 
4 4 42 M 33 912 
5 5 32 M 26.5 504 
6 6 38 M 37 240 
7 7 41 M 23 135 
8 8 34 M 0 696 
9 9 41 M 85 422 
10 10 18 F 46 552 
 
The lumen of the tubes were then rinsed with 5 ml of Phosphate Buffered 
Saline (PBS; 7 mM Na2HPO4, 130 mM NaCl) to remove any loosely 
adherent bacteria,.  Sectioning of the tubes was performed using sterile 
scalpel blades and scissors and three 1 cm long sections were generated.  
The portion of the tube chosen to be sectioned was the area with greatest 
curvature, and therefore where the airflow would likely create the highest 
level of turbulence.  This also corresponded to the area with the highest 
amount of visible soiling.  The most distal tube section was immersed in 4% 
(v/v) formalin prior to structural analysis, whilst the remaining more 
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proximal or cranial sections were divided longitudinally to give to 
semicircular lengths of tube.   
Sampling involved the physical removal of the biofilm using a sterile 
number 11 scalpel blade to scrape off the adherent biofilm on the luminal 
surface into 1 ml of PBS in a Petri dish.  The resulting solution was 
transferred to a microcentrifuge tube for subsequent cultural or molecular 
analysis as described in sections 2.3 and 2.4, respectively.   
3.2.3 Preparation of recombinant human epithelium for 
construction of biofilms in vitro 
 
Specimens of recombinant human epithelium (RHE) were obtained from 
SkinEthic Laboratories (Nice, France).  These 0.5 cm
2
 tissues consisted of 
human keratinocytes (human foreskin derived) with a well differentiated 
epidermis consisting of 4 separate layers of epidermis, the stratum basale or 
germinativum, stratum spinosum, stratum granulosum and finally the 
stratum corneum.  
The bacterial species S. aureus NCTC 1671 and P. aeruginosa ATCC 
15692 were cultured on blood agar at 37
o
C overnight in an aerobic 
environment.  The resulting growth was used to inoculate 10 ml of BHI 
which was incubated for a further 24 h in aerobic conditions at 37
o
C.  
Bacterial cells were harvested by centrifugation and washed three times 
with PBS.  The pelleted bacterial cells were resuspended in RHE tissue 
MCDB 153 maintenance medium (SkinEthic Laboratories).  This 
chemically defined medium contained 5 μg/ml of insulin and 1.5 mM 
calcium chloride with no antibiotics.  A 200-μl volume of the resulting 
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bacterial suspension added to the RHE and this was incubated for 24–28 h 
at 37 °C in a humidified atmosphere, enriched with 5 % CO2. 
After a minimum period of 48 h, the RHE was transferred to and stored in 
4% (v/v) formalin (Fisher Scientific Laboratories, Loughborough, UK).  
These were used as a baseline for the three dimensional structural analysis 
using confocal laser scanning microscopy (CLSM); see Section 2.5.3, 
allowing evaluation of the species specific probes. 
 
3.2.4  Collection and preparation of burned tissue, chronic 
wound biopsies and chronic wound dressings 
 
Five patients, who underwent excision of their burn wounds, consented for 
the discarded burn tissue to be used in this study (Table 8). The most 
superficial layer of burn tissue was collected and stored within moist gauze 
inside a sterile container for transport.  From the larger portions of tissue 
provided, three 1-cm
2
 sections were cut using either scissors or a scalpel 
blade.  One section was then placed in 4% (v/v) formalin for a minimum of 
24 h and the other two sections were placed into a Petri dish containing 1 ml 
of PBS.  The surface of the wound or dressing was then scraped into the 1 
ml of PBS to remove any biofilm, and then the resultant solution was 
transferred to a 1.5-ml microcentrifuge tube. 
 
Ten patients receiving treatment for chronic wounds at the Department of 
Wound Healing, Cardiff, UK were approached and asked to donate their 
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used discarded dressings to the study. The dressings were placed in a clear 
plastic bag, with some moist gauze, for transport to the laboratory.  In the 
laboratory, the dressings were cut into three 1-cm
2 
sections, and prepared in 
an identical fashion to the burn tissue outlined above. 
Of the ten „dressings patients‟, five were additionally asked to provide a 
tissue sample, in the form a punch biopsy taken under local anaesthetic.  For 
these patients, the total surface area of sample received was 6 mm
2
, and this 
was further divided into 3 pieces and prepared in the same way as the burn 
tissue and dressings (Table 9). 
 
Table 8: Burn patient demographics, days post-burn is included as this will 
have affected how long the burn has been exposed to antiseptics in the form 
of silver-based burn dressings. 
Burn Specimen 
Number 
Patient 
number 
Age Gender % burned of 
body 
surface area 
Days post-
burn 
1 1 28 M 2 19 
2 2 64 M 1 5 
3 3 26 M 4 16 
4 4 54 M 3 18 
5 5 32 M 3 24 
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Table 9: Demographics for Chronic Wound and Dressings patients, The 
wounds consisted of varying aetiologies, the dressings used were either 
hydrocolloid dressings (Aquacel), with or without silver (in the form of 
Aquacel Ag or Flamazine), or using a Iodine based non-adherent dressing 
(Inadine). 
Wound and 
dressing 
number 
Patient 
number 
Age Gender Aetiology 
of Ulcer 
Dressing 
regime 
1 1 64 M Venous  Aquacel Ag 
2 2 44 F Vasculitic Aquacel Ag 
3 3 67 M Venous & 
arterial 
Flamazine and 
Aquacel 
4 4 76 M Venous Aquacel Ag 
5 5 75 F Diabetic Inadine 
 
3.3 MICROBIOLOGICAL CULTURAL ANALYSIS 
 
Biofilm specimens were vortex mixed in 1.5 ml microcentrifuge tubes, and 
serial decimally diluted in PBS to 10
1
, 10
3
, 10
 5 
and 10
7
-fold.  Fifty µl was 
then plated on to BA, FAA and Sabouraud‟s Dextrose Agar (SDA) using a 
spiral plating system (Don Whitley Scientific, WASP); BA and FAA were 
supplemented with 5% (v/v) defibrinated sheep blood (TCS Biosciences 
Ltd., Buckingham, UK).  The ETTs and tracheostomy samples were also 
plated on to Mitis-salivarius Sucrose Bacitracin (MSB) agar (supplemented 
with 0.2 U/ml bacitracin and 20% [w/v] sucrose 20% w/v; agar from Difco, 
supplements from Sigma).  This agar is both selective and differential for 
Streptococcus mutans (Schaeken and Van Der Hoeven 1986).  Wound 
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samples were additionally plated on MacConkey Agar (Lab M Limited).  
Agars were incubated at 37
o
C for 48 h in a standard aerobic atmosphere, or 
for anaerobes in 10% v/v CO2, 20% v/v H2, 70% v/v N2 36-37
o
C for 72 h. 
Visual analysis was then undertaken for macroscopic/phenotypic variations 
of resulting colonies, and counting of the colony forming units present.  
Any yeast colonies subsequently cultured on SDA were sub-cultured on to 
Chromagar® Candida agar for presumptive species identification (in 
accordance with the manufacturer‟s recommendation).  Bacterial colonies 
on the remaining plates were purified to monoculture prior to identification. 
 
3.3.1 Identification of cultured isolates by PCR sequencing 
 
DNA extraction was performed on isolated and purified colonies obtained 
by culture and directly on ETTs samples.  The extraction was performed 
using a Puregene DNA isolation kit (Qiagen, Crawley, UK) using the 
manufacturer‟s Gram-positive bacteria and yeast extraction protocol 
(Appendix 9).  Five colonies were suspended in 300 μl of Puregene cell 
suspension solution, and 1.5 μl of Puregene lytic enzyme was added.  The 
solution was inverted several times to mix the reagents before being 
incubated for 30 min at 37°C.  This was then centrifuged at 16,000g for 1 
min, and the subsequent supernatant was carefully discarded. The cells were 
resuspended in 300 μl of Puregene Cell Lysis solution, along with 1.5 μl of 
Purgene RNase A solution, inverted to mix, and then incubated for 60 min 
at 37°C.  This was rapidly cooled on ice, before the addition of 100 μl of 
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Protein Precipitation solution, and subsequent vigorous vortexing for 20 s. 
A further 3 min of centrifugation at 16,000g followed, the resultant 
supernatant was decanted into a fresh 1.5 ml microcentrifuge tube 
containing 300 μl isopropanol (Sigma-Aldrich, Dorset, UK) and inverted 50 
times.  A further 1 min of 16,000g centrifugation followed, prior to drainage 
of the supernatant and subsequent washing of the pellet in 70% (v/v) 
ethanol (Sigma-Aldrich).  After air-drying the pellet, the DNA was 
dissolved in 100 μl of Puregene “DNA Hydration solution” prior to storage.  
 
DNA was extracted from pure monocultures grown from the ETTs, and 
PCR was performed using previously described universal bacterial primers, 
d88 and e94 (Table 10; Paster et al., 2001). 
PCR thermal cycling was performed using the G-storm GS1 (AlphaMetrix 
Biotech, Rodermark, Germany) with 25 cycles of denaturation at 96°C for 
10 s and annealing and extension at 60°C for 4 min.  The PCR products 
were purified by adding a 40-μl volume of 5 M sodium chloride and 40% 
polyethylene glycol (mol. wt. 8000; Sigma) and centrifuging at 16,000g for 
15 min.  The supernatant was carefully aspirated and replaced with 200 μl 
of 70% ethanol, which was then centrifuged for a further 15 min.  This 
previously described wash step was performed twice.  The supernatant was 
then decanted, and the remaining specimen left to aseptically air-dry 
overnight.   
The purified amplified DNA fragments were sequenced using 27F and 
1492R primers (Table 10, Lane 1991) and an automatic DNA sequencer 
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(ABI Prism 3100 genetic analyser; Applied Biosystems).  Sequences were 
identified by comparison to those held in the GenBank DNA sequence 
database (Benson et al., 2005).  Comparisons were done using the FASTA 
sequence homology search program found at 
www.ebi.ac.uk/Tools/fasta33/nucleotide.html (Pearson et al., 1990).  A 
>99% homology to the 16S rRNA gene sequence of the type strain, or other 
suitable reference strain, was the criterion used to identify an isolate to the 
species level.  If there were no significant matches to known reference 
strains the identity of the isolate was based upon the results of the 
indiscriminate GenBank search.  See Table 10 for a list of all primers used 
in this study. 
3.4 Molecular Analysis 
 
3.4.1 Extraction of DNA from clinical specimens 
 
For the clinical specimens, both endotracheal and tracheostomy tubes, along 
with burn tissue, chronic wound tissue and dressings, 1 cm
2
 sections were 
prepared as outlined in the sections above (section 3.2.2 and 3.2.3). These 
were placed into sterile plastic containers, and the biofilm on the surface 
was scraped into 1 ml of PBS.  DNA was then isolated as described 
previously using the Puregene kit (Qiagen) and following the “DNA 
Isolation From Gram-positive Bacteria Culture Medium protocol” (see 
Section 3.3.1.). 
3.4.2 Detection of bacterial species by species specific PCR 
 
82 
 
Species-specific PCRs was used to detect two oral bacterial species, namely 
Streptococcus mutans and Porphyromonas gingivalis, and the opportunistic 
pathogens, Staphylococcus aureus and Pseudomonas aeruginosa.  
For S. mutans PCR, the primers 479F and 479R were used (Table 10, Chen 
et al., 2007).  The PCR cycling parameters involved initial template DNA 
denaturation at 95°C for 2 min, followed by 40 cycles of 95°C for 30 s, 
65°C for 30 s and 72°C for 1 min, with a final product extension cycle of 5 
min at 72°C.  In the case of P. gingivalis, the primers used were pGing 16S-
1 and pGing 16S-2 (Table 10; Kulekci et al., 2007).  Cycling parameters 
used included an initial 3 min cycle of denaturing at 94
o
C, prior to 36 cycles 
of 94
o
C for 45 s, 55
o
C for 30 s and 72
o
C for 45 s, before a final elongation 
step at 72
o
C for 10 min.  The primers for S. aureus were Vick1 and Vick2 
(Table 10; Liu et al., 2007), these samples were denatured for 5 min at 
94
o
C, before undergoing 35 cycles of 94
o
C for 40 s, 50
o
C for 40 s and 72
o
C 
for 1 min, prior to a final single 10 min cycle at 72
o
C.  Finally, for P. 
aeruginosa, the primers ECF1 and ECF2 were used (Lavenir et al., 2007) 
See Table 10.  PCR cycling consisted of a single denaturation cycle of 95
o
C 
for 5 min, before undergoing 35 cycles of 94
o
C for 45 s, 58
o
C for 45 s and 
72
o
C for 1 min, before a final 5 minutes at 72°C.  
The subsequent PCR products were electrophoresed in a 1.5% (w/v) 
agarose gel containing 1 μl of ethidium bromide within a 1× Tris-acetate-
EDTA (TAE) buffer comprising 40mM Tris, 20mM acetic acid and 1mM 
EDTA buffer at 40 V/cm
2
 for 45 min.  The products were run alongside 
standard 100 base pair marker DNA ladders (Promega).  Completed agars 
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were visualised under ultraviolet light using a GelDoc system (Bio-Rad, 
Hemel Hempstead, UK). 
 
3.4.3 Denaturing Gradient Gel Electrophoresis (DGGE) to 
determine microbial diversity within samples 
 
Denaturing Gradient Gel Electrophoresis (DGGE) profiling was used 
alongside the microbiological culture approach to assess the diversity of the 
biofilm. 
 
3.4.4 Preparation of parallel denaturing gradient gels  
 
Polyacrylamide gels were cast using a model 385 gradient former (Bio-
Rad).  All gels consisted of 1×Tris-acetate-EDTA (TAE) buffer comprising 
40mM Tris, 20mM acetic acid and 1mM EDTA, with 10% (w/v) 
acrylamide, 0.1% (v/v) TEMED, and 0.1% (w/v) ammonium persulphate 
(all materials from Sigma).  Gels also contained a parallel 30-60% gradient 
of denaturants (where 100% denaturant concentration consisted of 7 M urea 
and 40% [v/v] deionised formamide; Sigma, Dorset, UK).   
 
3.4.5 Resolution of PCR products by denaturing gradient gel 
electrophoresis 
 
Parallel DGGE was performed using the Bio-Rad D-Code system.  
Following DNA extraction using the Puregene protocol outlined above 
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(Section 2.3.1.). PCR was performed using the 341F and 534R primers 
(Rolleke et al., 1996).  Denaturing of PCR product was carried out at 94°C 
for 1 min, primer annealing was performed at 55°C 1 min, and primer 
extension was performed at 72°C for 3 min.  Products from these ETT PCRs 
were run alongside a marker comprising of an equal mixture of PCR 
products from the three known bacterial stains.  The use of a marker 
allowed later normalisation of the gels and an early indication of possible 
target microorganisms in the clinical samples. 
DGGE was run in 1×TAE buffer at 56°C with a current of 170 V/cm
2
 for 20 
min, followed by 40 V/cm
2
 for 16 h.  In order to stain PCR products in the 
gel, the gel was placed in a solution of 300 ml of 1x Tris-Acetate EDTA and 
30 μl of SYBR green I (Sigma), and agitated for 30 min.  Stained gels were 
then visualised under ultraviolet light using a GelDoc system (Bio-Rad).  
DGGE banding profiles were then analysed using GelCompar II software 
(Version 5.1, Applied Maths Software) for calculation and construction of 
comparative dendrograms. A dendrogram of genetic similarity between 
samples was calculated.  The presence of individual bands in each profile 
was assessed using the same software, set to a 1% tolerance of band 
matching.  This study used Dice's coefficient, in preference to Jaccard or 
Sorensen similarity matrices, due to Dice‟s being relatively more common, 
with fuzzy logic and the Unweighted Pair Group Method with Arithmetic 
Mean (UPGMA) clustering method to assess similarity in construction of a 
dendrogram.
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Table 10: Primers used in PCR in this study, their target genes and the references which validated their use.
Species 
targeted 
Primer name Primer (5’-3’) Number of 
base pairs 
Reference 
Most d88 
e94 
GAGAGTTTGATYMTGGCTCAG 
GAAGGAGGTGWTCCARCCGCA 
Unknown Paster et al. 2001 
Universal 27F  
1492R 
AGAGTTTGATCMTGGCTCAG 
ACCTTGTTACGACTT 
Unknown Weisburg et al. 1991 
S. mutans 479F 
479R 
TCGCGAAAAAGATAAACAAACA 
GCCCCTTCACAGTTGGTTAG 
479 Chen et al. 2007 
P. aeruginosa ECF1 
ECF2 
ATGGATGAGCGCTTCCGTG 
TCATCCTTCGCCTCCCTG 
528 Lavenir et al. 2007 
S. aureus Vick 1 
Vick 2 
CTAATACTGAAAGTGAGAAACGTA 
TCCTGCACAATCGTACTAAA 
289 Liu et al. 2007 
P. gingivalis pGing 16S-1 
pGing 16S-2 
AGGCAGCTTGCCATACTGCG 
ACTGTTAGCAACTACCGATGT 
404 Kulecki et al. 2007 
86 
 
3.5 BIOFILM STRUCTURAL ANALYSIS 
 
Biochemical structural analysis was determined using a combination of 
peptide nucleic acid (PNA) probe hybridization and CLSM.  Initially, the 
specificity of PNA probes for target species was established through 
evaluation using planktonic cultures. 
 
3.5.1 PNA probe evaluation on planktonic cultures  
 
Initial CLSM studies were undertaken on known species of 
microorganisms, using a universal and species specific PNA probes to 
optimise the technique and confirm probe specificity.  The probes were 
manufactured by Boston Probes for Applied Biosystems, USA.  The 
universal bacterial probe (Bac-Uni-CY3) was labelled with the fluorophore 
cyanine 3 (Cy-3), and excited at a wavelength of 543 nm.  The P.  
aeruginosa probe was labelled with fluorescein isothiocyanate (FITC) and 
was excited at 488 nm, whilst the S. aureus probe was coupled with cyanine 
5 (Cy-5) and excited at 633 nm.  Additionally, a fourth custom probe was 
manufactured specific to S. mutans with a label that excited at 405 nm 
(Alexa 405). (Table 11).
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Target Fluorescent 
label 
Nucleotide sequence 
(5’-3’) 
Conc. 
(nM) 
Wavelength 
(nm) 
References 
PNA  
P.aeruginosa 
FITC AACTTGCTGAACCAC 300 488 Coull & Hyldig-Nielsen (2003) 
PNA  
S. aureus 
Cy-3 GCTTCTCGTCCGTTC 500 633 Perry-O'Keefe et al. (2001a) 
PNA 
S. mutans 
Alexa 405 ACTCCAGACTTTCCTGAC 150 405 Thurnheer et al. (2001) 
PNA 
Universal 
bacteria 
Cy-5 CTGCCTCCCGTAGGA 
 
150 561 Perry-O'Keefe et al. (2001b) 
 
Table 11: Summary of fluorchromes used in this study. Table listing targeted organism and the sequence of the PNA probes, 
with their associated flurophore label and the frequency at which it fluoresces.
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The test species were S. aureus NCTC 1671, P. aeruginosa ATCC 15692, 
S. mutans DSM 20523
T
, P. gingivalis NCTC 11834
T
, and C. albicans 
ATCC 90028, no specific probe was used for C. albicans as this was visible 
without a fluorescent label.  The organisms were cultured on the appropriate 
culture medium (BA, FAA or Sabouraud‟s dextrose  agar) for 24 h, and 
colonies sub-cultured into corresponding liquid medium  (BHI, FAA or 
Sabaroud broths) for incubation under appropriate gaseous conditions 
overnight at 37°C.  The resulting microbial growth was pelleted by 
centrifugation (13,000g for 5 min) and resuspended in PBS.  These 
suspensions were again centrifuged and resuspended in PBS with 4% (w/v) 
paraformaldehyde (Sigma) and fixed for 1 h.  The fixed cells were rinsed in 
PBS, resuspended in 50% (v/v) ethanol and placed at -20
o
C for at least 30 
min. 
A 100-μl volume of fixed cells was then pelleted by centrifugation and 
rinsed with PBS and resuspended in 100 μl of hybridization buffer (25mM 
Tris-HCl, pH 9.0; 100mM NaCl; 0.5% (w/v) SDS) containing 150 nM of 
the fluorescently labelled probe.  The preparation was incubated for 30 min 
at 55
o
C and then centrifuged (13,000g, 5 min) and cells resuspended in 500 
μl of wash solution (10mM Tris, pH 9.0, 1mM EDTA).  The cells were then 
incubated at 55
o
C for a further 10 min prior to pelleting by centrifugation.  
This procedure was repeated on two occasions. 
Following the last wash, the cells were suspended in 100 μl of wash 
solution, 2 μl of this preparation was then spread onto clean microscope 
slides and allowed to air dry, before being treated with Vectashield 
mounting medium (Vector Laboratories Ltd, Peterborough, UK) and then 
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overlaid with a coverslip.  These were then visualized using a Confocal 
Laser Scanning Microscope (Section 3.5.4.). 
 
3.5.2 Processing of RHE samples and chronic wound and 
burn tissue samples for CLSM 
 
The 0.5 cm
2
 of RHE specimens, the 1 cm
2
 sections of burn tissue, and the 6 
mm
2
 of chronic wound biopsy tissue which had previously been fixed in 4% 
(v/v) formalin (see sections 3.2.3 and 3.2.4 for specimen preparation) for a 
minimum of 24 h, were then processed through a graded alcohol series 
before embedding in paraffin wax.  A section of material was then cut (20 
µm), placed on microscope slides and rehydrated to water through a 
decreasing alcohol concentration gradient.   
One hundred μl of hybridization buffer (25 mM Tris-HCl, pH 9.0; 100 mM 
NaCl; 0.5% (w/v) SDS; Sigma) containing 150 nM of the fluorescently 
labelled probe was then applied to the surface of the slide.  The slides were 
incubated for 60 min at 55
o
C.  The probes were then removed from the 
section by gentle pipetting.  The slides were washed using 100 μl of wash 
solution (10mM Tris, pH 9.0, 1mM EDTA; Sigma) and then incubated at 
55
o
C for a further 10 min.  This was repeated on two further occasions.  
Following the last wash, the slides were mounted with Vectashield (Vector 
Laboratories Ltd, Peterborough, UK) mounting medium and overlaid with a 
coverslip.  These prepared slides were then submitted for examination by 
CLSM (Section 3.5.4.) 
90 
 
3.5.3 Processing of clinical and control endotracheal tubes 
and tracheostomy tubes for CLSM 
 
Initially, the tubes were processed on to microscope slides, at section 
thicknesses of 5 µm, 10 µm and 20 µm.  In addition, 2 mm sections were 
also similarly prepared and placed into the wells of standard 12 well 
microtitre plates.  These microtitre plate sections came directly from 4% 
paraformaldehyde immersion and required no rehydration or wax removal 
steps.  
For the tube sections four previously validated PNA probes were utilised, 
the S. aureus specific PNA probe, P.  aeruginosa probe, S.  mutans probe 
and the universal probe.  These PNA probes were pipetted into the lumen of 
each tube, and then incubated in a dark 55
o
C incubator for 1 h. These probes 
were then carefully pipetted off and replaced with pre-warmed wash 
solution; this was repeated on two more occasions.  Prepared samples were 
examined using CLSM.  Segments of tissue and dressing samples were 
examined using both the slide and microtitre plate preparation methods 
prior to CLSM. 
 
3.5.4 Confocal Laser Scanning Microscopy 
 
The Leica TCS SP2 AOBS spectral confocal microscope (Leica 
Microsystems, Wetzlar, Germany) was used to analyse specimens in both a 
standard upright and inverted mode. The upright stand was used for 
applications involving slide-mounted specimens; whereas the inverted 
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stand, which had a 37
o
C incubation chamber and CO2 enrichment 
accessories, was used for live cell applications.  The TCS SP2 AOBS 
confocal system had four lasers (one diode, one argon and two helium neon 
lasers) allowing excitation of a broad range of fluorochromes within the 
UV, visible and far red ranges of the electromagnetic spectrum. The upright 
microscope also had a transmission light detector making it possible to 
overlay a transmitted light image upon a fluorescence recording.  The 
microscope was controlled by Leica confocal software, which allowed 3D 
reconstruction of the images and measurements.  
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Chapter 4: RESULTS 
4.1 Bacterial and fungal growth on culture media from 
control and clinical specimens 
 
4.1.1 Cultural analysis of control endotracheal and 
tracheostomy tubes 
 
The plates from the control tubes which had previously been inoculated 
with strains of P. gingivalis, P. aeruginosa, S. aureus and S. mutans were 
examined at 24, 48 and 72 h.  No quantitative measurements of bacterial 
numbers were made from control tubes. The isolates which were recovered 
by cultural methods were subsequently identified using molecular analysis 
to confirm that DNA from the inoculated species could be recovered.  In all 
cases, S. aureus and P. aeruginosa were readily detected.  Streptococcus 
mutans was detected from one of the six tubes, and no P. gingivalis was 
detected. 
4.1.2 Cultural analysis of clinical endotracheal tubes 
 
Agars were examined at 48 h for the number of visibly different colony 
types present, and these were enumerated to give a number of colony 
forming units (CFUs) per ml since each ml was taken from a 1cm
2 
section 
of endotracheal tubes, the number of CFUs detected on the plates 
represented the number of CFUs per cm
2
 of endotracheal tube lumen.  The 
number of CFUs varied between 2.1 x 10
8 
per cm
2 
on Blood Agar for tube 
number 20, to no growth on Blood Agar on tubes 2, 3, 8, 21 and 24.  Of 
these, only tubes 21 and 24 had no bacterial growth, although specimen 
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number 24 was among those positive for Candida albicans. In total, seven 
ETT specimens were positive for growth of C. albicans.  These specimen 
numbers were 5, 10, 15, 16, 19 and 23.  
Strictly anaerobic or facultatively aerobic bacteria were grown on 
Fastidious Anaerobic Agar were recovered from 16 of the 25 specimens, 
with a range of 2.1 x 10
8 
per cm
2 
from specimen number 13, down to no 
growth on FAA on tubes 1, 2, 7, 9, 10, 19, 21, 24.  The only specimen to not 
have grown any bacterial or fungal colonies was tube 21 (Table 12)
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  Table 12: Cultural analysis of clinical endotracheal tubes, on different 
media, Blood agar (BA) to detect fastidious organisms and evidence of 
haemolysis; MacConkey agar (MAC) to selct for Gram negative bacteria; 
Fastidious Anaerobic Agar (FAA) to select for anaerobic bacteria, and  
Sabouraud‟s Dextrose Agar (SDA) with a low pH and containing 
gentamycin to select for fungal growth.
  Media: BAP MAC FAA SAB 
ETT 
Num. 
Pt. Hours 
intubated 
CFUs per 
cm2 
CFUs per 
cm2 
CFUs per 
cm2 
CFUs per 
cm2 
1 1  4 x 10
4 
8 x 10
4
 0  No growth 
2 2 108 0 2 x 10
4
 0   No growth 
3 3 60 0 4 x 10
4
 2.2 x 10
5 
  No growth 
4 4 95 4 x 10
4
 0 1.2 x 10
5
   No growth 
5 5 43 1.8 x 10
5
 0 1 x 10
6 
Positive 
6 6 25  0  0  0   No growth 
7 2 94 2 x 10
4
 0 0   No growth 
8 7 289 0 2 x 10
4
 8 x 10
4
   No growth 
9 8 173 1.96 x 10
6
 1.52 x 10
6
 0   No growth 
10 6 41 1.78 x 10
6
 1.96 x 10
6
 0 Positive 
11 9 198 1.3 x 10
7 
6.9 x 10
6
  0   No growth 
12 10 56 1.4 x 10
7
 60,000 2 x 10
9 
  No growth 
13 11 137 2.8 x 10
7
 2.7 x 10
7
 2.1 x 10
9
   No growth 
14 12 12 6.1 x 10
6
 2 x 10
4
 8 x 10
4
   No growth 
15 12 20 6.3 x 10
6
 0 6 x 10
4
 Positive 
16 12 96 8.2 x 10
6
 6 x 10
4
 7 x 10
5
 Positive 
17 13 224 7.7 x 10
6
 3.2 x 10
5
 5.2 x 10
5
   No growth 
18 14 49 7.7 x 10
6
 9.2 x 10
5
 6.4 x 10
5
   No growth 
19 15 29 4 x 10
4
 0 0 Positive 
20 16 67 2.1 x 10
9
 1.8 x 10
9
 1.3 x 10
9
   No growth 
21 17 20 0 0 0   No growth 
22 18 76 3 x 10
7
 2.3 x 10
7
 3.7 x 10
7
   No growth 
23 19 32 1.6 x 10
5
 0 6.6 x 10
5
 Positive 
24 17 143 0 0 0 Positive 
25 20 125 2.3 x 10
7 
2.3 x 10
7
 3.7 x 10
7
   No growth 
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4.1.2.1. Cultural analysis of clinical tracheostomy tubes 
 
From the ten tracheostomy tubes, the CFUs
 
per cm
2
 ranged from 3.4 x 10
9 
per cm
2 
to 400 CFUs per cm
2 
on Blood Agar, all of the specimens grew 
bacteria on the BA plates. The range of CFUs on FAA ranged from 1.4 x 
10
9 
on specimen number 9, to no growth from specimens numbered 2 and 7.  
Four out of the ten tracheostomy tubes (numbers 3, 4, 6 and 8) were also 
found to be positive for C. albicans (See Table 13).  
 4.1.3.1 Cultural analysis of Chronic Wound Dressings and Chronic 
Wound Biopsies 
Each 1 cm
2 
of dressing was analysed for number of CFUs present.  Number 
ranged from 120  106 CFUs per cm2 from specimen number 5, to 2800 per 
cm
2 
from specimen number 4.  The only specimen to have fungal growth, 
subsequently confirmed as C.  albicans, was number 5. (Table 14)  
Specimen 1 to 5 of the chronic wound biopsies correspond to Chronic 
Wound Dressing specimen numbers 1 to 5.  The biopsy specimen with the 
highest numbers of CFUs per cm
2 
was specimen 5, with 4.3  108 CFUs per 
cm
2
 correlating with specimen number 5 of the Chronic Wound Dressing 
cohort being most heavily infected.  However, dressing specimen number 4 
was the least populous from the dressings cohort, whereas biopsy specimen 
number 2 had the least number of CFUs per cm
2
 with only 4.2 x10
5
 CFUs 
per cm
2
.  None of the Chronic Wound Biopsy specimens grew any fungal 
elements, corresponding with the findings from the Chronic Wound 
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Dressing cohort, i.e. only of the specimens number five in the Chronic 
Wound Dressings group had positive fungal growth (Table 14).
   BA FAA SAB 
Tracheostomy Pt. Hours 
intubated 
CFUs per 
cm
2
 
CFUs per cm
2
 CFUs per 
cm
2
 
1 1 1128 2.4 x 10
6 
1.4 x 10
7 
 No growth 
2 2 840 7.5 x 10
5
 0  No growth 
3 3 1209 3 x 10
7 
2.8 x 10
8 
positive 
4 4 912 1.1 x 10
6 
2,000 positive 
5 5 504 3 x 10
8 
2.8 x 10
8 
 No growth 
6 6 240 3.4 x 10
9 
7 x 10
7 
positive 
7 7 135 400 0  No growth 
8 8 696 7.5 x 10
5 
5.6 x 10
5 
positive 
9 9 422 2.8 x 10
9 
1.4 x 10
9 
 No growth 
10 10 552 7.6 x 10
6 
6.2 x 10
5 
 No growth 
Table 13: Cultural analysis of clinical tracheostomy tubes using selective 
culture media for aerobic bacteria, anaerobic bacteria and for fungus. 
   BA FAA SAB 
Dressings Patient Dressing type CFUs per 
cm
2
 
CFUs per 
cm
2
 
CFUs per 
cm
2
 
1 1 Aquacel Ag 7 x 10
5 
 0  No growth 
2 2 Aquacel Ag 3.8 x 10
6 
 0 positive 
3 3 Flamazine 
and Aquacel 
6.2 x 10
5 
 0  No growth 
4 4 Aquacel Ag 2.8 x 10
3 
 0  No growth 
5 5 Inadine 1.2 x 10
9
  0 No growth  
 Table 14: Cultural analysis of clinical dressing samples using selective 
culture media for aerobic bacteria, anaerobic bacteria and for fungus. 
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Table 14 and 15: Cultural analysis of chronic wound samples using 
selective culture media for aerobic bacteria, anaerobic bacteria and for 
fungus. 
 
    BA  FAA  SAB 
Burns Patient Days post-
burn 
CFUs per 
cm
2
 
CFUs per 
cm
2
 
CFUs per 
cm
2
 
1 1 19 2 x 10
3
  0  No growth 
2 2 5 2.8 x 10
4 
3.3 x 10
4 
 No growth 
3 3 16  0  0 positive 
4 4 18 7 x 10
4 
 0  No growth 
5 5 24 0   0  No growth 
Table 16: Cultural analysis of burn wound samples using selective culture 
media for aerobic bacteria, anaerobic bacteria and for fungus. 
   BA FAA SAB 
Wounds Patient Aetiology CFUs per 
cm
2
 
CFUs per 
cm
2
 
CFUs per 
cm
2
 
1 1 VLU 8.4 x 10
5 
200  No growth 
2 2 Vasculitic 4.2 x 10
5 
 0   No growth 
3 3 Mixed 3.7 x 10
6 
 0   No growth 
4 4 VLU 4.2 x 10
6
  0   No growth 
5 5 DFU 4.3 x 10
9 
 0   No growth 
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4.1.3.2. Cultural analysis of burn wounds 
 
Two of the samples (Specimens 3 and 5) had no bacterial growth, although 
specimen 3 did grow C. albicans.  Specimen 4 was the most heavily 
infected specimen recording 70,000 CFUs per cm
2 
whereas Specimen 1 had 
only 2,000 CFUs present and specimen 2 had 28,000 present.  Other than 
Specimen 3, none of the other specimens contained C. albicans (Table 16). 
 
4.2.1 Identification of cultured isolates 
 
In an attempt to further elucidate the microbiological composition of the 
specimens, the DNA extracted from distinct cultured colonies was subjected 
to 16S rDNA PCR sequence analysis and then compared with the EMBL 
prokaryote database to identify microbial species.  These ranged from the 
expected S. aureus to the rarer Neisseria Perflava and Stenotrophomonas 
maltophilia.  These data are summarised in Tables 17-21.
99 
 
Specimen Number 
ETT no. 
Species recovered 
1 Bacilius pumilus 
2 Staphylococcus hominis 
3 Kocuria hominis 
4 Streptococcus pneumoniae 
5 Pseudomonas aeruginosa 
6 No growth 
7 No DNA recovered 
8 Pseudomonas aeruginosa 
9 Staphylococcus aureus 
10 Neisseria perflava 
11 Staphylococcus aureus, Stenotrophomonas 
maltophilia 
12 Enterobacter hormaechei 
13 Pseudomonas aeruginosa 
14 Staphylococcus homins 
15 Pseudomonas aeruginosa 
16 Staphylococcus haemolyticus 
17 Enterococcus faecium 
18 Staphylococcus aureus 
19 Staphylococcus aureus, Bacilus pumilus, 
Neisseria perflava 
20 Staphylococcus aureus, Pseudomonas aeruginosa 
21 Staphylococcus aureus 
22 Staphylococcus aureus 
23 Staphylococcus aureus 
24 No DNA recovered 
25 Pseudomonas aeruginosa 
   
Table 17: Culture dependent identification of bacterial species cultured 
from clinical endotracheal tubes using 16s rDNA PCR and gene 
sequencing. 
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  Media: BAP MAC FAA SAB 
ETT 
Num. 
Pt. Hours 
intubated 
CFUs per 
cm2 
CFUs per 
cm2 
CFUs per 
cm2 
CFUs per 
cm2 
1 1  4 x 10
4 
8 x 10
4
 0  No growth 
2 2 108 0 2 x 10
4
 0   No growth 
3 3 60 0 4 x 10
4
 2.2 x 10
5 
  No growth 
4 4 95 4 x 10
4
 0 1.2 x 10
5
   No growth 
5 5 43 1.8 x 10
5
 0 1 x 10
6 
Positive 
6 6 25  0  0  0   No growth 
7 2 94 2 x 10
4
 0 0   No growth 
8 7 289 0 2 x 10
4
 8 x 10
4
   No growth 
9 8 173 1.96 x 10
6
 1.52 x 10
6
 0   No growth 
10 6 41 1.78 x 10
6
 1.96 x 10
6
 0 Positive 
11 9 198 1.3 x 10
7 
6.9 x 10
6
  0   No growth 
12 10 56 1.4 x 10
7
 60,000 2 x 10
9 
  No growth 
13 11 137 2.8 x 10
7
 2.7 x 10
7
 2.1 x 10
9
   No growth 
14 12 12 6.1 x 10
6
 2 x 10
4
 8 x 10
4
   No growth 
15 12 20 6.3 x 10
6
 0 6 x 10
4
 Positive 
16 12 96 8.2 x 10
6
 6 x 10
4
 7 x 10
5
 Positive 
17 13 224 7.7 x 10
6
 3.2 x 10
5
 5.2 x 10
5
   No growth 
18 14 49 7.7 x 10
6
 9.2 x 10
5
 6.4 x 10
5
   No growth 
19 15 29 4 x 10
4
 0 0 Positive 
20 16 67 2.1 x 10
9
 1.8 x 10
9
 1.3 x 10
9
   No growth 
21 17 20 0 0 0   No growth 
22 18 76 3 x 10
7
 2.3 x 10
7
 3.7 x 10
7
   No growth 
23 19 32 1.6 x 10
5
 0 6.6 x 10
5
 Positive 
24 17 143 0 0 0 Positive 
25 20 125 2.3 x 10
7 
2.3 x 10
7
 3.7 x 10
7
   No growth 
Specimen Number Species recovered 
1 Bacilius pumilus 
2 Staphylococcus hominis 
 
3 Kocuria hominis 
4 Streptococcus pneumoniae 
5 Pseudomonas aeruginosa 
 
6 No growth 
7 No DNA recovered 
8 Pseudomonas aeruginosa 
9 Staphylococcus aureus 
10 Neisseria perflava 
11 Staphylococcus aureus, 
Stenotrophomonas maltophilia 
12 Enterobacter hormaechei 
13 Pseudomonas aeruginosa 
14 Staphylococcus homins 
15 Pseudomonas aeruginosa 
16 Staphylococcus haemolyticus 
17 Enterococcus faecium 
18 Staphylococcus aureus 
19 Staphylococcus aureus, 
Bacilus pumilus, Neisseria perflava 
20 Staphylococcus aureus, 
Pseudomonas aeruginosa 
21 Staphylococcus aureus 
22 Staphylococcus aureus 
23 Staphylococcus aureus 
 
24 No DNA recovered 
25 Pseudomonas aeruginosa 
Tables 12 and 17: Provided for comparison between cultural 
results, and outcomes of culture dependent PCR identification 
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Tracheostomy 
tube no. 
Species recovered 
1 Pseudomonas aeruginosa, Streptococcus pneumoniae, 
Staphylococcus aureus. 
2 Staphylococcus epidermidis, Pseudomonas 
aeruginosa, Staphylococcus epidermidis, 
Microbacterium trichotecenolyticum 
3 Kocuria marina, Pseudomonas aeruginosa 
4 Lactobacillus rhamnosus, Staphylococcus 
epidermidis, Pseudomonas aeruginosa 
5 Delftia spp 
6 Pseudomonas fulva 
7 Pseudomonas aeruginosa 
8 Pseudomonas aeruginosa 
9 Pseudomonas aeruginosa, Delftia tsuruhatensis 
10 Pseudomonas aeruginosa 
 
Table 18: Culture dependent identification of bacterial species cultured 
from clinical tracheostomy tubes using 16s rDNA PCR and gene 
sequencing.  
 Burn Specimen 
No. 
Species recovered 
1 Pseudomonas fulva, Oceanobacillus caeni, 
Staphyloccus aureus 
2 Staphylococcus aureus 
3 Staphylococcus sp. 
4 Staphylococcus aureus 
5 Staphylococcus aureus 
 
Table 19: Culture dependent identification of bacterial species cultured 
from clinical burn specimens using 16s rDNA PCR and gene sequencing. 
102 
 
   BA FAA SAB 
Tracheostomy Pt. Hours 
intubate
d 
CFUs per 
cm
2
 
CFUs per 
cm
2
 
CFUs per 
cm
2
 
1 1 1128 2.4 x 10
6 
1.4 x 10
7 
 No growth 
2 2 840 7.5 x 10
5
 0  No growth 
3 3 1209 3 x 10
7 
2.8 x 10
8 
positive 
4 4 912 1.1 x 10
6 
2,000 positive 
5 5 504 3 x 10
8 
2.8 x 10
8 
 No growth 
6 6 240 3.4 x 10
9 
7 x 10
7 
positive 
7 7 135 400 0  No growth 
8 8 696 7.5 x 10
5 
5.6 x 10
5 
positive 
9 9 422 2.8 x 10
9 
1.4 x 10
9 
 No growth 
10 10 552 7.6 x 10
6 
6.2 x 10
5 
 No growth 
Tracheostomy 
tube no. 
Species recovered 
1 Pseudomonas aeruginosa, Streptococcus pneumoniae, 
Staphylococcus aureus. 
2 Staphylococcus epidermidis, Pseudomonas 
aeruginosa, Staphylococcus epidermidis, 
Microbacterium trichotecenolyticum 
3 Kocuria marina, Pseudomonas aeruginosa 
4 Lactobacillus rhamnosus, Staphylococcus 
epidermidis, Pseudomonas aeruginosa 
5 Delftia spp 
6 Pseudomonas fulva 
7 Pseudomonas aeruginosa 
8 Pseudomonas aeruginosa 
9 Pseudomonas aeruginosa, Delftia tsuruhatensis 
10 Pseudomonas aeruginosa 
Tables 13 and 18: Provided for comparison between cultural 
results, and outcomes of culture dependent PCR identification in 
tracheostomy tubes 
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Chronic Wound 
No. 
Species recovered 
1 Streptococcus parasanguinis, Lactobacillus jensenii 
2 Enterobacter hormaechei 
3 No DNA recovered 
4 Staphylococcus aureus 
5 Streptococcus parasanguis 
 
Table 20: Culture dependent identification of bacterial species cultured 
from clinical chronic wounds 16s rDNA PCR and gene sequencing.  
Dressing No. Species recovered 
1 Staphylococcus aureus 
2 Staphylococcus epidermidis, Micrococcus luteus 
3 Staphylococcus aureus 
4 Staphylococcus aureus 
5 No DNA recovered 
 
Table 21: Culture dependent identification of bacterial species cultured 
from clinical dressings samples using 16s rDNA PCR and gene sequencing.  
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4.3 Molecular analysis of bacterial composition and diversity 
4.3.1 Detection of bacterial species by PCR 
The tracheostomy and endotracheal tube control specimens were analysed 
using PCR for specific bacterial species, to which they had already been 
exposed.  Pseudomonas aeruginosa and S.  aureus were detected from all 
the control tubes.  S.  mutans and P.  gingivalis were recovered from three 
tubes each (Figures 15-18). 
 
Figure 15: Gel showing PCR result of P. aeruginosa DNA species specific 
PCR from control ETT, with expected band of 528 base pairs (Lavenir et al. 
2007), alongside 100bp DNA marker ladders (Promega).
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Figure 16: Gel showing PCR result of S. aureus DNA species specific PCR 
from control ETT, with expected band of 289 base pairs (Liu et al. 2007), 
alongside 100bp DNA marker ladders (Promega). 
 
Figure 17: Gel showing PCR result of S. mutans DNA species specific PCR 
from control ETT, with expected band of 479 base pairs (Chen et al. 2007), 
alongside 100bp DNA marker ladders (Promega). 
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Figure 18: Gel showing PCR result of P. gingivalis DNA species specific 
PCR from control ETT, with expected band of 404 base pairs (Kulecki et al. 
2008), alongside 100bp DNA marker ladders (Promega). 
Clinical ETT and tracheostomy tube specimens were then processed using 
the specific primers for oral pathogens, S. mutans and P. gingivalis, and two 
opportunistic bacterial species, P. aeruginosa and S. aureus. (Figures 19-
22). Streptococcus mutans was present in six of the twenty five ETT 
specimens, P. gingivalis in five, P. aeruginosa and S. aureus were also 
present in five of the twenty five specimens.  In the tracheostomy tubes 
PCR products specific to the species S. aureus was found in five of the ten 
specimens, and P. aeruginosa in seven of the ten.  None of the tubes yielded 
PCR products from either S. mutans or P. gingivalis (Table 22).  
However, when comparing duration of intubation versus change in 
microbial composition, it can be seen that P. gingivalis is present in those 
who had been intubated for less than five days, compared with a 
preponderance of P. aeruginosa in those who had been intubated for longer 
than 5 days (Table 23). 
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ETT 
number 
P.aeruginosa S.aureus P.gingivalis S.mutans 
1 - - - - 
2 - - - - 
3 - - - - 
4 - - - - 
5 - + - - 
6 - - - - 
7 - - - - 
8 + - - - 
9 - + - + 
10 - + + - 
11 + + - - 
12 - - + + 
13 + - - - 
14 - - - - 
15 - - - - 
16 + - - + 
17 - - - - 
18 - + + - 
19 - - - - 
20 + + - + 
21 - - - - 
22 - + + - 
23 - - + + 
24 - - - - 
25 - - - - 
Table 22: Table showing the results of species specific PCR for each of the 
target species P. aeruginosa, S. aureus, P. gingivalis and S. mutans on 
clinical endotracheal tube specimens. 
Period of Intubation Less than 5 days Greater than 5 days 
P. gingivalis +ve 5/12 (41.67%) 0/9 (0%) 
P. aeruginosa +ve 1/12 (8.33%) 5/9 (55.55%) 
Table 23: Tabel showing change in microbiota over time, with a cut-off of 
96 hours there is demonstrable difference with a decrease of P. gingivalis  
numbers and a corresponding increase in P. aeruginosa  numbers.  
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Chronic wound, dressing and burn wound specimens were examined by 
species specific PCR analysis for the presence of the opportunistic 
pathogens S. aureus and P. aeruginosa.  The chronic wound dressings all 
revealed the presence of P. aeruginosa, but only one was S. aureus PCR 
positive.  Interestingly four dressings were positive for S. aureus by PCR 
whilst only one was positive for P. aeruginosa.  
In the five burn wounds, P. aeruginosa was recovered from two of the 
specimens, but no DNA was recovered from the remaining three dressings.  
 
Figure 19: PCR gel showing presence of P. aeruginosa in ETT, with 
expected band of 528 base pairs (Lavenir et al. 2007), alongside 100bp 
DNA marker ladders (Promega).
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Figure 20: PCR gel showing presence of S.aureus in ETT, with expected 
band of 289 base pairs (Liu et al. 2007), alongside 100bp DNA marker 
ladders (Promega) 
 
Figure 21: PCR gel showing presence of P. gingivalis in ETT, with 
expected band of 404 base pairs (Kulecki et al. 2008), alongside 100bp 
DNA marker ladders (Promega). 
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Figure 22: PCR gel showing presence of S.mutans in ETT, , with expected 
band of 479 base pairs (Chen et al. 2007), alongside 100bp DNA marker 
ladders (Promega).
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Table 24: A table showing the results of species specific PCR on Chronic Wounds, Dressings and Burns, assessing the 
presence or absence of the target species P. aeruginosa and S. aureus in the clinical specimens
Specimen   Specimen   Specimen   
Chronic 
Wound 
P.aeruginosa S.aureus Dressings P.aeruginosa S.aureus Burns P.aeruginosa S.aureus 
1 + - 1 + + 1 + - 
2 + - 2 - + 2 + - 
3 + - 3 - - 3 - - 
4 + + 4 - + 4 - - 
5 + - 5 - + 5 - - 
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4.3.2 DGGE to determine bacterial diversity of biofilm 
communities on ETTs and tracheostomy tubes 
 
Denaturing Gradient Gel Electrophoresis (DGGE) allows for assessment of 
multiple specimens at the same time, and givens an indication of the 
bacterial diversity present. The initial PCR performed with the universal 
primers gives multiple 194 base pair length products. These products are 
denatured by the gel at different rates depending on the proportion of A-T 
or C-G bonds between the nucleotides. This means that the different 
products will be spread out through the gel. Some bands may overlap within 
the gel, and some specimens may produce more than one band. On average, 
however, each separate band within the gel corresponds to a separate 
bacterial species. This, therefore, gives us a DNA “fingerprint” for each 
specimen allowing rapid comparison of the populations present in each 
clinical sample. DGGE profiling of the ETT specimens showed multiple 
bands present within many of the specimens, and showed objective 
similarities between the specimens and the positive controls (Figure 23).  
An average of 6 bands (range 3 to 22) per endotracheal tube sample was 
detected and the similarity in banding profiles ranged between 20 and 90%.  
There was no apparent relationship between the duration of intubation and 
the number of DGGE bands detected, nor was there a high level of 
similarity for the DGGE profiles obtained for multiple endotracheal tubes 
from the same patients (i.e. patient 2, tubes 2 and 7; patient 17, tubes 21 and 
24) The mixed marker containing DNA from P.aeruginosa, S.aureus and 
P.gingivalis showed bands consistent with those in Tubes 9, 18 and 20, 
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which all had the presence of S.aureus as determined by the species-specific 
PCR.   
Tracheostomy tube specimens also showed multiple bands, with an average 
of 5 bands (range 3 to 10) per sample (Figure 24). These showed a 
similarity in banding profiles between 30 and 67% (Figure 25). They were 
also compared to ETT specimens and to the duration of placement within 
patient. 
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Figure 23. Cluster analysis with Ward's algorithm based on the Dice 
coefficient demonstrating the diversity in DGGE profiles generated from 
endotracheal tube (ETT) biofilms. This figure shows the similarity or 
otherwise between different clinical endotracheal samples, with the most 
similar tubes being tubes 1 and 17, possibly due to a relative paucity of 
bands in these samples
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Figure 24: DGGE of Tracheostomy tubes, bracketed by marker species. This gel shows the number of different bands present 
in each sample, while some bacteria may produce two or more bands, and some bands may occupy the same location, this gel 
shows a quick fingerprint of the diversity of bacteria present within each specimen. 
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Figure 25. Cluster demonstrating the diversity in DGGE profiles generated 
from endotracheal and tracheostomy tubes. This dendrogram shows a 
comparison between the populations of both the ETT and TT, there is little 
grouping between the different tubes.
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Subsequently DGGE was used as a method to compare PCR products from 
chronic wounds and the PCR products from their associated dressings 
(Figure 26). 
 
Figure 26. Dendrogram analysis comparing similarities of chronic wound 
and dressing DGGE band distribution. In this image comparing the bands 
produced by each sample, if the dressings populations were a good allegory 
for the wound populations, I would expect to see dressing 1 grouped with 
chronic wound 1 and so forth. 
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4.3 Structural analysis of bacterial distribution and 
biofilm structure using confocal laser scanning microscopic 
(CLSM) analysis 
 
4.3.1 Validation of PNA probe specificity using planktonic 
bacterial cultures 
 
In order to assess the functionality of the PNA fluorescent probes, the 
probes were validated using fixed planktonic cells of known species (S. 
aureus, P. gingivalis, and P. aeruginosa) by hybridization and CLSM 
(Figures 26-28).  In this scenario, all probes worked as anticipated, as they 
were used on monocultures there was no evidence of cross reactivity. 
 
Figure 27. Planktonic P. aeruginosa control labelled with FITC fluorescent 
label using the specific P.aerugionsa PNA probe. 
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Figure 28. P. gingivalis in a planktonic phenotype, stained with the 
universal probe and labelled with the Cy-5 flurochrome. 
 
Figure 29. Planktonic S.aureus labelled with the specific S. aureus PNA 
probe and Cy-3 fluorescent label. The labels are all displayed as orange in 
the above images as this is the default setting for the confocal microscope.
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4.3.2 CLSM analysis of bacterial biofilms on recombinant 
human epithelium 
 
Sections of pre-infected fixed specimens of recombinant human epithelium 
were examined using PNA fluorescent probes.  Staining of both S. aureus 
and P. aeruginosa could readily be seen (Figures 30 and 31).  The bacteria 
were visible in aggregates along the length of the RHE section, on both 
sides, with expanses of the tissue showing no bacteria at all.  In no areas on 
the RHE did the target species occupy the same tissue location, but instead 
showed up as separate and distinct clusters. 
 
Figure 30. Species specific PNA probe staining an RHE section showing 
aggregrates of P. aeruginosa
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Figure 31. Species specific PNA probe staining an RHE section showing 
aggregrates of S. Aureus. 
 
4.3.3 CLSM analysis of bacterial biofilms on in vitro ETT 
  
Sections of control tubes were stained with the Universal, S. aureus and P. 
aeruginosa PNA probes.  These images showed a predominance of S. 
aureus and P. aeruginosa bacteria (Figures 32 and 33).  Due to the large 
numbers of brightly staining S. aureus (depicted blue) and P. aeruginosa 
(depicted green) it was impossible to determine whether smaller numbers of 
other bacterial species were being detected by the universal stain.  In these 
images it was, however, possible to see the bacteria forming three-
dimensional structures, and not merely assuming a laminar colony.  The 
bacteria have formed on both the inside and outside of the control tubes 
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equally, which were cultured in vitro and therefore lacking in external 
incentives to colonise one wall or another of the control tube. 
 
Figure 32. Mixed bacterial aggregates on control tube labelled with 
Universal probe, and species specific probes for S. aureus, P. aeruginosa, 
and S. mutans 
 
Figure 33. Species specific probes for P. aeruginosa on a control tube
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4.3.4 Confocal microscopy on clinical samples of 
endotracheal and tracheostomy tubes 
 
Imaging of clinical tracheostomy tubes showed both thick layering of S. 
aureus (Figure 34) and of other potent biofilm formers (Figure 35) and 
mixed biofilms of different species (Figure 36). Some of the three-
dimensional bacterial layering projected significantly into the lumen, 
whereas other colonies remain flattened against the tube wall.  Interestingly 
those aggregates which projected the most appeared to be comprised of a 
more uniform bacterial population, and those with a mixed population 
appear flatter.  Figure 36 shows an aggregate present both within and 
without the tube and across the sectioned end of the tube, this is unlikely to 
have occurred in vivo and may be as a result of the staining process 
dislodging the biofilm. 
 
Figure 34. Tracheostomy tube stained with Universal and species-specific 
probes for S. aureus, P. aeruginosa and S. mutans probes, showing only S. 
aureus aggregates. 
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Figure 35. Bacterial aggregates labelled with P. aeruginosa species specific 
label within endotracheal tube lumen 
 
Figure 36. Clinical tracheostomy tube specimen labelled using P.aeruginosa 
specific label (green), S. aureus label (red), Universal (yellow), and S. 
mutans specific label (blue). This shows two separate colonies, one of P. 
aeruginosa and the other of S. aureus. 
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Figure 37. Clinical tube specimen stained with all four probes, S. aureus 
here depicted as blue visible inside and outside of tube lumen
 
4.3.5 Confocal microscopy on Chronic Wounds, Dressings 
and Burn Wounds 
 
Chronic Wounds and Burn Wounds revealed limited amounts of bacteria, 
but those that were present tended to be aggregated (Figures 38 and 39), this 
possibly reflects a harsher environment in treated wounds when compared 
with the relative sanctuary of the lumen of an endotracheal tube.  
Conversely within the interstices of dressings a highly organized mixed 
species biofilm was clearly visible (Figures 40 and 41) adherent to the edges 
of the dressing matrix and forming a large three-dimensional biofilm 
(Figure 41).  This appeared to consist of only one bacterial type (those 
successfully stained with the S. aureus PNA probe, cyanine 5 exciting at 
633 nm), possibly those which were most resilient to the antiseptic with 
which the dressing was impregnated. 
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Figure 38. Chronic wound specimen labelled with P. aeruginosa (green), S. 
aureus (blue) and Universal (yellow) specific probes, showing diffuse 
Pseudomonas aggregate 
 
Figure 39. Burn wound specimen labelled with P. aeruginosa (green), S. 
aureus (blue) and Universal (yellow) specific probes, showing diffuse S. 
aurues aggregate 
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Figure 40. Bacteria within an Inadine dressing, fluorescing after having 
been labelled with the species specific probes for P.aeruginosa (green) and 
S. aureus (blue). 
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Figure 41. Bacterial aggregate within a dressing, showing the distinct square 
shape of the inner walls of the dressing (Inadine). 
 
Figure 42. Side of view of bacterial biofilm within a dressing intersticis, 
denoting its thickness and three-dimensionality 
Figures 40 – 42: Clinical dressing specimen labelled with Universal probe, 
and species specific probes for P. aeruginosa (green) and S. aureus (blue). 
129 
 
Chapter 5: Discussion 
This study is centered around biofilms, and their interaction with medical 
devices and patients. Different techniques have been employed to examine 
the biofilms, and the chapters have been laid out in a fashion to explore 
each of the different techniques. This study has focussed on the bacterial 
and, to a lesser extent, the fungal components of the biofilms. The 
Extracellular Polymeric Substances (EPS), while making up the majority of 
the biofilm in terms of volume, are not the focus of this MD. The majority 
of the pathogenicity of a biofilm comes from its bacterial progenitors and 
inhabitants, and it is for this reason that techniques such as Scanning 
Electron Microscopy (SEM) and similar were not employed. In the 
following sections, the results of each technique have been drawn together 
under their specimen sub-headings, to try to provide an over-arching 
understanding of how the biofilms interact in these arena, and to formulate 
further theories on how future studies may target them. 
Endotracheal tubes 
 
Biofilms seem to readily colonise artificial surfaces such as the lumen of an 
endotracheal tube (ETT) or venous cannulae.  Many treatments exist to 
target bacteria and even to reduce biofilm formation in these areas (Chastre 
2008).  Oral microflora within biofilms (i.e. dental plaque) has been shown 
to have a role in Ventilator-Associated Pneumonia (VAP) (Adair et al., 
1999; Ramirez et al., 2007).  The ETT provides a point where a biofilm 
may form and subsequently disperse into the lung fields (Pneumatikos et 
al., 2009).  The immunological devoid haven provided by an ETT is a moist 
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environment, with turbulent airflow that favours adherence and subsequent 
biofilm formation.  The use of oral hygiene methods to prevent „seeding‟ of 
oral biofilm forming bacteria into the lungs, potentially causing pneumonia, 
has been proven effective (Di Filippo and De Gaudio 2003) and there is 
mounting evidence to support the concept that poor oral health is related to 
the aetiology of bacterial VAP and a number of studies have suggested 
improved oral hygiene may be effective at reducing its incidence (Koeman 
et al., 2006; O‟Keefe-Mcarthy 2006; Tantipong et al., 2008).   
Cultural analysis of the ETTs in this study showed large numbers of readily 
recoverable aerobic bacteria often with a preponderance of P. aeruginosa 
and S. aureus, these bacteria showed large numbers of CFUs in both the in 
vitro and in vivo studies, possibly outcompeting other bacteria (Table 9, 
Chapter 3.1.2).  Standard methods of cultural analysis have been shown to 
be imperfect tools for analysing biofilm communities (Donlan and 
Costerton, 2002).  This was previously elucidated in 2007 by Bahrani-
Mougeot et al. who showed the presence of oral bacteria in VAP patients 
using clonal analysis techniques (Bahrani-Mougeot et al., 2007).  This 
present study was also able to demonstrate the recovery of DNA from 
potent oral biofilm formers from the lumen of the ETT confirming the 
theories of Sottile et al. (1996) that oral microflora does form biofilms with 
ETT.  This shows the potential benefits of the work started by Adair et al. in 
attempting to decrease patient VAP morbidity by modulating oral 
microflora.  Whether nebulised antibiotics (Adair et al., 1999) will prove to 
be sufficiently efficacious remains to be seen, or whether the use of biofilm 
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behaviour modifiers such as dispersal initiating quorum-sensing molecules 
can be applied clinically applied or not. 
Species-specific PCR for the oral marker species Streptococcus mutans and 
Porphyromonas gingivalis showed that these bacteria were present in 9 of 
the 20 ETT specimens (45%).  These marker bacteria were chosen because 
S. mutans is a recognised former of oral biofilms and has a proven role in 
dental caries (Burne 1998; Schaeken et al., 1986) and P. gingivalis as an 
indicator of strictly anaerobic oral flora and is commonly the responsible 
pathogen for subgingival abscess formation (Saini et al., 2003; Kulecki et 
al., 2008).  However, the analysis of tongue swabs in the 2007 paper by 
Bahranir-Mougeot et al. showed that in the patients with VAP there was no 
evidence of S. mutans or P. gingivalis, although the Perkins paper in 2010, 
found that of the 1263 gene sequences recovered from ETT in VAP 
patients, 348 were streptococcal, 179 were from Prevotella, and 143 from 
Neisseria species (Perkins et al., 2010).  
Candida albicans is yeast, which may be found as a common coloniser of 
the oral cavity.  The presence of Candida as an oral microbe is well 
founded, and its occurrence in cases of VAP has previously been 
documented (Azoulay et al., 2006; Wood et al., 2006).  The role of C. 
albicans in the formation of biofilms within the ETT does however remain 
unclear. The incidence of Candida albicans recovered in this study is 
approximately twenty five percent, which is analogous to the endogenous 
incidence within the general population.  Candida albicans was identified 
using cultural techniques in 5 of the specimens taken from the ETTs, and it 
is therefore tempting to postulate that it is involved in the formation of a 
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pathological biofilm with the ETT.  The interaction between different 
microflora to form a stable biofilm is complex, and the relationship between 
Candida and oral bacteria is based on co-aggregation and the facilitation of 
luminal binding, (Branting et al., 1989; Shinada et al., 1995; Shirtliff et al., 
2009) it is postulated the filamentous hyphae of Candida can add structural 
support to the biofilm (Lopez-Ribot, 2005), which may be particularly 
advantageous in the high shear environment of the ETT lumen.  Some loss 
of microbial viability between the time of removal of the ETT from the 
patient and its subsequent processing for culture is likely, despite the time 
between these procedures being kept as short as possible.  The fact that 
microbial DNA was obtained from these ETTs would suggest microbial 
cells (viable or non-viable) had been present and highlights the benefit of 
supplementing the culture analysis with molecular investigation. 
Confocal Laser Scanning Microscopy (CLSM) of clinical specimens 
showed both thick biofilm layering by S. aureus and of other potent biofilm 
formers, such as S. mutans and P. aeruginosa.  Mixed biofilms of other 
bacteria, which were not specifically targeted, were also present.  Some of 
the three dimensional bacterial layering projected significantly into the 
lumen, whereas other colonies remained flattened against the tube wall, it is 
believed the inner surface of the ETT provides a unique environment of 
high shear forces, bi-directional flow, and a restricted immunological 
environment, which favours a sessile rather than planktonic bacterial life 
form and thus biofilm formation.  Interestingly those colonies which project 
the greatest height appear to have a more uniform bacterial population, and 
those with a mixed population appear more sessile.  Comparing duration of 
133 
 
intubation with types of flora present may explain this phenomenon.  
Specimens which were examined after a relatively short period of intubation 
(<96 h) showed a preponderance of oral microbiota, whereas those 
specimens from patients who had been intubated for a longer period (>96 h) 
showed an increase in numbers of the traditional hospital acquired bacteria, 
namely P. aeruginosa and S. aureus (Table 15 and Figure 43).
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Figure 43: A graph showing how bacterial population with an ETT changes 
over time, based on positive detection rate on species specific PCR. 
 
 This corresponds to the 2010 study by Perkins et al. which showed 
approximately 70% of the sequences retrieved from eight ETTs had typical 
oral microflora, whereas the tube which had been in-situ for 23 days had a 
95% prevalence of P. aeruginosa (Perkins et al., 2010). The presence of 
oral microflora within the biofilm and as possible instigators of the biofilm 
has significant implications in the management of these patients. If the 
population of oral microflora can be decreased or modulated this may 
decrease the numbers involved in the initial formation of a biofilm, and the 
oral cavity provides an easily accessible portal to influence the ecology 
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within an endotracheal tube, compared with attempting to access the lumen 
itself. 
If instead of a cohesive symbiotic relationship between bacteria, what is 
actually being observed is hospital acquired bacteria „out-competing‟ 
existing host bacteria, it could potentially explain why a polymicrobial 
biofilm is flatter and not in a vertical growth phase. In a symbiotic scenario 
there would be less competition for available nutrients and other building 
blocks of the abiotic matrix, whereas in a competitive scenario energy and 
nutrients would be at a premium and allow for less expansive growth. A 
recent study by Mitria et al. (2011) showed that when nutrient competition 
is strong, the addition of new species can inhibit co-operation, whereas 
when nutrients are abundant co-operation is enhanced, and there was even 
evidence of species which are advantageous to the biofilm being 
“protected” within the biofilm to protect them from competition from non-
advantageous species (Mitria et al., 2011). Alternatively, in a monocultural 
biofilm, if all bacteria of the same type had a role in producing EPS it could 
in theory produce a thicker and more prominent biofilm structure compared 
to a multicultural biofilm where there would be differing abilities and 
genetic aptitudes to biofilm formation.  
Analysis of the biofilms using DGGE showed multiple bands present in all 
specimens indicating the presence of many different bacterial species, 
although the DNA detected need not necessarily be from viable bacteria, 
and may represent earlier inhabitants of the biofilm. 
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Accurate counts of colony forming units per 1 cm section of ETT were 
obtained for both aerobic and anaerobic bacteria using a number of different 
culture media; however subsequent DNA analysis to confirm species 
identity was only undertaken on aerobic bacteria.  Similarly, samples stored 
in formalin for CLSM perished and therefore three-dimensional analysis of 
the biofilm within the ETT lumen was not possible.   
Already, the use of improved oral hygiene has been shown to decrease rates 
of VAP, this study shows oral microbiota are found in endotracheal tubes 
upto the first five days of intubation and may therefore play an important 
role in the initiation of a biofilm within the lumen. Treatments targeted at 
this initial stage, such as the coating the inner lumen of the ETTs or targeted 
antibiotics at S. mutans and other oral biofilm formers prior to intubation 
may help. Additionally, as it is the passage of bacteria around the outside of 
the ETT balloon into the lung airways that allows inoculation of the bacteria 
within the ETT, then redesign of these tubes may prevent this crucial step. 
Whether it is more pliable balloon material, or more sizes available so that 
the tubes fitted more snugly remains to be seen. With the tracheostomy 
tubes there are tubes which have replacable inner linings, something similar 
could be designed to allow frequent changes of the inner lumen of the ETT. 
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Tracheostomy tubes 
 
The presence of biofilms within medical devices is well documented (Kuhn 
and Ghannoum 2004; Costerton et al., 2005; Weisbarth et al., 2007).  A 
recent observational study using scanning electron microscopy identified 
biofilms present on 4 out of 7 tracheostomy tubes in long term ear, nose and 
throat patients.  This study identified paired Gram-positive cocci in the 
biofilms, which they felt were consistent with Staphylococcus epidermidis 
biofilm formation (Meslemani et al., 2010).  This reaffirms the findings in 
the study by Jarrett et al. demonstrating the presence of both S. epidermidis 
and P. aeruginosa (Jarrett et al., 2002).  
Standard cultural analysis showed that there were viable bacteria present in 
tracheostomy tubes and subsequent DNA analysis, showed the presence of 
S. epidermidis in three of the specimens, and P. aeruginosa in five of the 
specimens confirming the findings of the above studies. This was further 
underlined using species-specific analysis where S. aureus was found in 
five of the ten specimens, and P. aeruginosa in seven of the ten.  None of 
the tubes yielded DNA from either S. mutans or P. gingivalis.  Additionally, 
other bacterial species were isolated such as S. pneumoniae, Lactobacillus 
rhamnosus and S. hominis suggesting a polymicrobial aspect to the biofilm 
colonies within tracheostomy tubes not previously elucidated.  The oral 
bacterial species Streptococcus mitis was isolated from one of the tubes, and 
C. albicans was recovered using standard microbiological culture 
techniques in four other cases, suggesting that there is an element of oral 
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seeding of the tracheostomy tube such as that seen in ETTs.  The 
subsequent structural analysis echoed the work of Jarrett et al. (2002) 
showing staphylococcal and Pseudomonas biofilms, but again it 
additionally showed polymicrobial colonies present in biofilm phenotype 
with the lumen. 
Comparing the data from ETT and tracheostomies there are a few notable 
differences, while the oral species thought to play a vital role in ETT 
biofilm formation, S. mutans and P. gingivalis were both present in the 
ETT, none was recovered from the Tracheostomy tubes. In almost all cases 
of surgical tracheostomy insertion the patient has a preceding ETT in their 
airway. It is possible in this way that the bacteria are inoculated into the 
patients‟ airways before subsequently re-infecting the tracheostomy tube. 
The pathway of a bacterium would be thus, oral cavity and teeth, into ETT 
lumen, blown into the airway by the process of ventilation, and then onto 
the tracheostomy tube as it is inserted surgically. The absence of S. mutans 
and P. gingivalis in the tracheostomy tubes may be due to these bacteria 
never having been present in the patients, or perhaps is due to the demise of 
these bacteria. Alternatively, these bacteria may have been present in the 
initial ETT inserted prior to tracheostomy insertion, and remained there 
adherent to the luminal wall and not been transferred to the patients‟ 
airways. These ETT are often only present for a fairly short time, typically 
less than 48 hours before being exchanged for a formal tracheostomy tube. 
If the C. albicans found in approximately 25% of patients in this study were 
indeed endogenous then it could have infected the tracheostomy tubes 
without needing the additional vector of the ETT. 
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Another reason for the variation between the two populations is that unlike 
an ETT which passes through the oral cavity, the tracheostomy tubes pass 
through the skin directly onto the anterior surface of the neck. This provides 
bacteria with another potential entry point into the airway, and may explain 
the presence of the skin commensural S. epidermidis within the 
Tracheostomy tube specimens. 
Burn wounds 
 
Burn wound sepsis is a frequent complication in the management of burns, 
and it is felt that wound infection is a common cause of wound progression 
or deepening (Singh., 2007).  Infection is the most frequent and most severe 
complication of burn injuries (Wassermann 2001).  A recent study by 
Kennedy et al. (2010) showed that biofilms could form on burn wounds, 
and may therefore play a role in the delayed healing of some burn wounds.  
P. aeruginosa is a common opportunistic pathogen in burn wounds, and has 
been shown to be an excellent biofilm former (Bielecki et al., 2008).  
Standard cultural analysis of the 5 burn tissue specimens revealed sparse 
growth, with 3 of the 5 specimens having no recoverable, viable bacterial 
growth; the other two specimens had growth of 2000, and 28,000 CFUs/cm
2
 
respectively. 
Using species-specific DNA analysis, P. aeruginosa was detected in 40% of 
the burn wound tissue, which corresponds with a recent paper by Rezaei et 
al. showing the presence of P. aeruginosa, Acinetobacter and Klebsiella 
spp. in burn wounds (Rezaei et al., 2011).  This was further confirmed by 
the use of CLSM which showed aggregated colonies of bacteria which 
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fluoresce after having been treated with the Pseudomonas specific probes 
(836), while the tissue specimens analysed showed some degree of 
polymicrobial contamination, they were much less diverse than the ETT 
colonies and this may represent a less favourable environment for biofilm 
formation. The relatively sparse diversity identified within the burn biofilms 
may therefore instead represent the apogee of competition within the 
biofilm. Further weight is added to this hypothesis when looking at diversity 
within the tracheostomy tubes, with an average intubation time of 664 h, 
where the degree of diversity is somewhere between that of ETTs and burn 
wounds. The theory of social evolution in biofilms suggests there is 
competition, as well as a degree of collaboration in biofilms between 
bacterial species (Poltak and Cooper 2011; Mitri et al., 2011) and whether 
the paring down of diversity represent finessing of collaboration, or the 
outcome of competition remains to be seen. 
 
Chronic Wounds and Dressings 
 
Chronic wounds may have many and varied aetiologies, ranging from 
vascular insufficiency, such as venous leg ulcers or arterial ulcers, to those 
caused by direct damage to the epithelium of the skin, such as trauma or 
pressure ulcers.  Chronic wounds are defined as wounds, which have failed 
to proceed through an orderly and timely reparative process to produce 
anatomic and functional integrity over a period of three months (Mustoe et 
al., 2006), these wounds provide an area where bacteria are able to grow 
and even thrive.  Often treating the underlying cause of an ulcer will allow 
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it to heal, however a significant delay in wound healing may occur with a 
contaminated or infected wound (Robson, 1997).  The combat of infection 
in such patients is often a prime objective of wound management strategies 
(Price 2005; Edwards 2009).  It should, however be mentioned that wound 
healing can still occur even in the presence of bacterial contamination 
(Krizek and Robson, 1975).  The impact of infected wounds to a patient 
should not be underestimated.  Pain and subsequent lack of sleep, and 
overpowering odour along with delayed wound healing are a few of the 
complications of infection that patients cope with on a daily basis (Price and 
Harding 1996, Ebbeskog and Ekman 2001).   
In all chronic wound specimens (tissue biopsies and dressing samples), 
viable bacteria were recovered.  All of the tissue biopsies had P. aeruginosa 
and one biopsy had S. aureus.  Conversely all of the dressings had viable 
staphylococcal bacteria on them, with only one yielding P. aeruginosa.  
With the dressings and the wounds in close proximity, one might expect 
there to be a similarity between the bacterial populations sampled.  For 
example, dressing 1 was taken from the same wound which was biopsied 
for wound 1.  However, using denaturing gradient gel electrophoresis 
(DGGE) to obtain a genetic fingerprint of each specimen, and subsequently 
comparing them using GelCompar software, showed almost no similarity 
between the populations.  This may be due to the properties of the dressing 
used, causing a selection bias of bacteria able to colonise the dressing 
compared to the wound surface. Some dressings are designed to absorb the 
bacteria within the body of the dressing such as Aquacel Ag. Additionally, 
the presence of Silver in both the Aquacel Ag dressings and the Flamazine 
142 
 
dressings will have a marked effect of the bacterial population therein.  
Indeed, structural analysis of the bacterial colonies present in both types 
(dressing and biopsy) of specimen show marked differences. CLSM of the 
wound surface shows quite flat aggregates of bacteria, with very little in the 
way of biofilm architecture, with the appearance more in keeping with a 
clumping effect; compared to the bacteria of the dressings, which shows a 
definite three dimensional structure in keeping with biofilm formation.  The 
biofilm within the dressing has formed within the interstices of the dressing 
mesh, which may have provided enough of an original scaffold for the 
biofilm to form on, almost analogous to the use of candidal hyphae in oral 
biofilms.  Additionally, the bacteria on the surface of the wound may have 
formed a biofilm between wound surface and dressing which has been 
disrupted and destroyed in the process of removing the dressing and 
sampling the wound.  This would explain why the biofilm within the 
dressing interstices have survived relatively unscathed, while the biofilm 
remnants left on the wound surface have collapsed into shapeless 
aggregates. This has significant impact in respect of being able to use 
dressings as surrogates in the diagnosis of biofilms. While the presence or 
absence of abiotic biofilm matrix might be visible on the removed dressing, 
the structure of the biofilm both on the dressing and on the wound will have 
been irreversibly damaged by the removal of the dressing. Currently this 
would impact our ability to tell the age of a biofilm, by the presence of 
water channels and so forth, but as our understanding of biofilm architecture 
and ecology grows, so greater forensic information may be lost in this 
manner. Similarly, only those bacteria closest to the uppermost surface of 
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the biofilm or in contact with the dressing will be identified in this manner, 
and a potentially significant portion may be left behind within the collapsed 
biofilm architecture. 
 
Study limitations 
 
As in the case of the chronic wound dressings and chronic wound biopsies, 
specimen sampling may negatively impact on the biofilm which is under 
investigation.  While the haven of the mesh dressing allowed direct 
visualisation of the biofilm there, any biofilm architecture stretching from 
wound surface to dressing was inevitably disrupted.  Similarly the methods 
for processing samples may disrupt the biofilm architecture, biofilms which 
are free standing on a luminal, or wound surface are exposed to shear forces 
during the preparation and staining of the specimens.  The use of different 
species-specific probes to enable different species to be detected gives 
evidence and ideas about the polymicrobial nature of the colonies present, 
but little idea of any biofilm architecture not directly related to the presence 
of bacteria, the abiotic portion of the biofilm may not be visualised in this 
way.  Some of the images obtained in control experiments, such as using the 
CLSM to look at infected recombinant human epithelium surfaces clearly 
show bacterial aggregates on both sides of the epithelium, when only one 
side was infected (Figure 30, Chapter 3.3.2). Many of the biofilms 
fragments have been flipped over or transposed during the preparation 
process. While the firmer bases of the ETT, tracheostomy tube, and dressing 
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material allow for preservation of biofilm architecture, the finer specimens 
are much more easily disrupted.  
The use of fluorescent in-situ hybridization (FISH) enables visualisation of 
bacterial species present and their orientation within the biofilm and to 
some extent allows postulation of the abiotic architecture, it has its 
limitations such as sampling and preparation problems, along with being 
unable to assess viability or accurately identify all species and bacterial 
subtypes present.  Many of the methods used throughout this study are able 
to accurately analyse one aspect of bacterial behaviour, but are deficient in 
other areas.   Cultural analysis is constrained by our current understanding 
of conditions in which bacteria may grow in-vitro, whatever environment 
we provide in an anaerobic incubator on specific growth media, it is 
unlikely to be a perfect match for those conditions found in the deepest 
parts of a biofilm.  Cultural analysis provides an estimate of viable 
microbial numbers present and as such represents a guide to the relative 
population of each specimen.  It does not, however, reveal anything about 
the natural history of the biofilms, which species may have taken the initial 
adherence steps before being swept away and out-competed by other 
bacteria.  In wounds which have been treated for many weeks, such as burn 
wounds, or even many months in the case of the chronic wounds, with 
antiseptics, and antibiotics, the bacteria which are available for culture may 
not be the same as those which originally initiated the biofilms, or may be 
existing within them as persister cells. 
Some of these limitations are offset with the use of DNA analysis 
techniques.  Species-specific PCR will tell us if certain choice bacteria are 
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present, such as oral pathogens in the ETT and tracheostomy samples, but 
will not reveal their viability.  The presence of the DNA shows only that the 
bacterial DNA was present, and not whether the bacteria it came from was 
viable or had indeed even been so.  
Subsequent DNA analysis using PCR techniques of the bacteria recovered 
using standard culture techniques provides another strand of information 
about the nature of the polymicrobial community.  This was performed on 
the bacteria which were recovered and grown in the laboratory from the 
original specimens.  It is therefore subject to the same problems as standard 
cultural analysis, that of sampling problems, and accurate culture 
conditions.  Assuming no environmental contamination of the specimens, 
this technique does, at least, tell us that some viable bacteria were present, 
and provides an accurate identification thereof.  
Another method used to gain an estimate of degree of bacterial diversity 
within a population is with DGGE.  DGGE can provides a fingerprint 
profile of a microbial population present based on different PCR product 
sequences, frequently these products are obtained from the 16s rRNA genes. 
The subsequent profile of bands for each specimen gives an indication of 
the richness of a population (number of bands) and the similarity of species 
(band positions).  However, bands at the same positions are not necessarily 
of the same size or indeed sequence and may therefore not originate from 
the same species.  DGGE technique is not culture dependent, but instead 
takes DNA samples directly from each specimen.  As such the method does 
not differentiate between living and dead bacteria present, but rather looks 
at all bacterial DNA present at a single point in time.  This method does not 
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tell us about the phenotype or potential for biofilm formation, its strength 
lies in its ability to compare many diverse samples, and with the help of the 
GelCompar software, give a measurement of similarity between specimens.  
In this way we can see that there is significant compositional complexity 
and inter-patient diversity between samples.  
 
Future Work 
 
This study has provided confirmatory data to support some of the existing 
work in the area of oral biofilms, such as that performed by Sottile and 
colleagues (Sottile et al., 1996) and the role of maintaining good oral 
hygiene in ventilated patients is already happening in the clinical 
environment, although a recent study by Needleman et al. (2011), showed 
no benefit on VAP rates when using a powered toothbrush on patients 
compared to using a tooth spongette.  
The presence of oral microbiota in the biofilm phenotype within ETT and 
tracheostomy tubes is a novel finding for this study.  However, further work 
needs to be directed into this area to continue to drive down morbidity and 
mortality in the critical care environment. For example, some critical care 
units use one disposable airway suction catheter for the duration of the 
patients‟ stay in critical care, and this may be an important source of 
bacterial inoculation into the airway, especially considering  the discovery 
of biofilms within endotracheal and tracheostomy tubes which may be 
acting as a reservoir of pathogens. The presence of a biofilm within the 
lumen of an ETT means that the lumen will be narrowed, and as such a 
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proportionally higher ventilatory pressure will be required to ventilate the 
patient. This incurs the problems of potentially blowing pathogens into the 
lung parenchyma, and has increased risks of iatrogenic barotrauma. 
Nebulised antibiotics have been prescribed with the aim of reducing the 
incidence of VAP (Adair et al., 2003); it may be that targeted quorum-
sensing or biofilm dispersal signalling agents delivered in small nebulised 
doses either at preintubation or during the course of the patients‟ stay in 
critical care may improve survival figures.  
The insertion of tracheostomy tubes is a difficult and skill intensive 
procedure with a high number of possible complications (Table 4, Chapter 
2), and as such it is often delayed until such time as it is apparent that there 
is no other alternative for safe patient ventilation. However, as this study 
shows, there is an increase in the number of hospital-based pathogens 
within the biofilm population within a patient‟s airway over time.  It may, 
therefore, prove to be of benefit if the patient has their ETT replaced with a 
tracheostomy earlier in the course of their illness.  A study comparing rates 
of VAP in selected populations with their timing of surgical tracheostomy 
insertion may show a significant decrease in morbidity associated with 
VAP; however, such a study would need to also assess whether there was a 
concomitant increase in complications associated with the tracheostomy 
tube itself.  Furthermore using DGGE, patients‟ oral microflora could be 
assessed pre-tracheostomy insertion and those patients with a favourable 
bacterial population could have tracheostomies inserted earlier as they could 
(in theory) be at a higher or lower risk dependent on the makeup of their 
oral flora. 
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This study looked solely at tracheostomy tubes garnered from burn injured 
patients, and therefore, studying a wider more varied population would also 
be recommended, as this may also allow for tracheostomies to be examined 
at an earlier stage in the patients‟ illness.  All of the tracheostomies in this 
study were obtained at the point of the patients‟ final extubation.  There 
exist, however, tracheostomies that have a separate inner tube or lumen; the 
use of this type of tube would allow for earlier examination of the nascent 
biofilms, as these inner tubes are changed much more often in critical care, 
indeed several tubes from one patient could be studied in this way in order 
to build up a picture over time. 
The impact biofilms have on burn wound healing has not been fully 
elucidated; that biofilms exist on burns has been proven both in this study 
and elsewhere (Kennedy et al., 2010). Whether or not, or to what extent, 
biofilms affect the speed of burn wound healing has not been fully assessed. 
Currently, it is understood that a burn which has damaged the dermal blood 
supply as well as the skin adnexal structures (such as sweat glands or hair 
follicles) will take longer to heal than a burn which is more superficial. This 
is also coupled with the many confounding factors affecting burn healing 
(temperature and duration of insult, adequacy of first aid, and patient co-
morbidities). Some burn centres use a device called a laser Doppler to 
assess dermal blood flow, and use this as an indicator of likely time that a 
burn will take to heal; it should therefore be possible to quantify the dermal 
blood flow data, and compare it against the bacterial biofilm measures that 
have been used in this study. For example, does an area with little or no 
blood flow predispose to the formation of complex biofilm structures as 
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may be seen using CLSM, or does a „wetter‟ burn such as a partial thickness 
burn wound from a scald have a higher number of bacterial bands on DGGE 
than a „dryer‟ wound produced by a flame burn.  This in turn would have an 
impact on both the use of particular dressings to manage the burn wound, 
but also may direct surgical choices regarding timing of burn wound 
debridement and skin grafting.  Already standard microbiological 
techniques are used prior to skin grafting, mainly to rule out the presence of 
streptokinase producing bacteria which would cause the skin graft to fail 
due to fibrinolytic non-adherence.  Whether further in-depth assessment 
techniques allow for better quantifying of bacterial numbers, the presence of 
bacterial biofilms and therefore the subsequent risk of graft failure remains 
to be seen. 
Similarly, the healing of chronic wounds is multifactorial; studies have 
already shown the presence of bacterial biofilms and large diverse bacterial 
populations in wounds (Hill et al., 2003), but the healing of these wounds is 
often difficult to predict based as it is on a number of factors (arterial or 
venous blood supply, patient co-morbidities, and various treatments 
employed).  A further study looking at the nature of the bacterial biofilm 
within wounds of differing aetiologies, and the variability of these 
populations would be interesting and could lead to the development of 
predictive markers of healing.  Levels of tissue blood oxygenation may be 
measured relatively simply using near-infrared spectroscopy, therefore a 
study comparing bacterial band numbers versus tissue oxygen saturation 
may prove interesting answers about the nature of wound bed biology and 
its subsequent impact on biofilm formation.  A commonly held hypothesis 
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in the management of chronic wounds is that reduction of wound depth will 
more easily allow for epithelial migration over the wound bed subsequently 
leading to epithelial closure and hence full healing.  No studies have been 
undertaken comparing depth of wound with diversity of bacteria or even 
depth and maturity of the biofilm. 
In this study, samples were only obtained following debridement of the burn 
wound in the operating theatre. Partial thickness burns are notoriously 
painful and tissue sampling prior to making the decision of whether or not 
to operate is liable to be a difficult clinical issue to resolve.  A similar 
problem is faced in the management of chronic wounds: not only are they 
often very painful, they are often in tissue that does not respond well to 
local anaesthetic infiltration.  Additionally, removal of the full depth of the 
wound bed risks making the chronic wound, or burn, more complicated and 
more difficult to heal.  While some success has been achieved using in vitro 
techniques such as a constant depth film fermenter to artificially create a 
biofilm, these by their nature cannot adequately duplicate the complex 
myriad of biochemical processes occurring in a biofilm wound bed 
interface.  This study used full thickness punch biopsies of wounds, which 
sampled the full depth of the biofilm, but were limited in the surface area 
sampled.  Nevertheless, it was hoped that the information garnered from 
this technique would correlate with the data from the wound dressings.  The 
technique of using a dressing or a spray-on foam to sample biofilms has 
been tried in various centres, but unfortunately the validation of the data has 
proved difficult.  In essence the sampling of the biofilm, by scraping or by 
ripping it in half using an interface dressing disrupts the very thing which is 
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being investigated.  The techniques used in this study can simultaneously 
measure different aspects of a biofilm and by inference try to build a 
complete composite picture of the biofilm being studied.  A finessing of 
these techniques would be welcomed, for example the development of more 
PNA probes which are specific for different bacterial species yet with a 
limited fluorescent spectrum would allow more probes to be used 
simultaneously. 
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Chapter 6: Conclusion 
 
Comparing the outcomes of this study with the stated aims, 
Aims: 
1. Collection of appropriate clinical specimens for analysis including, 
ETTs, tracheostomy tubes, excised burnt tissue, chronic wound 
biopsies and wound dressings. 
2. Cultural analysis of biofilms from the clinical specimens using 
standard microbiological methods to determine the presence of 
microbial species. 
3. Molecular analysis of clinical specimens to further elucidate the 
microbial diversity and composition of biofilms. 
4. Utilise specific molecular probes to establish the biofilm structure 
and distribution of targeted species within biofilms. 
We can see that all of the initial aims have been achieved. Samples were 
successfully collected for analysis, and subsequently underwent cultural 
analysis using standard microbiological techniques to prove the presence of 
viable microbial species. After this, specimens were subjected to molecular 
analysis, to provide a deeper understanding of the diversity of microbial 
genera present, ranging from oral flora to skin commensurals, and finally 
specific molecular PNA probes were used to provide visual information on 
the structure of biofilms, and the bacterial species therein. 
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Whilst the study has certain limitations, it has shown the benefit of multiple 
techniques for investigating biofilm populations in a wide and varied 
clinical environment.  Some of the work herein has confirmed that already 
postulated by others, yet it has also posed new and challenging questions of 
its own, and highlighted many new and potentially fruitful and ultimately 
clinically beneficial avenues of further study.  There are growing concerns 
both within the clinical environment and the public at large regarding 
microbial infections, antibiotic resistance and the associated public health 
concerns. The inherited antibiotic resistance which is now prevalent in 
many healthcare areas means that a deeper insight and understanding into 
the life cycle and physiology of bacteria is crucial. Biofilms do not seem to 
be a modern evolution of bacteria and fungi, but it is only latterly that 
mankind has become aware of the biofilm phenotype particularly in relation 
to the preponderance of medical devices now available.  The data from this 
study form part of an important first step by increasing our understanding of 
the characterisation of biofilms and the ways in which they can be detected 
across a range of devices; such data are vital if we are to develop products 
and treatments targeted at preventing device related infections. 
The work contained in this study, deepens our understanding of this 
phenotype, and provides insights into avenues where bacterial biofilms may 
be combated. In the future absolute reliance of antibiotics to combat 
bacterial infections will not be enough, instead we will need to rely on early 
identification of a potential biofilms, and then to prevent initial adherence, 
disrupt quorum sensing, artificially induce biofilm dispersal, and physically 
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expunge residual bacteria from the site. It is in these arenas that this study 
hopes to provide the first steps in a clinician‟s antibacterial armamentarium. 
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4. Definitions 
5. Procedure 
6. References 
 
1 PURPOSE 
The purpose of this Standard Operating Procedure (SOP) is to ensure that 
staff involved in research covered by the Human Tissue Act 2004 
understand the procedure and mechanisms for the disposal of human tissue. 
 
The purpose of the Human Tissue Act 2004 is to provide a consistent 
legislative framework for issues relating to whole body donation and the 
taking, storage and use of human organs and tissue. It makes consent the 
fundamental principle underpinning the lawful storage and use of human 
bodies, body parts, organs and tissue and the removal of material from the 
bodies of deceased persons. It introduces regulation of other activities like 
post mortem examinations, and the storage of human material for education, 
training and research. It is intended to achieve a balance between the rights 
and expectations of individuals and families, and broader considerations, 
such as the importance of research, education, training, pathology and 
public health surveillance to the population as a whole. 
 
2 SCOPE 
This SOP applies to all Cardiff University staff responsible for the disposal 
of human tissue for research or teaching purposes.   
 
220 
 
 
3 RESPONSIBLE PERSONNEL 
The Principal Investigator/Research Supervisor is ultimately responsible for 
ensuring that this SOP is correctly applied in the conduct of research and 
each researcher also has individual responsibility for applying this SOP 
when required to do so. 
 
The individual member of staff will be responsible for ensuring that this 
SOP is correctly applied when disposing of human tissue. 
 
The Corporate Compliance Unit (in conjunction with the Research and 
Commercial Development Division) are responsible for ensuring that the 
SOP remains fit for purpose. 
 
4 DEFINITIONS 
Anatomical examination – macroscopic examination of the body of a 
deceased person, or separated parts of such a body, by dissection for 
anatomical purposes (teaching or studying, or researching into the gross 
structure of the human body). 
 
Human Tissue – Any and all constituent parts of the human body formed by 
cells. 
 
Principal Investigator (PI) – is the appropriately qualified individual at each 
project site who has responsibility for the conduct of the project at that site. 
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5 PROCEDURE 
 
5.1 General Principles 
Human tissue must be disposed of with respect.  As an absolute minimum 
tissue identified for disposal should be disposed of separately from other 
clinical waste.   
 
Human tissue samples must be tracked and recorded at all times. 
 
Appropriate methods of destruction, storage and arrangements with people 
involved must be planned and arranged in advance, and considered when 
preparing risk assessments. 
  
No human tissue may be transported from one establishment to another 
unless both establishments have full ethical approval from a recognised 
ethical approval service (REC) or are subject to an appropriate Human 
Tissue Authority (HTA) Licence. 
  
Any recipient of transported tissue must be the subject of and compliant 
with an appropriate ethical approval or HTA licence. 
 
5.2 Organs/tissue removed from the living 
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The Human Tissue Act 2004 makes it lawful to treat as „waste‟ any relevant 
material which has come from a relevant person who was 
- in the course of receiving medical treatment 
- undergoing diagnostic testing or 
- participating in research 
 
Material no longer used, or stored for use, for any scheduled purpose can be 
dealt with as human tissue waste
1
. 
Material taken from the living should normally be disposed of by 
incineration in accordance with current guidelines
2
. Fetal tissue must be 
dealt with as per HTA advice
3
. 
 
5.3 Patients wishes 
Some patients/donors may wish to retain tissue samples or make their own 
arrangements for disposal.  Such requests should be considered on a case-
by-case basis assessing the risk to the patient and others.  Patients should be 
given sufficient information to allow them to make an informed decision.  
 
5.4 Organs/tissues removed after death 
Tissue and organs should be handled in accordance with any reasonable 
wishes expressed by relatives or the deceased person, as long as the method 
                                                          
 
1
 Cardiff University Guidance on the disposal of Hazardous Waste 
http://www.cf.ac.uk/osheu/environment/waste/envwaste.html  
2
 Safe disposal of clinical waste, second edition, HSE books, 1999. 
3
 Code of Practice – the removal, storage and disposal of human organs and 
tissue, Human Tissue Authority, 2006. 
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of disposal is legal.  The time, place and method of disposal must be 
recorded. 
 
5.5 Surplus material from tissue samples 
Such material should be disposed of as human tissue waste.  This includes: 
 
- tissue fragments trimmed from the tissue sample before it is 
processed 
- tissue in the sections trimmed from a wax embedded block before 
the usable sections are cut and 
- unrecoverable material that is washed out of tissue during its 
processing into a waxed block.   
 
5.6 Existing holdings of unidentifiable, and identifiable but unclaimed, 
tissue  
Detailed guidance on the disposal of such collections is available in 
Appendix A of HTA Code 5
4
 
 
5.7 Protective equipment 
Personal protective equipment (lab-coat, gloves) should be worn at all times 
when disposing of human tissue. 
 
5.8 Incineration (witness burns) 
                                                          
 
4
 Code of Practice – the removal, storage and disposal of human organs and 
tissue, Human Tissue Authority, 2006. 
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Witness burns are carried out by the approved OSHEU vendor. 
 
Material for disposal is identified on the database and marked appropriately.  
University staff place the material for disposal is sealable containers, which 
are then labelled correctly. 
The material is then collected by the company carrying out the witness 
burn, supervised by the appropriate member of University staff (generally 
the Person Designated). 
 
5.9 Cremation/Burial 
Cremations and burials are carried out by the approved OSHEU vendor and 
the deceased is moved in a careful and respectful manner in conjunction 
with local procedures and as per any specifically stated wishes of the 
relatives of the deceased.   
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Appendix 9: Puregene protocol for the extraction of bacterial DNA 
 DNA extracted from suspensions of pure bacterial isolate (1 – 5 colonies in 0.5 ml 
suspension solution) using a Puregene® DNA isolation kit (Qiagen) and following the 
“DNA Isolation From 1ml Gram-positive Bacteria Culture Medium” protocol 
(http://www.gentra.com/technical_assistance/ protocols.asp).  
 16S rRNA gene PCR reaction mix: 
o 0.5 µM of forward & reverse primer 
 e.g. either d88 / e94 (Paster et al, 2001) or 27F/1492R (Dymock et al, 
1996) 
o EITHER working concentration of Promega PCR master mix (25 uL) OR working 
concentration of Promega GoTaq green buffer, 3mM MgCl2, 200µM dNTPs + 
1.25U GoTaq polymerase 
o between 1 – 5 µl gDNA extract (approx 0.2 – 0.5 µg) 
o Total reaction volume of 50 µL 
 Use appropriate protocol on PCR machine 
o Protocol for d88 / e94 primer pair: 
 95˚C for 5 min 
 30 cycles of 95°C for 45 s denaturation, annealing at 60˚C for 60 s, and 
extension at 72˚C for 105 s.  The extension step is extended by 5 s per 
cycle.  
 Final extension step, 72°C for 5 min 
 Reactions held at 4°C 
o Protocol for 27F / 1492R primer pair: 
 94˚C for 5 min 
 12 cycles of denaturation at 94˚C for 1 min, annealing at 65˚C for 1 min, 
and extension at 72˚C for 2 min, with the annealing temperature being 
reduced by 2˚C per cycle 
 25 cycles of denaturation at 94˚C for 1 min, annealing at 41˚C for 1 min, 
and extension at 72˚C for 2 min 
 Final extension step, 72˚C  for 10 min 
 Reactions held at 4°C 
 
 For sequencing the PCR products should be purified by precipitation and washing with 
ethanol:  
o Firstly, add 15μl of 5M NaCl and 15 μl of 40% polyethylene glycol (Mol. Wt. 
8000; Sigma) to each PCR reaction volume.   
o Centrifuge (16,000g, 15 min) 
o Aspirate supernatant and replace with 200 µl 70% ethanol (v/v) 
o Repeat centrifugation, aspiration and ethanol washing steps 
o Centrifuge again after 2nd ethanol wash 
o Dry PCR products, either in a vacuum (approx. 30 min) or under a fume hood 
(overnight) – better results with slow drying in fume hood 
o  Re-suspend with 30 µl nuclease-free water.  Products can then be stored in 
freezer as necessary prior to sequencing.   
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Appendix 10: Molecular analysis of microbial communities in 
endotracheal tube biofilms – Paper generated from this MD  
Published: 
Cairns S, Thomas JG, Hooper SJ, Wise MP, Frost PJ, et al. (2011) Molecular Analysis of 
Microbial Communities in Endotracheal Tube Biofilms. PLoS 
ONE6(3): e14759. doi:10.1371/journal.pone.001475 
 
 
Abstract 
Background 
Ventilator-associated pneumonia is the most prevalent acquired infection of patients on 
intensive care units and is associated with considerable morbidity and mortality.  Evidence 
suggests that an improved understanding of the composition of the biofilm communities that 
form on endotracheal tubes may result in the development of improved preventative strategies 
for ventilator-associated pneumonia.   
Methodology/Principal Findings 
The aim of this study was to characterise microbial biofilms on the inner luminal surface of 
extubated endotracheal tubes from ICU patients using PCR and molecular profiling.  Twenty-four 
endotracheal tubes were obtained from twenty mechanically ventilated patients.  Denaturing 
gradient gel electrophoresis (DGGE) profiling of 16S rRNA gene amplicons was used to assess the 
diversity of the bacterial population, together with species specific PCR of key marker oral 
microorganisms and a quantitative assessment of culturable aerobic bacteria.  Analysis of 
culturable aerobic bacteria revealed a range of colonisation from no growth to 2.1×108 colony 
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forming units (cfu)/cm2 of endotracheal tube (mean 1.4×107 cfu/cm2).  PCR targeting of specific 
bacterial species detected the oral bacteria Streptococcus mutans (n=5) and Porphyromonas 
gingivalis (n=5).   DGGE profiling of the endotracheal biofilms revealed complex banding 
patterns containing between 3 and 22 (mean 6) bands per tube, thus demonstrating the marked 
complexity of the constituent biofilms.  Significant inter-patient diversity was evident. The 
number of DGGE bands detected was not related to total viable microbial counts or the duration 
of intubation.   
Conclusions/Significance 
 
Molecular profiling using DGGE demonstrated considerable biofilm compositional complexity 
and inter-patient diversity and provides a rapid method for the further study of biofilm 
composition in longitudinal and interventional studies.  The presence of oral microorganisms in 
endotracheal tube biofilms suggests that these may be important in biofilm development and 
may provide a therapeutic target for the prevention of ventilator-associated pneumonia. 
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Introduction 
Ventilator-associated pneumonia (VAP) is the most frequent nosocomial infection in the 
intensive care unit (ICU) occurring in 8-28% of mechanically ventilated patients [1], [2].  
Mortality rates are high (15-70%) and length of stay is increased, adding a cost of approximately 
$40,000 per patient [3], [4].  The presence of an endotracheal tube is an independent risk factor 
for developing VAP and whilst tracheal intubation is necessary to facilitate mechanical 
ventilation, it also circumvents elements of patients’ innate immunity.  The endotracheal tube 
disrupts the cough reflex, promotes accumulation of tracheobronchial secretions and mucus, 
and provides a direct conduit for pathogenic microorganisms to reach the lower respiratory 
tract, increasing the risk of infection [5].  Significantly, the endotracheal tube may also act as a 
reservoir for pathogens by providing a surface to which they can adhere and form biofilms [5], 
[6], [7].  Polymicrobial biofilms develop rapidly following intubation along the inner lumen of the 
endotracheal tube, with well-organised antibiotic-resistant structures detectable within twenty-
four hours [6], [7].  Furthermore, 70% of patients with VAP have been reported as having 
identical pathogens present within the endotracheal tube biofilm as encountered in the lung [8], 
suggesting that the biofilm represents a significant and persistent source of pathogenic bacteria.   
There is mounting evidence to support the concept that poor oral health is related to 
the aetiology of bacterial VAP and a number of studies have suggested improved oral hygiene 
may be effective at reducing its incidence [9]-[12].  Moreover, potential respiratory pathogens 
such as Pseudomonas aeruginosa and Staphylococcus aureus, that are not generally regarded as 
normal inhabitants of the oral microflora, are isolated more frequently in the dental plaque of 
ICU patients than that of the general population [13], [14].  Given that these potentially 
pathogenic bacteria are capable of adhering to and forming biofilms with the microflora of the 
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oral cavity (i.e. dental plaque), it seems plausible that oral plaque bacteria may also be present 
in biofilms of endotracheal tubes. The presence of oral microorganisms in a biofilm within 
endotracheal tubes may have significance beyond facilitating the adherence of potential 
respiratory pathogens.  Co-aggregation of different microbial species can enhance the virulence 
characteristics of certain bacteria, as well increasing their tolerance to antimicrobials [15].    
The composition of biofilms in general [16], and those originating in the oral cavity, in 
particular, is often misrepresented by traditional cultural analysis [17].  This distortion is 
apparent even for microorganisms amenable to culture, since recovery from a biofilm 
environment is subject to many biases including the ability of species to ‘out-compete’ 
neighbouring species in a given environment and variable replication times.  The oral microflora 
is the most diverse bacterial community in the human body with over 700 species present, and 
cultural analysis is complex.  In addition, given that over 50% of the oral microflora is considered 
to be unculturable or, more correctly, ‘not-yet-cultured’ the community composition is likely to 
be considerably distorted by cultural analysis [17].  
Numerous culture independent approaches are available for the analysis of mixed 
microbial communities.  One of the most useful has proven to be the community profiling 
technique known as denaturing gradient gel electrophoresis (DGGE), a method used extensively 
by microbial ecologists for the study of environmental communities [18], [19].  This approach 
has been successfully applied to the analysis of wounds, corneal ulcers, gastrointestinal tract 
and oral cavity [20]-[24].  DGGE is based on the PCR amplification of phylogenetically useful 
molecules (typically 16S ribosomal DNA) from mixed bacterial communities and the subsequent 
separation of the amplicons on a denaturing electrophoretic gel.  The conditions allow the 
separation of bands of the same length that have different nucleotide composition.  The 
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resulting banding profiles can be analysed to reveal differences in the predominant bacterial 
composition of samples in cross-sectional and longitudinal studies.  
The aim of this study was to characterise microbial biofilms on the inner luminal surface 
of extubated endotracheal tubes from ICU patients.  More specifically the presence of oral 
marker bacteria and VAP associated pathogens was determined by PCR and the usefulness of 
DGGE community profiling for the analysis of the endotracheal tube biofilm was assessed. 
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Materials & Methods 
 
Collection and processing of endotracheal tubes  
A total of 24 extubated endotracheal tubes were obtained from 20 patients (12 male and 8 
female; age range 20-79 years; mean 61 years) who were intubated and mechanically ventilated 
on the ICU of a university teaching hospital.  Two endotracheal tubes were obtained from each 
of two of these patients and one patient provided three endotracheal tubes.  The duration of 
intubation prior to endotracheal tube collection was 12-289 h (mean 92 h).  Prior to the study 
the South East Wales IRB confirmed that the project raised no ethical issues and 
therefore informed consent was not required.  
 
Collected endotracheal tubes were placed in a sealed sterile bag and transferred immediately to 
the microbiology laboratory for processing (undertaken within 1 h of endotracheal tube 
collection).  From the central region of each endotracheal tube two 1 cm sections were cut and 
processed.  One was used for quantitative microbial culture and the other for molecular 
analysis.  The biofilm was aseptically removed from the endotracheal tube lumen using a sterile 
scalpel and this was resuspended in 2 ml of phosphate buffered saline (PBS).  The preparation 
was vortex mixed for 30 s with sterilised glass beads to disrupt any biofilm aggregates.   
 
Quantitation of microbial colonisation of the endotracheal tube 
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The PBS solution containing recovered biofilm was serial decimally diluted 106-fold.  Using a 
spiral-plater system (Don Whitley Scientific, Shipley, UK), 50 µl volumes of each dilution was 
deposited on to agar media.  Quantitation of aerobic microorganisms was achieved by culture 
on blood agar (BA; LabM, Bury, UK) whilst CHROMagar® Candida (CHROMagar, Paris, France) 
was used to detect Candida.  Inoculated agars were incubated for 37°C for 48 h.  A total aerobic 
microbial count from the sections was obtained and expressed as total colony forming units 
(cfu) per cm2 of endotracheal tube section.  In addition, Candida species were identified based 
on colony colour and appearance on CHROMagar® Candida [25] and by biochemical profiling 
using the Auxacolor 2 system (Bio-Rad, Hemel Hempstead, UK) [26]. 
 
16S ribosomal RNA gene-defined 
bacterial colonisation of endotracheal 
tubes 
Sections from each region of the endotracheal tubes were analysed using molecular procedures.  
The method involved the extraction of total DNA from 500 µl of the PBS specimens using a 
Puregene bacterial DNA isolation kit (Qiagen).  A universal bacterial primer pair, 341F and 
534R [27] was then used to amplify the 16S rRNA gene targets within the extracted samples 
using standard PCR and reaction conditions.  Negative controls included a reagent control 
(sterile water served as PCR template) and a sample preparation control (sterile water used in 
place of the original sample and exposed to the entire extraction protocol).  Positive controls of 
template DNA from three known species Porphyromonas gingivalis NCTC 11834T, 
Staphylococcus aureus NCTC 6571 and Streptococcus mutans NCTC 20523T) were also included.  
PCR products were then resolved by denaturing gradient gel electrophoresis (DGGE) as outlined 
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below with the products from the control microorganisms serving as markers to facilitate gel 
normalisation.  
 
Denaturing Gradient Gel Electrophoresis 
Polyacrylamide gels were cast using a model 385 gradient former (Bio-Rad).  All gels comprised 
of 1×Tris-acetate-EDTA (TAE) buffer with 10% (w/v) acrylamide, 0.1% (v/v) TEMED, and 0.1% 
(w/v) ammonium persulphate (all materials from Sigma, Poole, UK).  Gels also contained a 
parallel 30-60% gradient of denaturants (where 100% denaturant concentration was equal to 7 
M urea and 40% [v/v] deionised formamide; Sigma).   
 
Parallel DGGE was performed using the Bio-Rad D-Code system.  Products from endotracheal 
tube extract PCRs were run alongside a marker comprising of an equal mixture of PCR products 
from the three known bacterial stains.  DGGE was run in 1×TAE buffer at 56°C and 160 V/cm2 for 
30 min, followed by 40 V/cm2 for 16 h. 
DGGE gels were stained with SYBR® Green I nucleic acid gel stain (Sigma) at approximately 4°C 
for 30 min.  Banding patterns were visualised under UV light using a GelDoc system (Bio-Rad).  
Gels were then aligned and standardised using the reference markers and GelCompar II 
software (Applied Maths, Sint-Martens-Latem, Belgium).  The presence of individual bands in 
each profile was assessed using the same software, set to a 1% tolerance of band matching.  
Using Dice's coefficient and the UPGMA clustering method, a dendrogram of genetic similarity 
between samples was calculated.   
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Detection of bacteria by species-specific PCR 
Species-specific detection of the oral marker organisms S. mutans and P. gingivalis, together 
with the accepted VAP causing organisms P. aeruginosa and S. aureus was also undertaken 
according to previously published protocols [28]-[31].  
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Results 
 
Culture of microorganisms from biofilms recovered from endotracheal tubes 
The results of microbial culture are summarised in Table 1.  In the case of five endotracheal tube 
samples, no microbial growth was observed.  The viable bacterial aerobic counts ranged 
between 2×104 and 2.1×108 cfu/cm2 of endotracheal tube section.  In 5 endotracheal tubes no 
viable aerobic bacterial growth was detected, although in one of these tubes Candida was 
cultured.  There was no apparent relationship between the determined bacterial load on the 
sample and the duration of intubation.  In six endotracheal tubes from five patients, C. albicans 
was isolated following subculture on CHROMagar®Candida and biochemical identification.   
 
DGGE estimation of species richness 
The number of bands obtained by DGGE analysis is shown in Table 1 and typical profiles are 
presented in Figure 1.  An average of 6 bands (range 3 to 22) per endotracheal tube sample was 
detected and the similarity in banding profiles ranged between 20 and 90% (Fig. 2).  There was 
no apparent relationship between the duration of intubation and the number of DGGE bands 
detected, nor was there a high level of similarity for the DGGE profiles obtained for multiple 
endotracheal tubes from the same patients (i.e. patient 2, tubes 2 and 7; patient 17, tubes 21 
and 24).  However, similarity at 75% was evident for the profiles of two endotracheal tubes (14 
and 15) which were obtained from patient 12 (Fig. 2).  DGGE was shown to be reproducible with 
consistent profiles being generated upon both repeat and duplicate testing.  The community 
profiles obtained demonstrated considerable inter-patient and intra-patient diversity.   
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Detection of marker bacteria by species specific PCR 
At least one of the oral marker bacterial species (S. mutans or P. gingivalis) was detected by PCR 
for 9 different patients.  Of these 9 patients, PCR was positive only for S. mutans in 4 patients, as 
was the case for P. gingivalis, the endotracheal tube from one patient (Patient 19, endotracheal 
tube 23) was positive for both oral bacterial species (Table 1).  Figure 3 shows a typical result of 
the P. gingivalis specific PCR using template DNA obtained from the biofilms recovered from the 
endotracheal tubes.  The detection of the VAP associated species P. aeruginosa and S. aureus 
occurred in 4 and 6 patients, respectively.  The patient distribution of these microorganisms is 
presented in Table 1. 
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Discussion 
Sottile and colleagues first suggested a link between the endotracheal biofilm and 
pulmonary infection [32], and this was supported by identical pathogenic bacteria being present 
in the lung of patients with VAP and the endotracheal biofilm [8].  This concept has been 
substantiated by a number of experimental and clinical studies, which have used antimicrobial 
(silver coated) endotracheal tubes to inhibit biofilm formation [33]-[36], reduce colonisation of 
the airway [33]-[36] and decrease the incidence of VAP [37].  The reduction in the number and 
delay of onset of VAP in a large clinical trial is encouraging, however, bacteria can develop silver 
resistance [38] and other strategies, which target biofilm formation, may prove to be valuable.  
In order to prevent endotracheal tube biofilm formation, knowledge of the source of the 
microorganisms involved is essential.  
Improved oral hygiene has proved to be an effective strategy for reducing VAP [9]-[12] 
and since potential respiratory pathogens are isolated from dental plaque (a biofilm) of 
mechanically ventilated patients [13], [14], we hypothesised that microbes which constitute the 
normal oral flora might be present in the endotracheal biofilm.  In an in vitro Ventilator-
Endotracheal-Lung model incorporation of representative species of the oral microflora prior to 
the addition of pathogens traditionally associated with respiratory infection, augments the 
subsequent biofilm (JG Thomas, unpublished data), raising the possibility that normal oral 
microflora may represent pioneering colonising species and promote subsequent endotracheal 
tube biofilm development.  The inner surface of the endotracheal tube provides a unique 
environment of high shear forces, bi-directional flow, and a restricted immunological 
environment, which favours a sessile rather than planktonic bacterial life form and thus biofilm 
formation.  The endotracheal biofilm is a complex three-dimensional structure with cyclical 
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bacterial communities many of which are difficult to isolate by conventional planktonic culture 
techniques [39].  Bacterial species regarded as appropriate markers of the oral microflora (P. 
gingivalis and S. mutans) were detected in 9 of the 20 patients using species specific PCR.  
Streptococcus mutans was selected as a target species due to its recognised ability to promote 
biofilm formation, whilst P. gingivalis was included as a representative species of strictly 
anaerobic bacteria.  
Interestingly, Candida albicans, which is also a common coloniser of the oral cavity, was 
detected by culture in the endotracheal tubes from 5 patients.  This yeast produces filamentous 
growth forms, which could readily enhance formation and structural stability of the biofilm [40].  
Interactions between individual elements of the oral microflora and their capacity to form 
biofilms are complex.  Streptococcus mutans enables C. albicans to bind to synthetic surfaces, 
coaggregation being dependent on the production of water insoluble glucans and direct cell-cell 
contact [41], [42], [43].  Candida albicans also demonstrates synergistic and antagonistic 
interactions with S. aureus and P. aeruginosa, which account for 20% and 24% of VAP 
respectively [44].  Pseudomonas aeruginosa can neither bind nor kill yeast-forms of C. albicans, 
however this bacterium can form a dense biofilm on C. albicans filaments [45].  Significantly, P. 
aeruginosa virulence factors associated with human disease (e.g. secreted phospholipase C) 
have also been linked with biofilm formation and killing of the filamentous forms of C. albicans 
which might then provide nutrients for bacterial biofilm development [45].  Colonisation of the 
respiratory tract with C. albicans is associated with an increased risk of Pseudomonas VAP [46], 
and conversely antifungal treatment of patients demonstrating airway colonisation with 
Candida spp. have less P. aeruginosa VAP [47].  An anti-candidal approach has also been 
successful in reducing the biofilm on laryngeal prosthetic devices [48].  The variation in aerobic 
bacterial counts between patients ranged between 0 and 2.1×108 cfu/cm2.  The reason for such 
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variation (including the absence of bacterial growth in 5 endotracheal tubes) could in part relate 
to the effectiveness of the seal between endotracheal tube cuff and mucosal wall of the trachea.  
A totally effective seal would prevent leakage of pooled secretions from above the cuff leading 
to subsequent contamination of the endotracheal tube lumen and lungs.  The effectiveness of 
the seal will vary with pressure variation between the balloon of the cuff and by the extent of 
‘folding’ in the cuff material.  Micro-channels generated by such folds can serve as conduits for 
microbial passage.  Oral hygiene parameters of the patients were not assessed in this study and 
it may be the case that patients with poorer oral hygiene exhibited higher endotracheal tube 
contamination and vice versa.  Some loss of microbial viability between the time of removal of 
the endotracheal tube from the patient and its subsequent processing for culture is likely, 
despite the time between these procedures being kept as short as possible.  The fact that 
microbial DNA was obtained from these endotracheal tubes would suggest microbial cells 
(viable or non-viable) had been present and highlights the benefit of supplementing the culture 
analysis with molecular investigation. 
The present study has shown that DGGE can be used to generate community profiles of 
the microflora associated with endotracheal tubes.  This non-cultural approach has revealed 
significant microbial diversity with between 3 and 22 (mean 6) bands present per sample.  These 
results are similar to those of other studies of microbial communities assessed by non-cultural 
methods.  In the majority of systems studied, molecular methods detect the presence of a 
greater number of species than culture alone.  For example, in the analysis of failed root canal 
lesions, between one and 26 bands (mean six) were detected by molecular methods compared 
to 3-4 isolates detected by culture [49].  
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There is no direct correlation between the number of bands detected by DGGE and the 
number of species present in a sample since numerous factors affect band number including 
sampling, PCR and differential DNA extraction biases, heteroduplex formation and divergence 
within multicopy number rDNA families.  However, following excision and sequence analysis of 
individual bands present on DGGE gels, it has been reported that on average each band 
represents not just one, but an average of 2.7 phylotypes or bacterial species [50].  Therefore, 
the species richness within the endotracheal tube may be even greater than that implied in the 
current study.   
Previous studies of complex human microbial communities using DGGE have revealed 
similar levels of diversity to that encountered in the present study.  In a study of the microflora 
associated with dental abscesses from two different geographical locations a total of 99 distinct 
bands were detected [51].  In both this and an earlier study of root canal lesions many of the 
observed bands were shared between patient profiles [49].  Although a small number of shared 
bands were observed in our current study, the inter-patient profile diversity was generally 
greater when compared to previous studies.  Moreover, there was significant intra-patient 
diversity for the three patients from whom more than one endotracheal tube community profile 
was obtained.  The marked diversity revealed is perhaps not surprising given that the 
oropharyngeal microflora is considered to be the most complex in the human body with more 
than 700 different species present of which over 50 % have not yet been cultivated [17].  
Of the numerous culture-independent approaches that are available, DGGE has proven 
useful in the analysis of many different microbial communities, both environmental and those 
associated with human infection.  The principle advantage is the ability to analyse those bacteria 
which are either difficult to culture or which have not yet been cultured.  The presence in 
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bronchoalveolar lavages (BALs) of both novel microorganisms and those that are already 
‘known’ on the basis of sequence characterisation but have not yet been cultivated, has been 
demonstrated [52].  This research employed a ribosomal RNA cloning and sequencing approach 
which provided valuable information on the microbial composition of BALs obtained from 
traumatic ICU patients.  The approach demonstrated considerable diversity of bacterial types 
present in BAL samples with over 54 different bacterial types present, of which 38 had not 
previously been detected at this site.   
Both DGGE and the cloning/sequencing approach have a role to play in the analysis of 
complex microflora including VAP associated bacteria.  DGGE is less technically demanding, less 
labour intensive and more affordable.  Consequently, it may be used for the simultaneous 
analysis of multiple samples, facilitating the direct comparison of bacterial communities from 
numerous sources and the effects of interventions in longitudinal studies.  DGGE has been used 
successfully to demonstrate differences in profiles between two distinct patients groups, both in 
geographic and clinical contexts.  The method has been used to demonstrate that both the 
diversity and complexity of the plaque microflora was less in children with caries compared to 
caries free children [50].  Differences in DGGE profiles of dental abscesses of Brazilian and USA 
origin have also been shown [51].  In contrast to many other profiling techniques, DGGE has the 
advantage that if marker signatures or bands appear to be significant, the bands can be excised 
and sequenced for further characterisation.  In this way, a better characterisation of the 
microflora associated with dental caries has been demonstrated [51].  Furthermore, as in the 
current study, the technique can incorporate marker profiles of species of interest [53].   
Care must however be taken if DGGE is used as a technique for species identification as it 
does have severe limitations in this regard.  Since sequences from different species can co-
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migrate to the same position in the gel [54] identification based on excised band sequencing 
requires every fragment to be singularised before sequencing.  This can involve either another 
gradient gel electrophoresis step or a time-consuming cloning process [55].  Furthermore if 
comparison is made with specific PCR analysis then consideration has to be made to the lower 
sensitivity of DGGE when compared to PCR directed against a specific microorganism [53].  It has 
been reported that the sensitivity of DGGE in a mixed community is about 103 cells [56].  
However, in terms of community profiling this may not necessarily be a disadvantage since 
DGGE will reflect the predominant microorganisms present and in the field of medical 
microbiology, numerical predominance is a fundamental principle.  
In summary, a combination of PCR, molecular profiling and culture was used to ascertain the 
bacterial diversity and presence of specific marker microorganisms in endotracheal tube 
biofilms.  In this context, molecular profiling using DGGE demonstrated considerable biofilm 
compositional complexity and inter-patient diversity and, as a method that facilitates the study 
of shifts in the ecological balance of biofilms, will prove invaluable in future longitudinal or 
interventional studies.  We hypothesised that oral microorganisms form part of the 
endotracheal tube biofilm and, indeed, demonstrated that these bacteria were present.  This 
observation offers the possibility of alternative therapeutic strategies, not necessarily based on 
anti-infective agents, for preventing VAP which may include mechanically reducing oral plaque, 
the targeting of quorum sensing signal molecules [57], [58] or modulation of the oral microflora 
[59].  
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Figure 1. DGGE profiles of PCR amplified 16S rRNA from marker bacteria and endotracheal tube 
(ETT) biofilm samples 
 
Figure 1a: 1, P. gingivalis; 2, S. aureus; 3, S. mutans; 4, mixed marker of P. gingivalis, S. aureus 
and S. mutans; 5, ETT1; 6, ETT2; 7, ETT3; 8, ETT4; 9, ETT5; 10, ETT7; 11, ETT8; 12, ETT9; 13, 
ETT10; 14, ETT11; 15, mixed marker of P. gingivalis, S. aureus and S. mutans. 
 
Figure 1b: 1, mixed marker of P. gingivalis, S. aureus and S. mutans; 2, ETT12; 3, ETT14; 4, ETT15; 
5, ETT19; 6 ETT21; 7, ETT25; 8, ETT26; 9, mixed marker of P. gingivalis, S. aureus and S. mutans. 
 
Figure 1c: 1, Plaque sample control; 2, mixed marker of P. gingivalis, S. aureus and S. mutans; 3, 
ETT13; 4, ETT16;5, ETT17; 6, ETT18; 7, ETT20; 8, ETT22; 9, ETT23; 10, ETT24; 11, mixed marker of 
P. gingivalis, S. aureus and S. mutans.  
 
Figure 2.  Cluster analysis with Ward’s algorithm based on the Dice coefficient demonstrating 
the diversity in DGGE profiles generated from endotracheal tube (ETT) biofilms. 
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Table 1. Band numbers obtained by DGGE analysis, PCR and culture results for selected organisms 
 
   DGGE PCR detection Culture 
Patient number Endotracheal tube Hours 
intubated 
Number of bands S. mutans P. gingivalis P. aeruginosa S. aureus  C. albicans Total aerobic bacterial count  
cfu/cm
2 
 endotracheal tube 
1 1 33 5      2.3×107 
2 2 108 16 +    + 6.3×106 
2 7 94 4      2.8×107 
3 3 60 17     + 1.8×106 
4 4 95 14   +   6.1×106 
5 5 43 22     + 2.0×104 
6 10 41 9  +  +  0 
7 8 289 8      3.0×107 
8 9 173 15 +  + + + 4.0×104 
9 11 198 10    +  2.1×108 
10 12 56 6  +    2.0×106 
11 13 137 5      7.7×106 
12 14 12 3      4.0×104 
12 15 20 5     + 0 
12 16 96 6 +    + 1.6×105 
13 17 224 4      0 
14 18 49 5  +  +  0 
15 19 29 3      4.0×104 
16 20 67 7 +   +  1.3×107 
17 21 20 5   +   0 
17 24 143 5   +   7.7×106 
18 22 76 4  +  +  1.4×107 
19 23 32 9 + +    1.8×105 
20 25 125 3      8.2×106 
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Appendix 11:DVD -  Bacterial sequences from 16S rDNA 
PCR 
 
Appendix 12: DVD – Further images of PNA FiSH CLSM 
 
